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Abstract
The hypothalamus is a key integrative center in the brain consisting of diverse cell types
that differ in morphology and the neuropeptides they produce. These neuropeptides
are required for the pivotal functions of the hypothalamus including homeostasis,
reproduction, cognitive behavior and stress response. Despite the knowledge of several
transcription factors important for the hypothalamic neuronal development, little is
known about how these transcription factors act in concert to generate the amazing
diversity of neuron types present in the hypothalamus. In this study, I focus on the
development of two hypothalamic areas in zebrafish, the preoptic area and the posterior
hypothalamus. The preoptic area plays an important role in homeostasis and stress
response whereas the posterior hypothalamus is important for cognitive behavior in
mammals. Consistent with their different functions, these two areas are composed of
distinct neuron types. However, the mechanism that contributes to this difference remains
largely unknown. In this thesis, I characterize the roles of four transcription factors,
Fezf2, Otp, Sim1a and Foxb1.2, for the development of the preoptic area and posterior
hypothalamus. I show that early in development Fezf2 is important for the regionalization
of the posterior hypothalamus, while later Fezf2 interacts with Otp, Sim1a and Foxb1.2 to
specify distinct neuron types. Interestingly, these regulatory interactions change during
development and vary between the anterior and the posterior hypothalamus, contributing
to the formation of regional differences in these areas. Further, these interactions generate
different domains in the posterior hypothalamus and contribute to the specification of
distinct neuron types such as those that produce vasoactive intestinal peptide (VIP) and
urotensin 1 (Uts1). In summary, this study provides the first regulatory and molecular
map of the posterior hypothalamus and demonstrates that the specification of preoptic
and posterior hypothalamic neurons require the dynamic regulatory interactions of Fezf2
together with Otp, Sim1a and Foxb1.2.
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Kurzzusammenfassung
Der Hypothalamus ist das integrative Hauptkontrollzentrum im Gehirn, bestehend
aus verschiedenen Zelltypen, welche sich in ihrer Morphologie und den Neuropeptiden
die sie produzieren, unterscheiden. Diese Neuropeptide werden für die essentiellen
Funktionen des Hypothalamus, wie Homöostase, Reproduktion, kognitives Verhalten
und Stress Antwort benötigt. Trotz der Kenntnis von einigen Transkriptionsfaktoren,
welche für die neuronale Entwicklung des Hypothalamus wichtig sind, ist es immer noch
kaum verstanden, wie Transkriptionsfaktoren zusammenarbeiten um die erstaunliche
Vielfalt an Neuronen im Hypothalamus zu bilden. In dieser Arbeit konzentriere ich
mich auf die Entwicklung zweier Regionen des Hypothalamus im Zebrafisch, die
präoptische Region und der posteriore Hypothalamus. Die präoptische Region hat
eine wichtige Aufgabe bei der Aufrechterhaltung der Homöostase und der Stress
Antwort, wohingegen der posteriore Hypothalamus beim kognitiven Verhalten in
Säugetieren eine Rolle spielt. Entsprechend ihrer vielzähligen Aufgaben sind diese zwei
Regionen aus verschiedenen Neuronentypen aufgebaut. Der Mechanismus der zu dieser
Diversität führt, ist jedoch kaum verstanden. In dieser Doktorarbeit charakterisiere
ich die Aufgabe von vier Transkriptionsfaktoren, Fezf2, Otp, Sim1a und Foxb1.2,
für die Entwicklung der präoptischen Region und des posterioren Hypothalamus. Ich
zeige, dass in der frühen Entwicklung Fezf2 wichtig für die Regionalisierung des
posterioren Hypothalamus ist, während Fezf2 später mit Otp, Sim1a und Foxb1.2
interagiert, um bestimmte Neuronentypen zu generieren. Interessanterweise ändern sich
diese regulatorischen Interaktionen während der Entwicklung und variieren zwischen
anterioren und posterioren Hypothalamus. Das trägt dazu bei regionale Unterschiede in
diesen Arealen zu etablieren. Zudem gestallten diese Interaktionen verschiedene Domänen
im posterioren Hypothalamus, wo sie zur Festlegung von speziellen Neuronentypen
beitragen, welche zum Beispiel vasoaktives intestinales Peptid (VIP) und Urotensin 1
(Uts1) produzieren. Zusammenfassend bietet diese Doktorarbeit die erste regulatorische
und molekulare Karte des posterioren Hypothalamus. Außerdem zeigt sie, dass die
Entwicklung von präoptischen und posterior hypothalamischen Neuronen die dynamische
regulatorische Interaktion von Fezf2 zusammen mit Otp, Sim1a und Foxb1.2 benötigt.
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11 Introduction
The central nervous system (CNS) is a highly complex structure composed of billions of
neurons, oligodendrocytes and astrocytes. Despite a large amount of studies addressing
the development of the CNS, the mechanism for the generation of the different neuronal
cell types is not fully understood. In vertebrates a single factor is not sufficient to induce a
distinct neuronal fate but a combination of factors is necessary. These factors are mostly
transcription factors (TF) that act together in a temporally and spatially restricted
regulatory code (Cayouette et al., 2006; Guillemot, 2007; Shirasaki and Pfaff, 2002).
1.1 Transcription factors in cell type specification
Transcription factors are proteins that bind to specific DNA sequences within the
enhancer region of a gene acting as an activator or a repressor of transcription (Latchman,
1997). The enhancer regions of genes contain several binding sites for TFs, also called
response elements, which are able to respond to developmental cues or to regulatory
signals. Transcription factors have specific DNA-binding domains and are classified on
the basis of these domains such as homeodomain (HD) TF, zinc-finger TF or basic
helix-loop-helix (bHLH) TF. Since approximately 8% of the vertebrate genome codes
for transcription factors (Babu et al., 2004), the combinatorial action of a subset of
the transcription factors is thought to be sufficient for the unique regulation of every
gene in the genome. However, how these TFs form a temporally and spatially restricted
regulatory code for cell type specification still remains elusive. In addition, transcription
factor often interact with other proteins (other transcription factors or co-regulatory
proteins), changing binding specificity and therefore changing their function. This fact
could results in a re-deployment of early regulators to become a part of a subtype-specific
combinatorial code (Baumgardt et al., 2007; Lee et al., 2008; Shirasaki and Pfaff, 2002).
Broadly, there are two different types of TFs: regulators that are constitutively active
nuclear factors in every cell and at every time point and those that are highly regulated.
Constitutively active regulators have important facilitating roles in the transcription of
genes such as structural proteins or ubiquitous metabolic enzymes. Further, these TFs
also participate in the formation of enhanceosomes together with TFs that are highly
regulated (Brivanlou and Darnell, 2002). These regulatory TFs are classified into two
broad categories: the first class are developmental or cell-type specific TFs and the second
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class are signal-dependent TFs that are inactive until the presence of an appropriate
intra- or extracellular signals (Brivanlou and Darnell, 2002). For this thesis the cell-type
specific transcription factors are of particular interest since these TFs are important for
the formation of distinct neuron types.
How neuron types in the cortex, the retina or within the spinal cord are specified
has been extensively studied over the last decades. The spinal cord is so far the most
extensively studied area of neuron subtype specification. In the ventral neural tube of the
spinal cord at least five different subtypes of neurons are present. Each of them expresses
a unique combination of transcription factors and emerges in a precise spatial order from
the proliferating progenitor cells along the dorsoventral axis (Shirasaki and Pfaff, 2002).
The dorsoventral patterning of the spinal cord is achieved through a secreted gradient of
Sonic hedgehog (Shh). Therefore, different Shh concentration leads to the formation of a
distinct neuronal cell type, which is dependent on the distance from the Shh source. This
graded Shh signaling leads to the expression of the so called class I and class II proteins
based on whether their expression is repressed or induced by Shh. Cross-repressive
interactions between class I and class II proteins (HD and bHLH proteins) that abut
a common progenitor domain lead to the establishment of individual progenitor domains
(Briscoe and Novitch, 2008; Shirasaki and Pfaff, 2002). Each of the progenitor domains
gives rise to specific neuronal subtypes indicating that neuronal subtype specification
involves the combinatorial use of a limited number of TFs (Shirasaki and Pfaff, 2002).
Other mechanisms have been suggested to explain how the great neuronal diversity
can be achieved by a small number of common factors. In the vertebrate retina, HD
proteins determine the laminar position of the retinal cells while bHLH proteins like Ath5
determine their time of birth. In the retina the time of birth is tightly correlated with
the neuron type that is produced (Guillemot, 2007). The lineage and the number of cell
divisions of the progenitor cell is important to determine which set of TFs are expressed
by the progenitor and therefore also by the daughter cell. In addition, the orientation
of cell divisions is used to define whether the progenitor cell undergoes a symmetric or
an asymmetric cell division. To ensure that the right amount of retinal subtypes will
be established, terminal differentiated neuronal subtypes provide a feedback inhibition
signal (Cayouette et al., 2006). Also cerebral cortex neurons are born on a predictable
schedule depending on timing mechanisms achieved by cell-intrinsic and environmental
factors. Similar to retinal cells, the multipotent progenitor cells in the cortex undergo
repeated asymmetric cell divisions to generate neuronal subtypes in their normal in vivo
order. Once a progenitor generates neurons of a particular layer, they can not generate
earlier born neurons. This timing mechanism is encoded within the progenitor cells by
distinct TF expression, generated by a division pattern, which leads to the generation
of characteristic neuronal lineage trees (Shen et al., 2006). The patterning of the cortex
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takes place by gradients of extracellular signaling molecules, like Shh, that comes from
instructive cell populations also known as local organizers. This graded signaling of
morphogens leads to a distinct expression of TF that specify the neocortical progenitors
(Molyneaux et al., 2007; Scholpp and Lumsden, 2010).
In contrast to spinal cord, retina and cortex our understanding of the mechanisms
by which hypothalamic neurons are specified is limited.
1.2 Development of the hypothalamus
The hypothalamus is an evolutionary ancient key integrative center in the brain
pivotal for the survival and the propagation of the vertebrate species. It orchestrates
complex adaptive behaviors that regulate multiple physiological functions including stress
response, food intake, thermoregulation, fluid homeostasis and reproductive behavior.
The hypothalamus can be grossly divided in the anteroposterior extent into four major
areas, the preoptic, the anterior, the tuberal and the mammillary area. In addition, it
can be divided in the mediolateral direction into the periventricular, the medial and
the lateral region (Saper, 2004; Simerly, 2004; Swanson, 1987; Szarek et al., 2010).
More than a dozen hypothalamic nuclei with specific functions and different cell types
are intermingled within different hypothalamic regions. In the lateral hypothalamus,
for example, the lateral hypothalamic area (LHA) can be found. A lesion of this area
leads to a reduction in food intake (Jain et al., 1999). Another nucleus of the lateral
hypothalamus is the supraoptic nucleus (SON), which is implicated in fluid homeostasis
and lactation (Swanson, 1987). The medial region of the hypothalamus contains the
ventromedial nucleus (VMH), which is most commonly associated with satiety or sexual
behavior (Saper, 2004). A special nucleus of the medial region of the hypothalamus is
the mammillary body (MB) associated with spatial and working memory and implicated
in neurodegenerative disorders such as the Korsakoff syndrome (Beracochea, 2005;
Radyushkin et al., 2005). Notably the periventricular region of the hypothalamus contains
most of the well-delineated nuclei of the hypothalamus including the arcuate nucleus
(ARC), which is important for feeding behavior and autonomic nervous system control
and the suprachiasmatic nucleus (SCN) responsible for controlling endogenous circadian
rhythms. The paraventricular nucleus (PVN) within the periventricular region of the
hypothalamus is a particularly good example for the fact that each nucleus typically
has multiple functions: The PVN is important for stress response, maternal behavior,
lactation and fluid homeostasis.
Critical for the diverse function of the hypothalamus are the cells that secrete
neurohormones located throughout the entire hypothalamus. These neurosecretory
cells can be divided into two groups: the magnocellular neurosecretory cells and the
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parvocellular neurosecretory cells. The magnocellular neurosecretory system directly
secretes the neurohormones arginine-vasopressin (AVP) and oxytocin (OXT) into the
posterior pituitary. The neurohormones AVP and OXT are expressed in the PVN and
in the SON. In contrast, the parvocellular neurosecretory system controls the release of
neurohormones into the anterior pituitary through the median eminence. Currently there
are seven parvocellular neurosecretory neuronal subtypes known (Szarek et al., 2010):
thyrotropin-releasing hormone (TRH, located within the PVN), corticotropin-releasing
hormone (CRH, located within the PVN), growth hormone-releasing hormone (GHRH,
located within the ARC), somatostatin (SS, located within the anterior periventricular
nucleus), gonadotropin-releasing hormone (GnRH, located within the ARC), dopamine
(DA, located within the ARC) and the gonadotropin-inhibiting hormone (GnIH, located
within the dorsomedial nucleus).
1.2.1 The early patterning of the diencephalon
1.2.1.1 The neural plate
Studies in mouse, chicken and fish revealed that the patterning of the neural plate and the
formation of the diencephalon is highly conserved among vertebrates (Blackshaw et al.,
2010; Cavodeassi and Houart, 2012; Scholpp and Lumsden, 2010; Toro and Varga, 2007;
Wilson and Houart, 2004). Although the forebrain is a highly complex structure, it derives
from a relatively simple sheet of neuroepithelial cells, the neural plate. In zebrafish within
the neural plate the anterior-posterior (A-P) axis are determined by caudalizing factors,
which are secreted by the germ ring that moves during epiboly towards the vegetal pole.
These caudalizing factors are mainly Wnt, but include also Fgf and Bmp, that form
global gradients by diffusion and also by the movement of the germ ring (Wilson and
Houart, 2004). A source of antagonists of the caudalizing factors is the prechordal plate
that migrates rostrally beneath the neural plate. Due to the gradients of the caudalizing
factors, domains with distinct TF expressions are formed within the neural plate. In the
anterior neural plate, pitx3 is expressed defining an area important for adenohypophysis
placode specification (Toro and Varga, 2007). Another important TF expression domain
within the neural plate is the domain of the Drosophila odd-paired like homolog zic1.
Fate map studies showed that Zic1-positive cells are retinal precursors that form the
eye field (Toro and Varga, 2007). A factor that abuts the zic1 expression domain is the
forkhead homolog foxb1.2. foxb1.2 is exclusively expressed posterior to the eye field by
diencephalic precursor cells. Interestingly, the prospective hypothalamus is demarcated
by a median protrusion of this foxb1.2 expression domain (Staudt and Houart, 2007;
Toro and Varga, 2007). After gastrulation these prospective hypothalamic cells move
anterior within the neural plate displacing the more dorsal forebrain tissue laterally.
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This cell movement depends on Nodal signaling (Varga et al., 1999) and is important for
the formation of left and right eyes from the single zic1 expression domain (Toro and
Varga, 2007; Wilson and Houart, 2004). Importantly, by the end of gastrulation these
hypothalamic precursors also start to express Hedgehog (Hh), which in concert with
nodal signaling is important for the hypothalamus specification (Mathieu et al., 2002).
1.2.1.2 The patterning of the diencephalon
Subsequent to the initial regionalization of the neural plate, local cell populations like
the floorplate or the isthmic organizer are established to build local sources of signals
within the developing forebrain. By the end of gastrulation these local organizers lead
to an initial regional patterning by inducing genes that start to subdivide the neural
plate into discrete areas displaying the features of the mature CNS (Wilson and Houart,
2004). One of the first local organizers established during the CNS patterning is the
mid-hindbrain boundary (MHB). This local organizer secretes posteriorizing signals like
Wnt, which is important for the A-P patterning of the diencephalon (Cavodeassi and
Houart, 2012; Sylvester et al., 2010). In addition, the anterior neural ridge expresses a
Wnt antagonist Six3 leading to a region of low graded Wnt activity within the forebrain.
Six3 is repressed by enhanced Wnt activity and vice versa, Six3 activity represses the
transcription of Wnt genes (Cavodeassi and Houart, 2012; Wilson and Houart, 2004).
Within this region of graded Wnt activity, other transcription factor expression domains
are established. In the anterior region of low Wnt activity close to Six3, the expression
of the zinc finger protein Fezf2 is established whereas in the more posterior region of
higher Wnt activity the expression of the iroquois homeobox protein Irx3 and of the
orthodenticle homolog Otx is initiated (Scholpp and Lumsden, 2010; Wilson and Houart,
2004). The Fezf2 domain directly abuts the Otx domain whereas there is a small gap
between the Fezf2 and the Irx3 domain. The repressive interaction of these factors
define a sharp boundary where within the Fezf2 and Irx3 interspace the zona limitans
intrathalamica (ZLI) is established (Blackshaw et al., 2010; Hirata et al., 2006; Jeong
et al., 2007; Scholpp and Lumsden, 2010; Staudt and Houart, 2007; Wilson and Houart,
2004). Within the ZLI, is an organizing cell population called mid-diencephalic organizer
(MDO), whose signals are crucial for the establishment of the entire thalamus. After
the correct positioning of the ZLI the expression of Shh is induced. The Shh expression
therefore expands progressively from the basal plate to the roof plate (Scholpp and
Lumsden, 2010) maintained by canonical Wnt signaling (Mattes et al., 2012). This
progressive maturation from ventral to dorsal is mediated by the expression of retinoic
acid in the roof plate that blocks Shh expression. The fully mature MDO expresses genes
of the Hedgehog family and other secreted signaling molecules in all vertebrates but the
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significant organizing function is mediated by Shh itself (Scholpp and Lumsden, 2010).
Following the exposure to Shh the prethalamus and the thalamus acquire their distinct
fates. Shh signaling also results in the zonation of proneural gene expression leading
to the rostral and the caudal thalamus and to the specification of thalamic neuronal
subtypes (Blackshaw et al., 2010; Scholpp and Lumsden, 2010).
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Fig. 1.1: The patterning of the diencephalon
A scheme that summarizes the interaction of different signaling pathways to establish
the ZLI and the prospective hypothalamus in zebrafish. The Wnt source is shown in blue
while the Six3 source is shown in orange. Adapted from Sylvester et al. (2010). A lateral
view is shown and anterior is to the left.
In contrast to the thalamus, the patterning of the hypothalamus is much less
understood. Apart from the establishment of the ZLI an additional function of Shh
is the dorsal-ventral (D-V) patterning of the prospective forebrain in concert with BMP
signaling. BMP, which is expressed in the roof plate, opposes the Shh action that is
expressed in the floor plate establishing a graded D-V axis (Cavodeassi and Houart, 2012).
All prospective hypothalamic cells are Shh-positive and through the opposing interaction
of Shh with BMP ventral forebrain cells are guided towards a hypothalamic rather than
a floorplate fate (Dale et al., 1997). Additionally, there are also locally derived BMPs
mediating the downregulation of Shh expression in the posterior-ventral hypothalamus
(Manning et al., 2006). This downregulation of Shh induces the expression of Fgf and of
the empty spiracles homeobox protein Emx2, which is a marker for the posterior-ventral
(PV) hypothalamus, while the continuous Shh expression demarcates the anterior-dorsal
(AD) hypothalamus (Mathieu et al., 2002; Wilson and Houart, 2004). The function of
Fgf signaling within the hypothalamus is not completely understood. However, there is a
study showing that Fgf signaling from the hypothalamic floor regulates the proliferation
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of progenitors in the tuberal hypothalamus (Manning et al., 2006). Complementing the
Shh-BMP signaling, a further pathway important for the ventral CNS midline cells to
adopt hypothalamic instead of floorplate identity is the Wnt/Axin/β-catenin pathway.
In this pathway Axin1 acts as a repressor of Wnt signaling to induce hypothalamic
fate while it additionally promotes Nodal signaling in the PV hypothalamus (Kapsimali
et al., 2004). Nodal signaling is required for the hypothalamic precursor cells to adopt
PV hypothalamic fate. In contrast, Shh signaling is essential for the development of the
AD hypothalamus. Cells that do not receive signals from either signaling pathway fail to
become hypothalamic cells (Mathieu et al., 2002). After adopting a hypothalamic fate,
canonical Wnt signaling is required for the neurogenesis in the posterior hypothalamus.
This is mediated through the lymphoid enhancer factor Lef1 that is required for the
expression of proneural and neural genes in that area (Lee et al., 2006). Interestingly
Fezf2, which is strongly expressed in the hypothalamus by late somitogenesis is part of
the Wnt/Lef1 pathway (Hashimoto et al., 2000; Jeong et al., 2007; Russek-Blum et al.,
2008). This and the role of Fezf2 on DA neuron development imply a role of Fezf2 in
promoting the development of hypothalamus (Jeong et al., 2007). Although the above
mentioned signaling pathways are known to be important for the establishment of the
hypothalamic cell fate, how distinct domains or nuclei and their neuronal cell types in
hypothalamus form is still poorly understood.
1.2.2 Transcriptional regulation of the hypothalamus
development
1.2.2.1 The homeodomain transcription factor Otp and the bHLH-PAS
transcription factors Sim1/Arnt2
Genetic analyses in mouse have begun to identify transcription factors that play
key roles in the formation of hypothalamic nuclei. The homeodomain transcription
factor Orthopedia (OTP) and the heterodimeric complex formed by the bHLH-PAS
transcription factors SIM1 and ARNT2 are required for development of virtually all
magno- and parvocellular neurons of the PVN and SON, as well as neurons in the
anterior periventricular nucleus (aPV) (Michaud et al., 2000). Both OTP-/- and SIM1-/-
mutant mouse embryos lack AVP, OXT, CRH and TRH neurons in the PVN, SON and
aPV while only OTP -/- mice lack SS neurons in the ARC (Acampora et al., 1999;
Caqueret et al., 2005; Michaud et al., 1998; Szarek et al., 2010; Wang and Lufkin, 2000).
Furthermore, OTP-/- mice lack a small population of hypothalamic dopamine (DA)
neurons present near the central periaquiductal gray (belonging to the so-called A11 DA
group) (Ryu et al., 2007). Notably, OTP-/- mice show reduced cell proliferation resulting
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in hypocellular PVN and SON. Additionally, they show abnormal cell migration and
defects in the differentiation of neuroendocrine progenitors (Acampora et al., 1999; Wang
and Lufkin, 2000).
SIM1 ARNT2 OTP
CRH VP OTTRHSS
PVN/SONARN
aPV
SIM2 ARNT2 BRN2
Fig. 1.2: Transcriptional regulation of hypothalamic neuron types in mouse
A scheme summarizing the role of OTP, SIM1, ARNT2, SIM2, BRN2 on the development
of distinct neuronal subtypes in mouse. The arrows do not indicate direct interactions
but genetic interactions. Modified from Caqueret et al. (2005).
Reflecting their parallel action, Otp and Sim1 show an identical expression pattern
within the hypothalamus and the amygdala (Wang and Lufkin, 2000). Accordingly,
SIM1-/- mice exhibit hypocellular PVN and SON. However in contrast to Otp,
SIM1/ARNT2 act during the late differentiation stage of the postmitotic hypothalamic
progenitors (Michaud et al., 1998). Notably, SIM1+/- mice become hyperphagic and
obese revealing a gene dosage effect of SIM1. These heterozygous SIM1 mutants have
fewer AVP-, OXT- and TRH-positive neurons while there was no effect on CRH and SS
neurons (Duplan et al., 2009; Xi et al., 2012). SIM1/ARNT2 and OTP act upstream of
both the POU domain transcription factor BRN2 and the close homolog of SIM1, SIM2
to control the development of PVN, SON and a part of aPV neurons. Both Brn2 and
Sim2 expression are diminished in Otp and Sim1 mutant mice. BRN2 mutant mice do not
show defects in the initial hypothalamic development nor in the migration of progenitors
but the mutants display defects in the maturation of the neurosecretory neurons CRH,
AVP and OXT (Nakai et al., 1995; Schonemann et al., 1995). SIM2 mutant mice show a
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reduction in SS and TRH neurons in the PVN and aPV. Since SIM1 is acting upstream
of SIM2 and is a close homolog to SIM2, SIM1 can partially compensate for the loss of
SIM2. Additionally, it is likely that ARNT2 is a heterodimerization partner of SIM2 as
well (Goshu et al., 2004).
Interestingly, the function of the hypothalamic regulators appears to be highly
conserved during evolution. In zebrafish, recent analyses show that Otp and Sim1/Arnt2
are required for the development of oxytocin-like (Oxtl), arginine-vasopressin-like (Avpl),
as well as CRH and SS neurons in the neurosecretory preoptic area (NPO) (Blechman
et al., 2007; Eaton and Glasgow, 2006, 2007; Eaton et al., 2008; Hill et al., 2009; Löhr
et al., 2009; Ryu et al., 2007). Additionally, similar to mouse, Otp (this thesis) as well as
Sim1 (Löhr et al., 2009) are required for the development of hypothalamic TRH neurons.
Moreover, Brn2 (Pou3f2) expression in the NPO is downregulated in zebrafish embryos
lacking either Sim1a/Arnt2 or Otp function (Löhr et al., 2009). Interestingly, studies in
zebrafish first revealed the importance of Otp and Sim1 for the formation of DA neurons
(Blechman et al., 2007; Borodovsky et al., 2009; Löhr et al., 2009; Ryu et al., 2007).
This Otp dependency has been shown to be the case for A11 DA neurons in mouse as
well (Ryu et al., 2007).
Sim1a Arnt2 Otp
Brn2
CRH AVPL OXTLTRHSS
?
Fig. 1.3: Transcriptional regulation of hypothalamic neuron types in
zebrafish
The scheme summarizes the requirement of Otp, Sim1a, Arnt2 and Brn2 for the
formation of distinct hypothalamic neuron types. Black arrows show genetic but no
direct interactions while the gray bar suggests a potential interaction.
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The zebrafish was also the fist model organism where upstream regulators of Otp
and Sim1 activity were found. For Sim1, so far, only one upstream regulator has been
discovered. The bHLH protein Olig2 that is known to be one of the first factors expressed
in neural progenitors activates sim1a expression in a specific progenitor population
important for the formation of A11 related DA neurons (Borodovsky et al., 2009).
Recent studies revealed factors that regulate Otp. Nodal in concert with Fgf8 and
Shh modulates otp expression in the NPO while Nodal but not Fgf8 and Shh regulates
otp expression within the posterior tuberculum (PT) (Del Giacco et al., 2006). Further,
the homeobox gene Prox1, a homolog to the Drosophila prospero, acts upstream of
otp to specify DA neurons in the PT (Pistocchi et al., 2008). Two additional factors
acting upstream of otp are the zinc finger-containing transcription factor Fezf2 and the
G-protein-coupled receptor Pac1. While Fezf2 is a transcriptional activator for otp, Pac1
regulates otp on the post-transcriptional level to specify DA and serotonergic neurons in
the PT and Oxtl neurons in the NPO (Blechman et al., 2007).
1.2.2.2 The zinc finger protein Fezf2
The forebrain embryonic zinc finger-like protein Fezf2 (also known as Fezl) contains six
C2H2-type zinc fingers and an engrailed-homolog repressor motif (Shimizu and Hibi,
2009). Fezf2, which was originally discovered as a gene that is positively regulated by
the over-expression of the Wnt inhibitor Dickkopf 1 (Dkk1) (Hashimoto et al., 2000),
was known to control monoaminergic neuron development in a non-cell autonomous
manner in zebrafish (Guo et al., 1999; Levkowitz et al., 2003). In addition, Fezf2 controls
the expression of the bHLH protein Neurogenin 1 (Ngn1), which is also a determinant
of PT DA neurons in zebrafish (Jeong et al., 2006). Fezf2 plays a role in establishing
regional subdivisions within the diencephalon and in promoting the development of
the hypothalamus and the telencephalon has been found (Jeong et al., 2007) (also see
paragraph 1.2.1.2). More recently, two more downstream targets of Fezf2 the TF eomesa
or Tbr2 and the Lim homeobox protein Lhx2 have been found (Chen et al., 2011).
The function of Fezf2 appears to be highly conserved across species. In mouse, it is
expressed in the thalamic eminence, the prethalamus, the hypothalamus and the dorsal
telencephalon, which later becomes confined to the deep layers of the cortex (Shimizu
and Hibi, 2009). Like in zebrafish (Jeong et al., 2007) FEZF2 controls the rostro-caudal
patterning of the diencephalon in mouse, since FEZF2 -/- mice show a complete loss of
the prethalamus and defects in the formation of the ZLI. In addition, it represses the
caudal diencephalic fate and establishes the prethalamic fate (Hirata et al., 2006; Shimizu
and Hibi, 2009). Although Fezf2 is expressed in the developing mouse hypothalamus
(Hirata et al., 2004) it remains unknown whether it plays a role in hypothalamic neuron
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development in mammals. Another function of FEZF2 in mouse is its importance for the
birth, specification and axon growth of corticospinal motorneurons and other subcerebral
projection neurons. A lack of FEZF2 activity leads to a fate change of those neurons since
no cell death or abnormal migration was detected (Chen et al., 2005a,b; Molyneaux et al.,
2005; Shimizu and Hibi, 2009). Unlike the zebrafish mutant FEZF2 mutant mice do not
show defects in hypothalamic monoaminergic neurons suggesting that this function is
not conserved between mouse and zebrafish (Hirata et al., 2004).
1.2.2.3 Additional transcription factors involved in the hypothalamic
development
Another TF that appears to be crucial for the correct development of the hypothalamus
is the thyroid specific-binding protein T/ebp also known as Nkx2.1. In mouse Nkx2.1 is
expressed in lung progenitors, heart progenitors, the thyroids and a restricted area in
the ventral forebrain (Kimura et al., 1996; Pabst et al., 2000). NKX2.1 -/- mice, which
die at birth, display in addition to the defects in the formation of the lung, heart and
the thyroid also defects in the ventral forebrain: from the septal area anteriorly to the
MB of the hypothalamus posteriorly (Kimura et al., 1996). A more detailed analysis
showed that NKX2.1 mutants have largely normal PVN, SON and SCN while the aPV
might be slightly smaller. The ventromedial hypothalamus (VMH) and the dorsomedial
nucleus are reduced whereas the ARC and the whole mammillary area (MA) containing
the MB, the premammillary nucleus (PM), the supramammillary area (SuM) as well
as the tuberomammillary nucleus (TM) are absent (Kimura et al., 1996; Szarek et al.,
2010). Additionally, the pituitary does not form (Kimura et al., 1996). In zebrafish two
nkx2.1 genes exist, nkx2.1a that is exclusively expressed in the ventral diencephalon
and nkx2.1b that is primarily expressed in the ventral telencephalon. Since the ventral
diencephalic expression domain of nkx2.1a is exclusively found in the hypothalamus, this
expression is used as a marker to demarcate the zebrafish hypothalamus (Rohr et al.,
2001). Further, Nkx2.1a can be detected in the thyroid of zebrafish as well (Elsalini
et al., 2003) indicating an evolutionary conserved role of Nkx2.1a between zebrafish and
mammals.
For the development of the VMH, in addition to NKX2.1 the orphan nuclear hormone
receptor steroidogenic factor 1 (SF1) is important. SF1 is involved in the development
of several neuroendocrine systems, since SF1 -/- mice have no gonads, adrenals and an
impaired function of pituitary gonadotrophs (Caqueret et al., 2005). SF1 is specifically
expressed in the VMH and is important for several phases of its development. Initially
it is involved in the survival and migration of the VMH neurons but not for an
appropriate VMH cell number. Later in development it is required for the aggregation
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and condensation of the VMH and the terminal differentiation (Caqueret et al., 2005;
Szarek et al., 2010). In zebrafish Sf1 is called nuclear receptor subfamily 5, group A,
member 2 (Nr5a2). The expression of the SF1 homolog nr5a2 is restricted within a
distinct hypothalamic domain implicating a conserved function for this factor as well
(Kurrasch et al., 2007). Another protein implicated in the VMH and ARC development
is the bHLH transcription factor Mash1 or Ascl1, which plays a role in neurogenesis
and subtype specification of several regions in the CNS. MASH1 -/- mice display an
underdevelopment of the VMH and the ARC caused by neurogenic failure and an increase
in apoptosis (McNay et al., 2006). Additionally, MASH1 is required for the expression
of the homeobox gene Gsh1, which is important for the formation of GHRH expressing
neurons in the ARC (Szarek et al., 2010). In addition to MASH1, the homeobox genes
Hmx2 and Hmx3 are required for the expression of Gsh1 and therefore for the formation
of GHRH neurons within the ARC but not within the VMH (Wang et al., 2004). The
sine oculis homeobox homolog 3 protein (Six3) is required for the formation of the SCN
assessed by using SIX3 -/- mice (VanDunk et al., 2011). For the development of the MB
the only transcription factor found so far is the forkhead box B protein Foxb1. Mice
lacking Foxb1 fail to develop a proper MB (Wehr et al., 1997).
Although several transcription factors important for the formation of distinct nuclei
in the hypothalamus have been identified the mechanism by which these factors define
distinct hypothalamic nuclei still remains to be determined. Currently all identified
transcription factors affect the development of several neuronal types therefore it still
needs to be determined how distinct neuronal fates are specified.
1.3 The hypothalamus anatomy and function
1.3.1 The paraventricular nucleus
The PVN is one of the best studied nuclei of the hypothalamus. Already nearly 100 years
ago a role of the PVN in energy homeostasis has been suggested (Cleveland and Davis,
1936). Monkeys, dogs, cats and rats with distinct hypothalamic lesions that involved
the PVN display an extremely rapid developing obesity caused by a highly enhanced
food intake (Brobeck, 1946). Around 40 years later more defined knife cut studies and
electrolytic lesions could show that it was indeed the PVN, or afferents and efferents in
the vicinity of this nucleus, that are important for normal regulation of food ingestion
(Leibowitz et al., 1981). In addition to its function in controlling normal eating and
drinking behavior, the PVN is also one of the most important parts of the brain to
control the stress response. It is a major part of the hypothalamic-pituitary-adrenal gland
(HPA) axis by controlling the release of adrenocorticotropic hormone (ACTH) through
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its CRH neurons. It also controls the release of neuroendocrine hormones both from
the anterior and the posterior part of the pituitary glands (Löhr and Hammerschmidt,
2011). By far the largest proportion of parvocellular neurosecretory neurons projecting
to the median eminence can be found in the PVN consisting of CRH, TRH, SS, DA and
GHRH neurons (Swanson, 1987). Together with the SON it also forms the magnocellular
neurosecretory system where OXT and AVP are released into the bloodstream through
the posterior pituitary. These two hormones are important for parturition and lactation
and for controlling diuresis and blood pressure respectively (Gainer and Wray, 1994). In
addition to its magno- and parvocellular neurosecretory neuron portion, there is a third
type of neurons in the PVN, which forms the descending division (Fink, 2000). These
neurons send descending projections to the brain stem and the spinal cord, especially to
the regions important for nociceptive information, autonomic reflexes and somatic motor
behavioral responses. The afferent control of the PVN is highly complex and includes
more than 50 different sources of neural input (Fink, 2000). Most of the neural inputs
appear to innervate more than one cell type within the PVN. Inputs that relay sensory
information come from distinct regions of the hindbrain while cognitive influences come
from the bed nuclei of the stria terminalis. Also many other neurons from other nuclei
within the hypothalamus send projections to the PVN such as the neurons in the SCN
(circadian rhythm). Apart from the neural inputs, the PVN might be also influenced
by hormonal inputs since several neurons in the PVN express hormone receptors, which
may change plasma membrane electrical properties and by this the gene expression in
PVN neurons (Fink, 2000).
In zebrafish the homologues structure to the PVN and SON is the neurosecretory
preoptic area (NPO) (Forlano and Cone, 2007; Peter, 1977). It was found due to its
unique composition of neuronal subtypes that are typical for the PVN/SON. From 2
days post fertilization (dpf) onwards there is an otp and sim1a positive region in the
anterior diencephalic area that contains Avpl, Oxtl, CRH and more ventral TRH and SS
neurons (Blechman et al., 2007; Löhr et al., 2009; Ryu et al., 2007). Since this is the only
region in the zebrafish hypothalamus that is Oxtl- and Avpl-positive it was concluded
that the NPO is the homologous structure to both the PVN and the SON. Since the
Oxtl, Avpl and CRH neurons project axons to the pituitary gland and have extensive
axonal projections throughout the teleost brain and to the spinal cord, these neurons
are likely to exhibit similar functions as their mammalian counterpart (Goossens et al.,
1977; Pepels et al., 2002; Saito et al., 2004; Yulis et al., 1986).
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Fig. 1.4: The NPO is the homologous structure to the PVN/SON
(A-F) Whole mount in situ hybridization (WISH) with probes for otpa (A), otpb (B),
sim1a (C), oxtl (D), avpl (E) and crh (F) to detect their conserved expression within the
PVN/SON homologues structure, the NPO. Lateral views are shown. The arrows point
to the NPO. Abbreviations used: telencephalon (Tel), hypothalamus (Hyp), tectum (T).
The scale bar represents 200 µm.
1.3.2 The mammillary area
The posterior most region of the hypothalamus the mammillary area (MA) or corpus
mamillare is an evolutionary highly conserved hypothalamic area, whose existence is
even discussed in lamprey where anatomists interpreted the caudal part of the dorsal
hypothalamic nucleus as a primordial corpus mamillare (Nieuwenhuys et al., 1998). In
mammals the most prominent structure of the MA is the mammillary body (MB), which
is comprised of two or three nuclei depending on anatomist: the medial, the lateral and
the dorsal premammillary nucleus (Alvarez-Bolado et al., 2000a; Canteras and Swanson,
1992; Swanson, 1987; Vann, 2010). The medial mammillary nucleus is the largest of the
three nuclei, which can be divided further into the pars lateralis, the pars medials and
the pars basalis (Vann, 2010). Both the medial as well as the lateral mammillary nucleus
are different in terms of their cell morphology while within each nucleus there appears to
be only one cell type (Allen and Hopkins, 1988; Veazey et al., 1982) of mainly projection
neurons (Takeuchi et al., 1985) and no apparent interneurons (Veazey et al., 1982). The
medial and the lateral mammillary nuclei have connections to the same structures. While
the main inputs originate from the hippocampus and from the tegmentum (tegmental
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nuclei of Gudden), their main outputs are to the thalamus (anterior thalamic nucleus) and
to the tegmentum (tegmental nuclei of Gudden) (Vann, 2010). The principal mammillary
tract (pm) is the major axon bundle from the MB that sprouts at a specific point
forming the mammillotegmental (mtg) and the mammillothalamic tract (mth)(Szabo
et al., 2011). Since the lateral and the medial mammillary nuclei are connected with
the same structures but different subregions of those structures they form two parallel
systems (Vann and Aggleton, 2004). In contrast, the dorsal premammillary nucleus
(PMd) projects to the precommissural nucleus, the periaquiductal gray and the thalamus
while it receives input from parts of the hypothalamus, the perifornical region and some
telencephalic regions (Canteras et al., 2001).
Beside the MB the MA consists of the supramammillary area (SuM) and the
tuberomammillary nucleus (TM) both of which innervate the MB nuclei (Vann, 2010).
The TM axons project widely throughout the CNS from the cerebral cortex, amygdala to
the posterior pituitary and the spinal cord (Haas and Panula, 2003; Saper, 2000) while the
supramammillary area projects to the entire cerebral cortex (Saper, 2000), the thalamus,
to the amygdala and to other parts of the hypothalamus (Pan and McNaughton, 2004).
In humans only very few cases of accidental MB lesions are known. These patients
suffered from slight anterograde amnesia, impaired recognition memory and a delayed
recall. More severe symptoms can be detected in patients suffering from Korsakoff’s
syndrome. This syndrome is most frequent in alcoholics and the patients suffer from
degeneration of the MB and other brain regions (Beracochea, 2005; Vann and Aggleton,
2004). Behavioral lesion studies in mammals led to the assignment of specific functions
to distinct domains within the MA. These studies showed that the MB is not a
typical hypothalamic nucleus that controls endocrine function or homeostasis but rather
cognitive processes. MB lesions disrupt spatial working memory, object recognition and
scene discrimination, which can also be affected by lesions of the mammillothalamic
tract although to a smaller extent (Vann, 2010; Winter et al., 2011). Animals with
MB lesions are also less anxious or less emotionally aroused (Vann, 2010). Lesions
mainly specific to the SUM area showed its involvement in cognitive processing, fear
conditioning and passive avoidance (Pan and McNaughton, 2004). Since lesion studies
usually include a larger area than a distinct nucleus, electrophysiological studies have
been carried out to define functions of the MA. Although the distinct mammillary
body nuclei appear to consist of only one cell type, physiological studies showed that
neurons in the medial mammillary nucleus are electrophysiologically different whereas
lateral mammillary nuclei neurons are electrophysiologically homogeneous (Vann, 2010).
These studies additionally showed that the lateral mammillary nucleus is part of the
head-direction system containing head-direction cells and angular velocity cells (Blair
et al., 1999, 1998; Stackman and Taube, 1998) connected with other head-direction
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regions of the brain forming (Bassett et al., 2007). In contrast, the medial mammillary
nucleus is situated within the “theta-related” system. It contains no head-direction cells
but cells responsive to angular head velocity, which fire differentially for clockwise and
counterclockwise movements (Sharp and Turner-Williams, 2005). In addition, nearly all
cells of the medial mammillary nucleus modulate their firing rate at a frequency of theta
showing a strong correlation with the CA1 field of the hippocampus (Vann, 2010). It
has been suggested that spatial working memory is theta-dependent (Givens, 1995).
Therefore, it is likely that the medial and the lateral mammillary nucleus are not only
electrophysiological but also functionally distinct.
Neurophysiological studies on the supramammillary area showed that it is also part
of the “theta-related” system, although even large lesions of the SuM led only to a
slight reduction in theta frequency (Pan and McNaughton, 2004). The function of the
tuberomammillary area was investigated after the discovery that the TM is the sole
seat of the histaminergic neurons with their wide projections in the brain (Haas and
Panula, 2003). Studies in mouse lacking histamine or with injected histamine as well as
neurophysiological studies revealed that the TM is involved in arousal, sleep, memory as
well as feeding (Haas and Panula, 2003). In zebrafish it was found that the histamine
system is essential for the development of a functional hypocretin system as well as
for the rapid and adequate behavioral responses of zebrafish larvae to changes in the
environment (Sundvik et al., 2011). For the function of the PMd, cFos staining and
chemical lesion initially suggested that it is involved in the expression of fear responses
(Canteras et al., 2001). Later pharmacological blockade of the PMd showed that the
NMDA/NO pathway plays an important role in the processing of predatory threats
mediated by the PMd (Aguiar and Guimaraes, 2011; Canteras et al., 2008).
An impressive amount of work has been put into the investigation of the function
and the neurophysiology of the mammillary area but so far the development of the MA
is surprisingly poorly understood. The only transcription factor known to play a role
in MB development is the winged helix-loop-helix protein FOXB1. It was shown that
mouse mutants for FOXB1 do not develop a proper MB (Wehr et al., 1997). In addition,
FOXB1 is essential for the formation of the mammillothalamic tract (Alvarez-Bolado
et al., 2000b) and it is expressed in migrating cells (Alvarez-Bolado et al., 2000a; Zhao
et al., 2008). Consistent with recent findings, FOXB1 mutant mice display impairment
in spatial and working memory mainly through the ablation of the medial mammillary
nucleus as well as the mammillothalamic tract (Radyushkin et al., 2005). More recent
studies revealed additional factors that are involved in later aspects of MB differentiation
contributing to the formation of the mammillothalamic tract like the bHLH transcription
factor SIM1 (Marion et al., 2005), the paired box protein PAX6 (Szabo et al., 2011)
and the paired-like homeodomain transcription factor PITX2 (Skidmore et al., 2012).
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However, apart from the above mentioned transcription factors no additional regulators
of MA development have been identified yet.
Furthermore, only limited studies about neuropeptides expressed within the MA
have been published. In adult zebrafish it has been shown that urotensin1 (Uts1)
the teleost ortholog of the mammalian urocortin1 (UCN1) (Vaughan et al., 1995) is
homogeneously distributed within the corpus mamillare (Alderman and Bernier, 2007).
In mammals UCN1 is widely distributed in the brain and also in the periphery having
important physiological functions in various tissues. In the central nervous system it
appears to modulate energy and water homeostasis and stress adaptation, while in the
periphery it is implicated in immunomodulation and cardioprotection (Oki and Sasano,
2004). UCN1 is widely expressed in the CNS as its expression was first detected in
the Edinger-Westphal nucleus, the lateral superior olive of the midbrain, the supraoptic
nucleus of the hypothalamus as well as in the spinal chord (Oki and Sasano, 2004). Later
also other places of UCN1 expression have been detected. Interestingly, in colchicine
treated rats, UCN1 expression was detected in the lateral mammillary nucleus, the
supramammillary area as well as in the posterior hypothalamic area displaying low-level
expression of UCN1 (Bittencourt et al., 1999). Although the function of UCN1 in
the MA is not known the conserved expression in zebrafish suggests an evolutionary
conserved function, which still needs to be elucidated. Another neuropeptide known to
be expressed within the MA is VIP. VIP-ir as well as VIP binding sites have been found
in the MA (Saper, 2000; Sarrieau et al., 1994). The function of VIP in this area of the
hypothalamus is poorly understood. Additionally, VIP is broadly expressed in the body
and has pleiotropic regulatory effects. In the CNS the strongest VIP expression can be
found in the suprachiasmatic nucleus of the hypothalamus where it is involved in the
generation and synchronization of the circadian oscillatory clocks (Vosko et al., 2007)
and in the PVN where it is co-expressed with CRH (Ceccatelli et al., 1989; Hokfelt et al.,
1987).
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2 Aim of the thesis
The hypothalamus is a key integrative center in the brain, which is composed of several
nuclei that consist of multiple neuronal subtypes. Although a great amount of work
led to the assignment of specific functions to distinct nuclei, the development of these
nuclei and the neurons that are present within them, remains largely unknown. So far,
several transcription factors important for the specification of hypothalamic neuron types
have been identified using genetic analyses in rodents and in zebrafish. These regulators
include OTP, SIM1, ARNT2, BRN2, SIM2 and FOXB1.2 (Eaton and Glasgow, 2006,
2007; Eaton et al., 2008; Goshu et al., 2004; Löhr et al., 2009; Michaud et al., 2000,
1998; Nakai et al., 1995; Ryu et al., 2007; Schonemann et al., 1995; Wang and Lufkin,
2000; Wehr et al., 1997). Although the function of hypothalamic regulators appears to be
highly conserved from mammals to fish (Machluf et al., 2011), how these factors specify
distinct neuron types and nuclei is poorly understood. Additionally, many of the so far
identified transcription factors are broadly expressed, suggesting that these regulators
might play a role in the development of several neuron types in the hypothalamus. The
overall goal of my thesis was to gain insight into the transcriptional mechanism that
specify distinct nuclei and neuron types focusing on the neurosecretory preoptic area
(NPO) and the posterior most region of the hypothalamus the mammillary area (MA).
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3.1 Regulatory interactions of transcription factors, crucial for
the development of the preoptic area and the posterior
hypothalamus
3.1.1 The identification of transcription factors regulated by
Otp
It is known that Otp plays an important role in the development of neuroendocrine
neurons (Blechman et al., 2007; Eaton and Glasgow, 2007; Eaton et al., 2008; Ryu et al.,
2007). However, its expression is found in multiple hypothalamic regions, including the
retrochiasmatic region, the ventral tuberal region and the mammillary area (Shimogori
et al., 2010; Simeone et al., 1994). Also in zebrafish otpa and otpb have additional
expression domains in the posterior and in the ventral hypothalamus (Ryu et al.,
2007) suggesting an evolutionary conserved function of Otp in this region. To find
novel regulators of hypothalamic neuron type specification, I hypothesized that such
factors may act downstream of broad hypothalamic regulators such as Otp. To this end
I carried out an in situ hybridization-based screen analyzing transcription factors in
zebrafish embryos lacking Otp activity. I selected from the zebrafish expression database
(www.zfin.org)(Bradford et al., 2011) more than 80 different transcription factors (see
also Material and Methods chapter 6 in section 6.1.12) expressed in Otp-positive
hypothalamic domains and analyzed their expression in 2 dpf otpam866 mutant embryos
injected with 4 ng of otpb morpholino (MO) (Ryu et al., 2007). Using this approach I
was able to find three transcription factors, which showed changes in their expression in
the embryos lacking Otp activity.
One of these factors is the zinc-finger transcription factor Fezf2. Although known to
act upstream of Otp (Blechman et al., 2007), its expression was reduced in the NPO
(Fig. 3.1A,B, n=11/11), while it was expanded in the posterior hypothalamus (Fig.
3.1C,D, n=11/11). The second factor affected by the loss of Otp function is the winged
helix-loop-helix transcription factor Foxb1.2, the zebrafish ortholog of mouse FOXB1
(Odenthal and Nüsslein-Volhard, 1998). Similar to fezf2, the foxb1.2 expression domain
was expanded in the posterior hypothalamus (Fig. 3.1E,F, n=17/17).
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Fig. 3.1: Otp regulates the expression of fezf2, foxb1.2 in the diencephalon
and of pitx3 in the hindbrain
(A-H) Whole-mount in situ hybridization (WISH) to detect the expression of fezf2 (A-D),
foxb1.2 (E,F) and pitx3 (G,H) in 2 dpf wild-type (A,C,E) and otpam866 mutant embryos
injected with 4 ng otpbmorpholino (MO). (A-D) In embryos lacking Otp activity, the fezf2
expression domain is strongly reduced in the NPO (arrows in A and B) and expanded
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in the MA (bars in C and D, C and D represent more dorsal planes to A and B in the
same embryo, n=11/11). (E,F) In embryos lacking Otp activity, foxb1.2 expression is
expanded in the MA (arrowheads, n=17/17). (G,H) Loss of Otp function results in the
loss of the hindbrain (Hb) expression domain of pitx3 (arrows, n=4/4). Dorsal views are
shown and the scale bar represents 200 µm.
FOXB1 in mouse is specifically expressed in the mammillary body (MB) where it is
necessary for a proper development of this hypothalamic region (Wehr et al., 1997).
Foxb1.2 in zebrafish displays one highly specific expression domain in the hypothalamus
of 2 dpf embryos: in the posterior most part of the hypothalamus, where also Otp
can be detected. In rodents, Otp was found to be expressed in the mammillary area
(Shimogori et al., 2010). Based on the conserved expression of these factors in the
posterior hypothalamus I refer to the region surrounding the Foxb1.2-positive domain
as the mammillary area (MA) in zebrafish. The third transcription factor was pitx3,
whose hindbrain expression domain was lost (Fig. 3.1G,H, n=4/4). Since the focus of my
thesis is hypothalamus development, the regulatory interaction between otp-pitx3 was
not further characterized in the course of this thesis.
The development of the MA in zebrafish has not been studied so far, nevertheless
these results show a conserved expression of foxb1.2 in the MA of zebrafish and identify
Foxb1.2 and Fezf2 as potentially involved in the formation of the MA downstream of
Otp.
3.1.2 The expression domains of fezf2 and foxb1.2 delineate
subregions within the posterior hypothalamus
Given the fact that Fezf2 as well as Foxb1.2 are important for the patterning of the
diencephalon (Jeong et al., 2007; Scholpp and Lumsden, 2010; Staudt and Houart, 2007;
Toro and Varga, 2007), I asked next whether these two factors also play a role in the
patterning of the hypothalamus. To answer this question I first examined the expression
of fezf2 and foxb1.2 in comparison to the known markers of the zebrafish hypothalamus.
At 1 dpf, nkx2.1a is a marker for the whole hypothalamus (Rohr et al., 2001), whereas
shh and emx2 delineate the anterior-dorsal and the posterior-ventral hypothalamus,
respectively (Mathieu et al., 2002). Using three-color whole-mount fluorescence in situ
hybridization (FISH), I observed that fezf2 as well as foxb1.2 were expressed within
the nkx2.1a positive posterior hypothalamic area, where fezf2 labeled more ventral
and foxb1.2 more dorsal domains. The posterior hypothalamic domains of fezf2 and
foxb1.2 overlapped in a small area (Fig. 3.2A-A”’). The expression of shh and fezf2
directly abutted each other but did not overlap, while the expression domains of shh and
foxb1.2 partially overlapped in the more posterior and dorsal extent (Fig. 3.2B-B”’). The
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expression of the posterior-dorsal hypothalamic marker emx2 was completely contained
within the hypothalamic fezf2 domain, but smaller. foxb1.2 slightly overlapped with
the expression of emx2 in its most ventral extent (Fig. 3.2C-C”’). A summary of the
hypothalamic markers co-expressed with fezf2 and foxb1.2 is shown in Fig. 3.2D.
Fig. 3.2: fezf2 and foxb1.2 mark subregions within the posterior
hypothalamus
(A-C”’) Three-color fluorescent whole-mount in situ hybridization (FISH) of 1 dpf
wild-type embryos with probes for nkx2.1a, shh, emx2, fezf2 and foxb1.2 revealed that
fezf2 and foxb1.2 are expressed in the posterior hypothalamus. A maximum projection
of 10 µm in the lateral view is shown. (A-A”’) The hypothalamic expression of fezf2 and
foxb1.2 is located within the posterior part of the nkx2.1a expression domain. (B-B”’)
The expression domains of fezf2 in the posterior hypothalamus and shh in the anterior
hypothalamus are non-overlapping, whereas foxb1.2 is partially co-expressed with fezf2
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and shh in the posterior-dorsal extent. (C-C”’) emx2 is expressed in the posterior-ventral
hypothalamus within the fezf2 domain, while emx2 and foxb1.2 expression slightly
overlap. (D) A model summarizing the relative expression patterns of fezf2, foxb1.2,
shh, nkx2.1a, and emx2. For simplicity, only the hypothalamic emx2 expression is shown.
The white dashed lines in A”’, B”’, C”’ and D delineate the hypothalamus and the length
of the scale bar is 60 µm.
These results demonstrate that the zebrafish hypothalamus at 1 dpf can be divided
into more subregions than what was known before. The hypothalamic fezf2 expression
delineates mainly the posterior hypothalamus, whereas foxb1.2 is a marker for the
posterior-dorsal and emx2 is a marker for the posterior-ventral hypothalamus.
3.1.3 Fezf2 is involved in the regionalization of the posterior
hypothalamus
To directly test the role of Fezf2 and Foxb1.2 in the patterning of the hypothalamus
I used a fezf2 splice morpholino (MO) (Jeong et al., 2006) and a foxb1.2 ATG-MO
generate embryos with reduced Fezf2 and Foxb1.2 function. Neither the loss of Fezf2
(Fig. 3.3A,B, n=27) nor of Foxb1.2 (Fig. 3.3A,C, n=23) function led to a change
in nkx2.1a expression. As already shown in previous studies (Jeong et al., 2007) in
fezf2 morphants the expression domain of shh along the ZLI moved towards anterior
into the original prethalamic fezf2 expression domain (double-headed arrows) and the
anterior-dorsal hypothalamic area was reduced (Fig. 3.3D,E, n=23/23, double-headed
arrows). The reduction of Foxb1.2 function led to no apparent change in shh expression
(Fig. 3.3D,F, n=27). Interestingly, in fezf2 morphants also the ZLI domain of emx2
was shifted anteriorwards (double-headed arrow), whereas the domain labeling the
posterior-ventral hypothalamus was highly reduced (Fig. 3.3G,H, n=34/43, arrowheads).
Foxb1.2 morphants show no change in emx2 expression (Fig. 3.3G,I, n=22). So far my
results show that Fezf2 is important for the regionalization of the hypothalamus by
regulating the expression of emx2. Since the emx2 domain in the posterior ventral
hypothalamus at 1 dpf is contained within the fezf2 domain, I hypothesized that emx2
might be regulated by fezf2 later in development and that it might delineate a specific
posterior hypothalamic domain at 2 dpf. To test this, I performed a loss-of-function
analysis. The WISH with probes for emx2, foxb1.2 and fezf2 showed that indeed, emx2
is downregulated in loss of Fezf2 function embryos (Fig. 3.3J,K, arrowheads, n=21/21),
while reduced Foxb1.2 activity led to no apparent change in emx2 expression (Fig.
3.3J,L, n=28/28). In addition, the loss of Otp function results in no change of emx2
expression (data not shown).
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Fig. 3.3: Fezf2 plays a role in posterior hypothalamus formation
(A-L) WISH of wild-type embryos (A,D,G) and embryos injected with either 4ng fezf2
MO (B,E,H) or 8 ng foxb1.2 MO (C,F,I) to detect changes in the expression of nkx2.1a
(A-C), shh (D-F) and emx2 (G-L) at 1 dpf (A-I) and 2 dpf (J-L). Lateral views are
shown in (A-I) and dorsal views are shown in (J-L). (A-C) The loss of Fezf2 (n=27) as
well as the loss of Foxb1.2 (n=23) function leads to no change in nkx2.1a expression.
(D,E) The expression of shh in the ZLI is shifted to the anterior and reduced in the
anterior-dorsal hypothalamus in loss of Fezf2 function (double-headed arrows, n=23/23)
while the loss of Foxb1.2 has no apparent effect (D,F, n=27). (G,H) fezf2 morphants
also show a shifted emx2 expression domain along the ZLI (double-headed arrows) and
a reduced posterior-ventral hypothalamic emx2 domain (arrowheads, n=34/43). foxb1.2
morphants show no change in emx2 expression (G,I, n=22). (J-L) The loss of Fezf2
function results in a reduction of emx2 expression in the posterior MA (n=21/21), while
the loss of Foxb1.2 leads to no apparent change (n=28/28). The scale bar represents 200
µm.
3.1 Regulatory interactions crucial for hypothalamus development 25
My results indicate that emx2 is expressed within the posterior fezf2 -positive MA
domain, regulated independently of Foxb1.2 and Otp. The positive regulation of Fezf2
on emx2 expression suggests a co-expression of fezf2 and emx2 at 2 dpf.
Thus, similar to what has been reported in mouse (Wehr et al., 1997) Foxb1.2 does
not affect hypothalamus patterning. In contrast, Fezf2 affects hypothalamus patterning
at 1 dpf by regulating the expression of emx2 in the posterior-ventral hypothalamus and
through a non-cell autonomous effect on hypothalamic shh expression. Although Fezf2
affects the hypothalamus patterning it appears not to change the hypothalamic identity,
because the expression of nkx2.1a is not altered.
Since Fezf2 plays a role in hypothalamus patterning and foxb1.2 is expressed within
the posterior-dorsal hypothalamus the question arises whether these two factors regulate
each other. To answer this question, I performed WISH on fezf2 and foxb1.2 morphants
to detect changes in the expression of foxb1.2 and fezf2. While the loss of Foxb1.2
function had no apparent effect on the expression of fezf2 (Fig. 3.4A,B, n=18), the
loss of Fezf2 function led to a shift in the foxb1.2 domain anteriorwards along the
ZLI domain and a slight expansion in the posterior-dorsal hypothalamus (Fig. 3.4C,D,
n=44/44 double-headed arrows). This shift and expansion of foxb1.2 in the posterior-
dorsal hypothalamus in fezf2 morphants implies a negative regulation of Fezf2 on foxb1.2
and shows the important role of Fezf2 for the patterning of the hypothalamus at 1 dpf.
Fig. 3.4: Fezf2 negatively regulates foxb1.2 at 1 dpf
(A-D) WISH of 1 dpf wild-type embryos (A,C) and embryos injected with 10 ng foxb1.2
MO (B) and 4 ng fezf2 MO (D) to detect the expression of fezf2 (A,B) and foxb1.2 (C,D).
Lateral views are shown. (A,B) foxb1.2 morphants show no effect on the expression
of fezf2 (n=18). (C,D) The loss of Fezf2 function results in a shifted and expanded
expression of foxb1.2 along the ZLI domain and in the posterior-dorsal hypothalamus
(double-headed arrows, n=44/44). The scale bar represents 200 µm.
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3.1.4 Fezf2 controls the expression of regulators for neuron
type specification at 1 dpf
In zebrafish otpa/otpb and sim1a are involved in the specification of various
neurosecretory neuronal subtypes in the diencephalon (Eaton and Glasgow, 2006, 2007;
Eaton et al., 2008; Löhr et al., 2009; Ryu et al., 2007). Although the expression of sim1a
already starts at the 2-somites stage (around 11 hpf) and otp starts to be expressed at
the 14-somites stage (around 16 hpf), these two transcription factors appear not to be
involved in the patterning of the hypothalamus, because the loss of these regulators has
no effect on the expression of fezf2 and foxb1.2 in the hypothalamus (Fig. 3.5A-F, n=1,
n=16, n=2, n=25) and also not on shh and nkx2.1a expression (Eaton and Glasgow,
2006, 2007).
Fig. 3.5: Otp and Sim1a do not affect hypothalamus patterning
(A-F) Probes for fezf2 (A-C) and foxb1.2 (D-E) detected with WISH in 1 dpf wild-type
embryos (A,D), otpam866 mutant embryos injected with 4 ng otpb MO and embryos
injected with 1 ng sim1a MO. (A-C) The expression of fezf2 does not change upon loss
of Otp (n=1) and loss of Sim1a function (n=16). Additionally, the expression of foxb1.2
is not changed in embryos with reduced Otp (n=2) and Sim1a activity (n=25). The scale
bar represents 200 µm.
In contrast, it is known that Fezf2 directly regulates the expression of otpb (Blechman
et al., 2007) and that Fezf2 and Foxb1.2 are regulators important for diencephalic
patterning (Jeong et al., 2007; Scholpp and Lumsden, 2010; Staudt and Houart, 2007;
Toro and Varga, 2007). Therefore, it is likely that Fezf2 and Foxb1.2 may regulate
otpa, otpb or sim1a expression. To validate this hypothesis I performed a WISH with
probes for otpa, otpb and sim1a on 1 dpf wild-type embryos and embryos lacking either
Fezf2 or Foxb1.2 function. Indeed, similar to what has been reported for otpb at 52
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hpf (Blechman et al., 2007) the expression of otpa and otpb at 1 dpf was severely
downregulated in fezf2 morphants (Fig. 3.6A,B,D,E, n=27/29, n=24/24). This effect was
observed in the telencephalic otp expression domain as well as in the anterior (arrows) and
the posterior (arrowheads) diencephalic expression domains. Similarly, in loss of Fezf2
function embryos the expression of sim1a was reduced in the telencephalic expression
domain as well as in the anterior (arrows) and posterior (arrowheads) diencephalic
expression domain but not in the more posterior domains (Fig. 3.6G,H, n=21/21). The
loss of Foxb1.2 function did not result in changes in the expression of otpa, otpb or sim1a
(Fig. 3.6A,C,D,F,G,I, n=11, n=23, n=22).
Fig. 3.6: Fezf2 regulates the expression of otp and sim1a at 1 dpf
(A-I) 1 dpf wild-type embryos and embryos injected with 4 ng fezf2 and 8 ng foxb1.2 MO
subjected to WISH to detect changes in the expression of otpa, otpb and sim1a. Lateral
views are shown. (A-C) The loss of Fezf2 function results in a reduction of otpa expression
(anterior diencephalon arrows, posterior diencephalon arrowheads, n=27/29), while the
loss of Foxb1.2 function shows no apparent effect on otpa (n=11). (D-F) Similar to otpa,
fezf2 morphants show a reduction of otpb expression in the telencephalic domain and
the anterior (arrows) as well as posterior (arrowheads) diencephalic expression domain
(n=24/24). foxb1.2 morphants show no change in otpb expression (n=23). (G-I) sim1a
expression in embryos with reduced Fezf2 function is reduced in its telencephalic, anterior
(arrows) and posterior (arrowheads) diencephalic expression domain (n=21/21), while
sim1a expression is not affected in the posterior most domains. A reduction in Foxb1.2
function results in no change of sim1a expression (N=22). The scale bar has a length of
200 µm.
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Together these results show that Fezf2, in addition to its function in hypothalamus
patterning, regulates otp and sim1a that are known to be important for neuron type
specification. In contrast, Foxb1.2 is not important for the regulation otp and sim1a
expression and also not for hypothalamus patterning, although its expression delineates
a specific hypothalamic region.
In conclusion, my results revealed that Fezf2 is a key transcription factor in
hypothalamus development. This conclusion is based on several results: Fezf2 positively
regulates the expression of emx2 in the posterior-ventral hypothalamus (Fig. 3.3), otpa
(Fig. 3.6), otpb (Blechman et al., 2007) and sim1a (Fig. 3.6) and negatively regulates
foxb1.2 and shh in the posterior-dorsal and anterior-dorsal hypothalamus. In addition
to its function within the hypothalamus, Fezf2 negatively controls the expression of shh
(Jeong et al., 2007), emx2 (Fig. 3.3) and foxb1.2 (Fig. 3.4) in the prethalamus abutting
the area of the ZLI. Figure 3.7 provides a summary of the observed genetic interactions
of Fezf2 within the diencephalon at 1 dpf.
Fezf2
emx2
shh
ZLI
Fezf2 emx2
shh
Hypothalamus
foxb1.2foxb1.2
otp
sim1a
Fig. 3.7: Fezf2 is a key transcription factor for diencephalic development at
1 dpf
A scheme summarizing the observed genetic interactions of Fezf2 on emx2, otp and sim1a
in the hypothalamus and on shh and emx2 in the ZLI at 1 dpf. Green arrows specify
positive regulation while red bars indicate negative regulation.
3.1.5 The interactions between Fezf2 and Foxb1.2 change over
time and the regulatory interactions of Fezf2 vary
between anterior and posterior hypothalamus
Since I found that Fezf2 is a key transcription factor for hypothalamus development
at 1 dpf, I asked whether later in development Fezf2 still plays a major role in the
specification of distinct regions or neuronal subtypes in the hypothalamus. Fezf2 controls
the development of monoaminergic neurons in a non-cell autonomous manner (Guo et al.,
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1999; Levkowitz et al., 2003) and dopaminergic cell fate by controlling the expression
of Ngn1 (Jeong et al., 2006) or Otpb (Blechman et al., 2007). However, so far the role
of Fezf2 in the specification of neurons in the preoptic and the posterior hypothalamus
is not known. From mouse it is known that FOXB1 and SIM1/SIM2 play a role in the
development and specification of the mammillary body (Marion et al., 2005; Wehr et al.,
1997) and I showed that Otp regulates the expression of both fezf2 in the PO and the
MA and foxb1.2 in the MA in 2 dpf old zebrafish embryos (Fig. 3.1). Additionally, Otp
and Sim1a play a major role in the specification of neuroendocrine neurons in the NPO
of zebrafish (Eaton and Glasgow, 2006, 2007; Eaton et al., 2008; Löhr et al., 2009; Ryu
et al., 2007). Based on these findings I hypothesized that Fezf2, Foxb1.2, Otp and Sim1a
play a role in the formation of the MA in zebrafish and tested the genetic interaction
between fezf2, foxb1.2, otpa/otpb and sim1a in a loss-of-function analysis at 2 dpf.
Fig. 3.8: Fezf2 and Foxb1.2 regulate the expression of otp and sim1a
differentially
(A-I) WISH on 2 dpf wild-type (A,D,G) embryos and embryos injected with 4 ng fezf2
MO (B,E,H) and 10 ng foxb1.2 MO (C,F,I) to detect alterations in the expression of otpa
(A-C), otpb (D-F) and sim1a (G-I). In the lateral views that are shown, double-headed
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arrows display the extent of the PO expression domain, while arrowheads point to the
MA. (A,B,D,E) Loss of Fezf2 function results in a reduction of otpa (n=11/14) and
otpb (n=14/17) expression, while (A,C,D,F) loss of Foxb1.2 function results in a slight
expansion of otpa (n=13/22) and otpb (n=7/22) MA domain to the anterior. (G,H) The
expression of sim1a in fezf2 morphants is reduced in the PO and expanded in the MA
(n=19/19). foxb1.2 morphants show a slight expansion of sim1a in the MA, while sim1a
in the PO is not affected (n=12/12). The scale bar represents 200 µm.
Similar to what has been reported for otpb (Blechman et al., 2007) and to what
I showed for 1 dpf old embryos (Fig. 3.6), the loss of Fezf2 function results in a severe
reduction of otpa (Fig. 3.8A,B, n=11/14) and otpb (Fig. 3.8D,E, n=14/17) expression at 2
dpf both in the PO (double-headed arrows) and in the MA (arrowheads). The reduction of
Fezf2 activity at 1 dpf resulted in a reduction of sim1a expression (Fig. 3.6). Interestingly
at 2 dpf (Fig. 3.8G,H), sim1a expression in the PO was reduced (double-headed arrow),
while it was expanded in the MA (arrowheads, n=19/19). The loss of Foxb1.2 function,
in contrast, led to a slight expansion of the MA otpa (Fig. 3.8A,C, arrowheads, n=13/22)
and otpb (Fig. 3.8D,F, arrowheads, n=7/22) domain anteriorwards. Also sim1a is slightly
expanded in the MA (arrowheads) in foxb1.2 morphants and not affected in the PO (Fig.
3.8G,I, n=12/12).
These genetic interactions show that Fezf2 positively regulates otp, while its
interaction with sim1a changes over time and varies between the anterior and the
posterior hypothalamus. Foxb1.2 although an important marker for the MA, affects the
expression of otp and sim1a only slightly.
Fig. 3.9: fezf2 and foxb1.2 negatively regulate each other
(A-D) Wild-type (A,C), 4 ng fezf2 MO (B) and 10 ng foxb1.2 MO (D) injected 2
dpf embryos subjected to WISH to reveal cross-regulatory interactions between foxb1.2
(A,B) and fezf2 (C,D). Lateral views are shown in A, B and dorsal views are shown
in C, D. (A,B) fezf2 morphants display an expanded foxb1.2 expression in the MA
(n=32/32). (C,D) The expression of fezf2 in foxb1.2 morphants is expanded in the
anterior (double-headed arrows) and posterior (arrowheads) MA (n=19/25). The scale
bars show 200 µm.
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Next I asked, whether there is a genetic interaction between fezf2 and foxb1.2 at 2
dpf, because in 1 dpf old embryos Fezf2 negatively regulates the expression of foxb1.2.
Loss-of-function analysis of WISH embryos that were injected with fezf2 or foxb1.2 MO
revealed that indeed there are genetic interactions between these two factors. Loss of
Fezf2 function resulted in an expanded foxb1.2 expression domain in the MA (Fig.
3.9A,B, arrowheads, n=32/32) while a reduction of Foxb1.2 activity led to an expansion
of the anterior (double-headed arrows) and posterior MA (arrowheads) fezf2 expression
domain (Fig. 3.9C,D, n=19/25). The expansion of foxb1.2 and fezf2 in the MA of fezf2
and foxb1.2 morphants respectively, indicates the existence of cross-repressive genetic
interactions between these two factors.
It has been suggested that Otp and Sim1a act in a parallel pathway to specify
neuronal fates (Löhr et al., 2009). If this is true, Otp and Sim1a should not interact
genetically. Further, the loss of Sim1a function should lead to similar phenotypes as the
loss of Otp.
Fig. 3.10: sim1a has no cross-regulatory interactions with otp, fezf2 or
foxb1.2
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(A-J) WISH of 2 dpf wild-type embryos (A,C,E,G,I), embryos injected with 1 ng sim1a
MO (B,D,F,H) and otpam866 embryos injected with 4 ng otpb MO to detect the expression
of otpa (A,B), otpb (C,D), fezf2 (E,F), foxb1.2 (G,H) and sim1a (I,J). Lateral views are
shown. (A-D)Loss of Sim1a function results in no changes in the expression of otpa (n=54)
or otpb (n=50). (E,F) Additionally, sim1a expression is not altered in fezf2 morphants
(n=46) as well as in (G,H) foxb1.2 morphants (N=43). (I,J) the loss of Otp function led
to no changes in sim1a expression (n=5). The scale bar represents 200 µm.
In order to test this hypothesis I performed a WISH on embryos injected with a sim1a
splice-MO (Löhr et al., 2009) and with otpam866 embryos injected with 4 ng otpb MO.
As expected the loss of Sim1a function induced no change in the expression of otpa or
otpb (Fig. 3.10A-D, n=54, n=50). Vice versa, the loss of Otp function embryos displayed
no altered sim1a expression compared to wild-type (Fig. 3.10I,J, n=5). However, the
reduction of Sim1a activity resulted in no apparent changes in the expression of fezf2
(Fig. 3.10E,F, n=46) or foxb1.2 (Fig. 3.10G,H, n=43).
These results suggest that, although otp and sim1a do not regulate each other, their
genetic interactions with other transcription factors are not the same. Therefore, they
might act in parallel for the specification of certain neuron types but are likely to have
also divergent functions.
In summary, the loss-of-function analysis revealed that at 2 dpf a cross-regulatory
network of fezf2, otp and sim1a is important for the formation of the preoptic area, while
this network together with the additional regulator foxb1.2 is crucial for the formation of
the mammillary area. At 2 dpf, Fezf2 changes its genetic interaction in different areas. In
the PO Fezf2 positively regulates sim1a expression but in the MA it negatively regulates
sim1a (Fig. 3.8). Also the genetic interaction of Otp changes in different areas of the
hypothalamus. In the PO, Otp positively regulates fezf2 expression, whereas it negatively
regulates fezf2 in the MA (Fig. 3.1). Further, Foxb1.2 negatively regulates the expression
of fezf2 (Fig. 3.9) and the expression of otp and sim1a (Fig. 3.8).
Interestingly, the interactions of the transcription factors not only vary in different
areas of the brain but also change over time. Foxb1.2 displayed no genetic interactions
with fezf2, otp or sim1a at 1 dpf (Fig. 3.4, 3.6), but negatively regulates their expression
at 2 dpf (Fig. 3.8, 3.9). In addition, Otp did not regulate the expression of foxb1.2 and
fezf2 at 1 dpf (Fig. 3.5), whereas at 2 dpf the interaction becomes cross-regulatory (Fig.
3.1). Also the interaction of fezf2 changes during development. Early on Fezf2 is a key
transcription factor for the hypothalamus patterning, but later in development it forms
a cross-regulatory network important for the specification of two important nuclei of the
hypothalamus, the PO and the MA. Figure 3.11 summarizes and compares the genetic
interactions of fezf2, foxb1.2, otp and sim1a at 1 dpf and 2 dpf.
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Fig. 3.11: A cross-regulatory network of fezf2, foxb1.2, otp and sim1a is
crucial for the formation of PO and MA in the zebrafish
hypothalamus
A summary of the observed genetic regulatory interactions among fezf2, otp, sim1a
and foxb1.2 at 1 dpf and 2 dpf. In addition, the cross-regulatory network in the MA
compared to the interactions observed in the PO at 2 dpf are summarized. Interestingly,
the interactions of otp and fezf2 vary over time and are different in the PO and in the
MA at 2 dpf. Green arrows indicate positive regulation while red bars represent negative
regulation and the orange bars indicate slight negative regulation.
3.1.6 Regulatory interactions of fezf2, foxb1.2, otp and sim1a
pattern subregions of the MA
Following the identification of the different genetic interactions of fezf2, foxb1.2, otp and
sim1a, in the MA and the PO, I asked whether these cross-regulatory interactions can
pattern different subregions within the MA compared to the PO.
Fig. 3.12: otpa, otpb, sim1a and fezf2 are mostly co-expressed in the PO
(A-D”) FISH of 2 dpf wild-type embryos to reveal the spatial relationship among otpa
(A,B’,C’), otpb (A’), sim1a (B,D’) and fezf2 (C,D) in the PO. (A-B”) The expression of
otpa mainly overlaps with the expression of otpb (A”) and sim1a (B”). (C-D”) The fezf2
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domain is contained within the otpa (C”) and sim1a (D”) expression domain, although
slightly smaller. Maximum projections of 10-15 µm in the dorsal view are shown. The
scale bar represents 60 µm.
In the PO, where Fezf2 positively regulates otp and sim1a and where Otp positively
regulates fezf2, FISH analysis using 2 dpf wild-type embryos showed that these regulators
are mainly co-expressed (Fig. 3.12). Since otpa and otpb were mainly co-expressed in the
PO (Fig. 3.12A-A”), I only show the co-expression analysis of otpa with sim1a and fezf2.
Consistent with its assumed parallel action in neuron type specification (Löhr et al.,
2009), sim1a and otpa were mainly co-expressed within the PO (Fig. 3.12B-B”). fezf2
was contained within the otp (Fig. 3.12C-C”)and sim1a (Fig. 3.12D-D”) PO expression
domain, although the fezf2 domain was slightly smaller.
In contrast to the PO, the complex regulatory interactions among fezf2, foxb1.2,
otp and sim1a resulted in the generation of distinct subregions within the MA. In the
MA otpa and otpb expression overlapped in the more anterior part of their expression,
but otpb had an extra domain in the posterior most MA (Fig. 3.13A-A”). Therefore, I
will use otpb expression to detect the spatial relationship of otp and fezf2, foxb1.2 and
sim1a. Consistent with their cross-repressive genetic interaction foxb1.2 and fezf2 were
expressed in a mostly non-overlapping manner. Only the anterior most fezf2 domain
slightly overlapped with the posterior extent of foxb1.2 (Fig. 3.13B-B”). Since foxb1.2
was expressed in a compact medially located domain, I will refer to this area as the central
MA from now on. The central MA is delineated in figure 3.13 by white dashed lines.
The main part of the fezf2 expression domain formed a separate domain posterior to the
central MA. Laterally adjacent to the central MA expression of fezf2 (Fig. 3.13C-C”) and
foxb1.2 (Fig. 3.13D-D”), otpb was expressed in the peripheral MA. This finding reflects
the cross-repressive genetic interaction of otp and foxb1.2 and fezf2. The expression of
sim1a showed some overlap with fezf2 (Fig. 3.13E-E”) and foxb1.2 (Fig. 3.13F-F”) in the
central MA but extended more to the lateral. The sim1a expression domain additionally
overlapped with that of otpb in the peripheral MA (Fig. 3.13G-G”).
Taken together, this co-expression analysis showed that strong foxb1.2 expression
demarcates the central MA with contribution by fezf2 and sim1a expression. Domains
peripheral to the central MA are delineated by the expression of fezf2 marking the
posterior, otpa/otpb found in lateral and posterior domains and sim1a labeling lateral and
anterior domains (Fig. 3.14). Thus, the negative and positive genetic interactions of fezf2,
foxb1.2, otp and sim1a pattern different subregions within the posterior hypothalamus,
while the positive genetic interactions of otp, sim1a and fezf2 lead to no distinct
subregionalization in the PO (Fig. 3.14).
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Fig. 3.13: Co-expression analysis of otp, sim1a, foxb1.2, and fezf2 reveals
subregions within the MA
(A-G”) Two-color FISH of 2 dpf wild-type embryos with probes for otpa (A), otpb
A’,C,D,G), sim1a (E’,F,G’), fezf2 (B,C’,E,) and foxb1.2 (B’,D’,F’) reveal their relative
expression patterns in the MA. (A-A”) otpa and otpb are mostly co-expressed in the more
anterior MA, while otpb has an extra domain in the more posterior MA. (B-B”) Strong
foxb1.2 expression marks the central MA where fezf2 expression partially overlaps but
extends further towards the posterior. In contrast, (C-C”) otpb is expressed laterally and
adjacent to fezf2 and (D-D”) foxb1.2. (E-E”) The fezf2 and sim1a domains are partially
co-localized in the central MA. (F-F”) sim1a partially overlaps with foxb1.2. (G-G”) In
the peripheral MA sim1a is co-expressed with otpb. The white dashed lines demarcate
the central MA in B”, C”, D”, E”, F” and G”. Dorsal views of 10-15 µm maximum
projections are shown. Scale bar represents 60 µm.
otpa/otpb
sim1a
fezf2
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Fig. 3.14: Regulatory interactions among fezf2, foxb1.2, otp and sim1a
pattern subregions within the MA
A scheme showing the relative expression pattern of the transcription factors in the PO
and the MA at 2 dpf. The white dashed line delineates the central MA.
3.1.7 otp expression at 1 dpf delineates the prospective
preoptic and the mammillary area
The co-expression analysis at 2 dpf showed that in addition to foxb1.2, otp and fezf2 could
serve as a marker for the MA in the zebrafish hypothalamus. Given the fact that fezf2
(Levkowitz et al., 2003), foxb1.2 and otp (Ryu et al., 2007) are expressed in the posterior
hypothalamus at 1 dpf, I hypothesized that the expression of these regulators may
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delineate the prospective MA already at 1 dpf. In addition, a continuous co-expression of
fezf2 and otp in the anterior diencephalon could delineate the prospective PO, because
in contrast to the MA these two factors are positively regulating each other and they
are co-expressed in the PO at 2 dpf.
Fig. 3.15: otp is expressed in distinct hypothalamic areas at 1 dpf
(A-C”’) Three-color FISH to detect the relative expression of otpb (A”,B”,C’), nkx2.1a
(A), foxb1.2 (A’), emx2 (B), fezf2 (B’,C) and shh (C”) in 1 dpf wild-type embryos. Lateral
views of 10 µm projections are shown and the scale bar represents 60 µm. (A-A”’) The
anterior diencephalic otpb expression domain (arrow) is nkx2.1a- and foxb1.2 -negative,
while the posterior diencephalic domain (arrowhead) is contained within the foxb1.2
domain and mainly overlaps with nkx2.1a. (B-B”’) There is a slight overlap between the
posterior otpb expression and the posterior-ventral emx2 domain. (C-C”’) The forebrain
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otpb expression domains are fezf2 -positive, while very few posterior otpb-positive cells
express shh as well. (D) A model summarizing the relative expression patterns of
otpb, fezf2, foxb1.2, shh, nkx2.1a, and emx2. For simplicity, only the hypothalamic
emx2 expression is shown. White dashed lines in A”’, B”’, C”’ and D delineate the
hypothalamus.
To address this, I performed three-color FISH to reveal the spatial relationship
between otp and fezf2 and foxb1.2 in the context of the hypothalamic markers nkx2.1a
(Rohr et al., 2001), shh and emx2 (Mathieu et al., 2002)(Fig. 3.2). At 1 dpf the
expression of otpa and otpb are comparable. From the anterior to the posterior there
are a telencephalic domain, diencephalic domains and a domain in the hindbrain (Ryu
et al., 2007). Due to this fact, I only used the expression of the otpb probe for the following
experiment. Interestingly, at 1 dpf the posterior most diencephalic otpb expression
domain was contained within the foxb1.2 domain, while the anterior diencephalic domain
was foxb1.2 - as well as nkx2.1a-negative. This posterior otpb-, foxb1.2 -positive domain
was only partially nkx2.1a-positive (Fig. 3.15A-A”’). Additionally, this posterior otpb
domain slightly overlapped with that of emx2 (Fig. 3.15B-B”’). Confirming the positive
regulation of Fezf2 on otpb in the forebrain at 1 dpf, all forebrain otpb-positive domains
were also fezf2 positive, while only a very small proportion of the posterior otpb positive
cells appeared to express shh as well (Fig. 3.15C-C”’). Figure 3.15D shows a model that
summarizes the observed co-expression.
These results suggest that indeed otp could serve as a marker to delineate prospective
hypothalamic regions already at 1 dpf. Although not nkx2.1 -positive I hypothesized that
the anterior diencephalic otp domain that is contained within the fezf2 stripe delineating
the ZLI is a marker for the prospective PO (Fig. 3.15 arrows). In contrast, the posterior
diencephalic nkx2.1a-positive otp domain that is additionally fezf2 - and foxb1.2 -positive
could mark the prospective MA (Fig. 3.15 arrowheads).
To further corroborate this hypothesis I performed two-color FISH at different time
points of development to track the changing transcription factor expression domains.
At 24 hpf, fezf2 (Fig. 3.16A-A”) and foxb1.2 (Fig. 3.16B-B”) were mainly co-expressed
with otpb in the posterior hypothalamus or the prospective MA (arrowheads), while
foxb1.2 was not expressed in the prospective PO (arrow). At 30 hpf (Fig. 3.16C-C”) the
posterior hypothalamic expression domain of fezf2 started to become more condensed in
the prospective MA, where otpb was still partially co-expressed with fezf2. The otp cells
in the prospective PO appeared to increase their cell number. At 36 hpf the prospective
otpb-positive PO still appeared to increase its cell number (Fig. 3.16D”, arrow), while
the fezf2 domain was decreasing its size.
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Fig. 3.16: otp expression delineates the prospective preoptic and
mammillary area from 1 dpf onwards
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(A-G”) Two-color FISH with probes for otpb (A’,B’,C’,D’,E’,F’,G’), fezf2 (A,C,D,F) and
foxb1.2 (B,E,G) to reveal their spatial relationship in wild-type embryos at 24 hpf (A-B”),
30 hpf (C-C”), 36 hpf (D-E”) and 48 hpf (F-G”). Lateral views of 10 µm projections are
shown. (A-A”) otpb is mainly co-expressed with fezf2 at 24 hpf, while (B-B”) only the
posterior hypothalamic otpb domain is foxb1.2 positive. (C-C”) At 30 hpf the posterior
hypothalamic fezf2 domain becomes more condensed within the prospective MA. The
anterior diencephalic otpb domain is fezf2 positive, while the more posterior domain is
partially fezf2 positive. (D-E”) Around 36 hpf the posterior otpb domain is separated from
the fezf2 (D-D”) and the foxb1.2 (E-E”) domains. Although the size of the prospective
PO fezf2 domain decreases, the otpb domain remains fezf2 -positive. (F-G”) In the lateral
view at 48 hpf, the PO (arrow) forms a stripe, which is otpb- and fezf2 -positive. The
foxb1.2 expression together with parts of the fezf2 expression mark the central MA
surrounded by the peripheral MA (arrowheads) otpb expression domain. Arrows point
to the prospective (A-E”) and the established (E-G”) PO and arrowheads point to the
prospective (A-E”) and the established (E-G”) MA. The scale bar represents 60 µm.
Interestingly, the expression of otpb in the prospective MA (arrowheads) started to
separate from the fezf2 (Fig. 3.16D-D”) and foxb1.2 (Fig. 3.16E-E”) expression domain,
leading to only partially overlapping expression domains. At 48 hpf the PO (arrows)
and the MA (arrowheads) were clearly detectable. In the lateral view the PO at 2 dpf
formed a dorsal to ventral otp-positive stripe. This stripe contained the fezf2 expression
domain that reduced its size during development (Fig. 3.16F-F”). Furthermore, the PO
was foxb1.2 -negative from 24 hpf onwards. In the posterior hypothalamus at 48 hpf, the
central MA, which is delineated by the foxb1.2 expression domain, was clearly visible in
the lateral view and surrounded by otpb expressing cells (Fig. 3.16G-G”) that form the
peripheral MA. These otpb expressing cells were also adjacent to the central MA fezf2
domain (Fig. 3.16F-F”).
Taken together these results suggest that the preoptic area as well as the mammillary
area can already be marked by the expression of otp or a combination of foxb1.2 and otp
at 1 dpf.
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3.2 Transcriptional regulation of the hypothalamic neuronal
subtypes
3.2.1 Identification of neuropeptide genes regulated by fezf2,
foxb1.2, otp and sim1a
To test the roles of fezf2, foxb1.2, otp and sim1a on the specification of hypothalamic
neuronal subtypes, I first identified markers for neuronal subtypes in the MA and in
the PO. Therefore, I searched the zebrafish expression database (www.zfin.org) to find
neuropeptides that are expressed in the MA or in the PO. I cloned more than 30 genes
coding for different neuropeptides expressed either in the PO or in the MA or both.
A complete list of the probes can be found in the Material and Methods chapter 6 in
section 6.1.12. To test whether fezf2, foxb1.2, otp and sim1a control the specification of
the identified neuropeptides, I first examined their expression in loss of Otp function
embryos. I choose Otp for this initial screen because Sim1a is assumed to work in
parallel to Otp in neuron type specification (Löhr et al., 2009) and should therefore
display a similar phenotype. Furthermore, Fezf2 and Foxb1.2 are both important for
early patterning of the diencephalon (Jeong et al., 2007; Staudt and Houart, 2007; Toro
and Varga, 2007) and the loss of their function would result in a broad effect resulting
from the patterning defects. For several neuropeptide-expressing cells it was previously
shown that their specification is regulated by Otp. These neuronal subtypes are th, crh,
oxtl, avpl and ss expressing cells (Eaton and Glasgow, 2007; Eaton et al., 2008; Ryu
et al., 2007). I confirmed these observations in 2 dpf wild-type embryos and otpam866
embryos injected with 4 ng of otpb MO; the th expression was severely reduced in the
posterior tuberculum (PT) in loss of Otp function embryos (Fig. 3.17A,B, arrowheads,
n=4/4). Also the crh expression was lost in the PO (arrows) while reduced in the
posterior tuberculum close to the MA (arrowheads)(Fig. 3.17C,D, n=4/4). Consistent
with the published data, the preoptic expression domains of oxtl and avpl were absent in
loss of Otp function embryos (Fig. 3.17E-H, arrows, n=7/7, n=3/3). During this screen I
found that embryos injected with 4 ng otpb MO that did not carry the otpam866 mutation
mainly displayed no or only a slight phenotype. Therefore, I concluded that only the
complete loss of both Otpa and Otpb function induces severe defects in the specification
of neuropeptide-expressing cells. At 3 dpf a complete loss of Otp function resulted in a
slight reduction of ss (Fig. 3.17K,L, arrows, n=4/4) and trh expression in the ventral PO
was reduced (Fig. 3.17M,N, arrows, n=4/4). In addition to confirming previous reports,
I identified for the first time six neuropeptide-expressing neuronal subtypes that are
regulated by Otp.
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Fig. 3.17: Otp is crucial for the specification of several neuronal subtypes
(A-X) Wild-type embryos (A,C,E,G,I,K,M,O,Q,S,U,W) and otpam866 mutant embryos
injected with 4 ng otpb MO (B,D,F,H,J,L,N,P,R,T,V,X) at 2 dpf (A-J) and 3 dpf (K-X)
subjected to WISH to reveal the effect of Otp on the expression of th (A,B), crh (C,D),
oxtl (E,F), avpl (G,H), vip (I,J), ss (K,L), trh (M,N), penka (O,P), slit2 (Q,R), slc18a2
(S,T), uts1 (U,V) and pdyn (W,X). Lateral views are shown. (A,B) th is reduced in the
posterior tuberculum (PT) (arrowheads) in embryos lacking Otp activity (n=4/4), while
(C,D) crh is reduced in both the PO and the PT upon loss of Otp function (n=4/4). (E-H)
oxtl (n=7/7) and avpl (n=3/3) are both absent in loss of Otp function embryos in the
NPO (arrows). (I,J) vip expression is lost in embryos lacking Otp activity (n=19/19) both
in the PO (arrows) and in the MA (arrowheads). (K-M) The reduction of Otp activity
results in a reduced expression of ss in the PO (n=4/4) and of trh in the ventral PO
(n=4/4). (O,P) The expression of penka in the PO (arrows) and in the MA (arrowheads)
become reduced in loss of Otp function embryos (n=5/5). (Q,R) The expression of slit2 in
the PO (arrows, n=8/8) is absent in embryos lacking Otp activity, which also results in an
absent slc18a2 expression domain in the PT (arrowheads, n=7/7). (U-X) Interestingly,
the loss of Otp function leads to an extended expression domain of uts1 (n=21/21) and
pdyn (n=5/5) in the MA (arrowheads). The scale bare represents 200 µm.
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One of these neuronal subtypes were the vasoactive intestinal peptide (vip) -expressing
cells. vip in wild-type embryos appeared to be expressed in the PO (arrows) as well as in
the MA (arrowheads) whereas in 2 dpf loss of Otp function embryos its expression was
lost in both areas (Fig. 3.17I,J, n=19/19). The expression of proenkephalin a (penka) is
very broad throughout the hypothalamus. However, penka that appeared to be expressed
in the PO and in the MA in 3 dpf wild-type embryos was reduced upon complete loss
of Otp function both in the PO (arrows) and in the MA (arrowheads) (Fig. 3.17O,P,
n=5/5). The expression domains of slit2 in the PO (arrows) and of slc18a2 in the PT
(arrowheads) were severely downregulated in loss of Otp function embryos (Fig. 3.17Q-T,
n=8/8, n=7/7). In contrast, the expression domains of urotensin1 (uts1 ) and pdynorphin
(pdyn) in the MA (arrowheads) were extended in embryos lacking Otp activity (Fig.
3.17U-X, n=21/21, n=5/5).
Together, this initial screen for neuronal subtypes whose specification is controlled by
Otp, shows that Otp is important for the formation of several different neuronal subtypes
in mainly the PO, the PT and the MA. In addition, it shows that the expression of the
neuropeptides is regulated differentially by Otp in different hypothalamic regions.
3.2.2 Specification of hypothalamic neurons requires Fezf2,
Foxb1.2, Otp and Sim1a activity
So far my results show that Otp regulates the specification of numerous neuronal
subtypes. Interestingly, I observed that this regulation was not only positive but
also negative resulting in more cells expressing a distinct neuropeptide. Therefore,
the question arises whether this variable regulatory potential results from the differential
regulatory interactions of otp, fezf2, foxb1.2 and sim1a. To answer this question I
performed a comprehensive loss-of-function analysis of the TFs and tested for the
expression of the neuropeptide genes that were including th-, crh-, vip-, oxtl-, avpl-,
uts1 -, pdyn- and penka-positive neurons. In addition, I tested the expression of cck due
to its specific expression in the MA. By using probes for oxtl and avpl I was able to
analyze the fate of the magnocellular neurosecretory neurons, while the crh expression
serves as a marker for the specification of a subset of parvocellular neurosecretory
neurons. Since the probes for th and slc18a2 are both labeling dopaminergic neurons
and the loss-of-function analysis for slc18a2 expression displayed the same phenotype
(data not shown) as th expression I only show the results for th in this thesis. Slit2 is
implicated in axon midline crossing in zebrafish forebrain (Barresi et al., 2005) a topic,
which this thesis did not investigate further.
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Most neuropeptide-expressing cells were examined at 2 dpf, the time point at which
the regulatory interactions of fezf2, foxb1.2, otp and sim1a were investigated. Since not
all of the neuropeptides are expressed at this stage I also performed the loss-of-function
analysis with these neuropeptides at 3 dpf. Consistent with the published data, th
expression was severely downregulated in the hypothalamus in loss of Otp and Sim1a
function embryos (Fig. 3.18A-C, arrowheads, n=4/4, n=14/14) (Löhr et al., 2009; Ryu
et al., 2007), while the loss of Fezf2 function resulted in a slight reduction of th cells
(Fig. 3.18A,D, arrowheads, n=4/11) (Blechman et al., 2007). foxb1.2 morphants showed
no change in th expression (Fig. 3.18A,E, n=13). Also for crh expression it has been
shown that reduced Otp and Sim1a activity results in a lost expression of crh in the PO
(arrows) and a reduced expression in the PT (arrowheads) (Löhr et al., 2009; Ryu et al.,
2007). I confirmed this observation (Fig. 3.18F-H, n=4/4, n=12/12) and showed that
fezf2 morphants display a reduction of the PO (arrows) signal. Further, the reduction
of the crh PT (arrowheads) expression domain was more severe than in the loss of Otp
function embryos (Fig. 3.18F,I, n=13/13). The loss of Foxb1.2 function had no effect on
crh expression (Fig. 3.18F,J, n=15). Hitherto, the expression of vip in zebrafish embryos
has not been published. The WISH results (Fig. 3.18K) indicate that vip expression
domains are found in the PO (arrows) and in the MA (arrowheads). While the loss of
Otp, Sim1a and Fezf2 function resulted in an absent PO domain (Fig. 3.18K-N, arrow,
n= 14/19, n=47/53, n=39/39), only embryos with reduced Otp activity additionally
displayed an absent MA expression domain (Fig. 3.18K,L, n=16/19). sim1a morphants
showed a slightly reduced MA vip domain, while fezf2 morphants displayed more severe
reduction (Fig. 3.18K,M,N, n=30/53, n=37/39). The loss of Foxb1.2 function led to
no apparent changes in vip expression (Fig. 3.18K,O, n=21). Regulatory action of Otp
and Sim1a on oxtl and avpl neuron specification has been studied previously (Eaton
and Glasgow, 2006, 2007; Eaton et al., 2008) as well as the function of Fezf2 in the
specification of oxtl neurons (Blechman et al., 2007). I confirmed that in loss of Otp,
Sim1a and Fezf2 function embryos oxtl expression was absent (Fig. 3.18P-S, arrows,
n=7/7, n=27/37, n=24/31). Additionally, I showed that the loss of Foxb1.2 function had
no impact on oxtl expression (Fig. 3.18P,T, n=14). Furthermore, I confirmed the complete
absence of PO avpl expression in the embryos with reduced Otp and Sim1a activity (Fig.
3.18U-W, arrows, n=6/6, n=40/42). fezf2 morphants displayed a severe reduction of PO
avpl-positive cells (Fig. 3.18U,X, arrows, n=28/28) while foxb1.2 morphant showed no
change in avpl expression (Fig. 3.18U,Y, n=14).
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Fig. 3.18: Specification of hypothalamic neurosecretory neurons requires
fezf2, foxb1.2, otp and sim1a at 2 dpf
(A-Y) WISH of 2 dpf wild-type embryos (A,F,K,P,U), otpam866 mutant embryos injected
with 4 ng otpb morpholino (B,G,L,Q,V), embryos injected with 1 ng sim1a MO
(C,H,M,R,W), 4ng fezf2 MO (D,I,N,S,X) and 8 ng foxb1.2 MO (E,J,O,T,Y) to detect
changes in the expression of th (A-E), crh (F-J), vip (K-O), oxtl (P-T) and avpl (U-Y).
Lateral views are shown. (A-E) The expression of th is highly reduced (arrowheads)
in loss of Otp (B, n=4/4) and Sim1a (C, n=14/14) function embryos, while slightly
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reduced in fezf2 morphants (D, n=4/11) and not changed in foxb1.2 morphants (E,
n=13). (F-J) The expression of crh in the PO (arrows) is absent in embryos with reduced
Otp (G, n=4/4) and Sim1a (H, n=12/12) activity, while reduced in fezf2 morphants (I,
n=13/13). The PT crh expression domain (arrowheads) is reduced in loss of Otp, Sim1a
and Fezf2 function embryos, whereas the loss of Foxb1.2 function results in no apparent
change in crh expression (J, n=15). (K-O) Embryos with reduced Otp (L, n=15/19),
Sim1a (M, n=47/53) and Fezf2 (N, n=39/39) activity display an absent vip expression
domain in the PO (arrows), while loss of Otp function only resulted in a loss of the
vip MA expression domain (L, n=16/19) whereas sim1a and fezf2 morphants display a
reduced MA vip domain (M,N, n=30/53, n=37/39). foxb1.2 morphants shown no change
in vip expression (O, n=21). (P-T) oxtl expression is absent in loss of Otp (Q, n=7/7),
Sim1a (R, n=27/37) and Fezf2 (S, n=24/31) function and not changed in loss of Foxb1.2
function (T, n=14). (U-Y) Embryos with reduced Otp and Sim1 activity show no PO
avpl expression (V,W, arrows, n=6/6, n=40/42), while fezf2 morphants display a highly
reduced PO avpl domain (X, arrow, n=28/28) and foxb1.2 morphants show no apparent
change in avpl expression (Y, n=14). The scale bar represents 200 µm.
Nothing is known about the transcription factors necessary for the specification of
Uts1-, Pdyn-, Penka- or Cck-positive neurons. At 3 dpf, uts1 is expressed in several
distinct hindbrain domains and a single hypothalamic domain. This domain appeared
to be within the MA (Fig. 3.19A, arrowhead). The loss-of-function analysis showed
that a reduced Sim1a and Fezf2 activity led to a reduced uts1 domain in the MA
(Fig. 3.19A,C,D, arrowheads, n=29/42, n=17/42), while, in contrast, the loss of Otp
and Foxb1.2 function resulted in an expansion of the hypothalamic uts1 domain (Fig.
3.19A,B,E, arrowheads, n=21/21, n=58/76). pdyn has a broad expression domain in the
ventral hypothalamus and a faint expression domain in the MA (Fig. 3.19F, arrowheads).
Comparable to the uts1 phenotype, this faint MA expression domain of pdyn was highly
reduced in embryos lacking Sim1a and Fezf2 function (Fig. 3.19F,H,I, arrowheads,
n=23/23, n=26/26). Interestingly, the loss of Otp and the loss of Foxb1.2 function
resulted in a ventrally expanded pdyn domain in the MA (Fig. 3.19F,G,J, arrowheads,
n=5/5, n=16/21). In contrast, the expression of penka is broadly distributed throughout
the zebrafish hypothalamus. Although very scattered one can detect a preoptic or slightly
dorsal to PO expression domain (Fig. 3.19K, arrow) and a domain, which appears to
be expressed in the MA (Fig. 3.19K, arrowheads). Upon loss of Otp, Sim1a and Fezf2
function the preoptic expression domain of penka was reduced (Fig. 3.19K-N, arrows,
n=5/5, n=10/22, n=11/17) while the mammillary expression domain (arrowheads)
of penka appeared to be reduced in embryos with reduced Otp activity but not in
sim1a and fezf2 morphants. The loss of Foxb1.2 function showed no apparent effect on
penka expression (Fig. 3.19K,O, n=22). cck appears to be specifically expressed within
the hypothalamus of zebrafish at 3 dpf. In the hypothalamus it is expressed in the
ventral part and it appeared to be expressed in the MA or slightly anterior to the MA
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(arrowheads). The loss Fezf2 function resulted in a reduced cck expression domain (Fig.
3.19P,S, arrowheads, n=20/25), while the reduction of Otp, Sim1a and Foxb1.2 activity
resulted in no apparent change in cck expression (Fig. 3.19P-R,T, n=6, n =25, n=23).
The expression of cck appears to be slightly reduced in loss of Otp and Sim1a function
embryos but this is due to the reduced age of the embryo and therefore no reliable result.
Fig. 3.19: The regulatory action of Fezf2, Foxb1.2, Otp and Sim1a is
necessary for the specification of uts1, pdyn, penka and cck
expressing neurons
(A-T) 3 dpf old wild-type embryos (A,F,K,P), otpam866 mutant embryos injected with 4
ng otpb morpholino (B,G,L,Q), embryos injected with 1 ng sim1a MO (C,H,M,R), 4ng
fezf2 MO (D,I,N,S) and 8 ng foxb1.2 MO (E,J,O,T) subjected to WISH to detect changes
in the expression of uts1 (A-E), pdyn (F-J), penka (K-O) and cck (P-T). Lateral views are
shown. (A-E) sim1a and fezf2 morphants display a reduced uts1 expression in the MA
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(C,D, arrowheads, n=29/42, n=17/42), while embryos with reduced Otp and Foxb1.2
activity show an expanded MA uts1 domain (B,E, arrowheads, n=21/21, n=58/76).
(F-J) While the loss of Sim1a and Fezf2 function results in a severe reduction of pdyn
expression (H,I, arrowheads, n=23/23, n=26/26), loss of Otp and Foxb1.2 function leads
to an expanded pdyn expression domain in the MA (G,J, arrowheads, n=5/5, n=16/21).
(K-O) The expression of penka in the PO (arrows) is reduced upon loss of Otp (L, n=5/5),
Sim1a (M, n=10/21) and Fezf2 (N, n=11/17) function, while in the MA (arrowheads)
the penka expression appears to be diminished in loss of Otp function embryos but
not changed in sim1a and fezf2 morphants. The loss of Foxb1.2 had no apparent effect
on the penka expression (O, n=22). (P-T) While the loss of Otp (Q, n=6), Sim1a (R,
n=25) and Foxb1.2 (T, n=23) function results in no change of cck expression in the MA
(arrowheads), the loss of Fezf2 function reduced cck expression in the MA (S, arrowheads,
n=20/25). The scale bar shows 200 µm.
The previous results demonstrate, that the activity of Otp, Sim1a and Fezf2 was
necessary for the formation of oxtl-, avpl-, vip- and uts1 -expressing neurons (Fig.
3.18K-Y; Fig. 3.19A-E). To further investigate how the loss of Otp, Sim1a, Fezf2 and
Foxb1.2 function affects the specification of these neuron types I analyzed their cell
number in the PO (Fig. 3.20A-C) and in the MA (Fig. 3.21A,B) at 2 dpf and 3 dpf using
Wilcoxon Signed rank test.
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Fig. 3.20: Otp, Sim1a and Fezf2 activity is necessary for the formation of
oxtl, avpl and vip expressing neurons in the PO
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(A-C) Chart bars indicate the percent change in the number of (A) Oxtl-, (B) Avpl- and
(C) VIP-positive neurons in otpam866 mutant embryos injected with 4 ng otpb morpholino,
wild-type embryos injected with 1 ng sim1a MO, 4ng fezf2 MO and 8 ng foxb1.2 MO
compared to uninjected wild-type embryos. The number of oxtl-, avpl- and vip-expressing
cells was compared using the Wilcoxon Signed rank test, which uses the medians of
wild-type embryos as a reference. At 2 dpf the number of oxtl-expressing cells in wild-type
embryos has median and mean (± s.e.m.) values of 16 and 15.5 (± 0.37), respectively. (A)
The loss of Otp, Sim1a, and Fezf2 function leads to a reduction in oxtl-expressing cells
(no P value, complete loss; P<0.001; P<0.001), whereas foxb1.2 morphants show a slight
decrease compared to the wild-type embryos (P=0.0032). The number of avpl-expressing
cells in wild-type embryos has median and mean (± s.e.m.) values of 7 and 6.5 (±
0.44), respectively. (B) Embryos lacking Otp, Sim1a and Fezf2 activity have a decreased
number of avpl-expressing cells (no P value, complete loss; P<0.001; P<0.001). The
loss of Foxb1.2 leads to no changes in Avpl cell number (P=0.8582). The number of
vip-expressing cells in the PO of wild-type embryos has median and mean (± s.e.m.)
values of 5 and 4.7 (± 0.25), respectively. (C) The loss of Otp, Sim1a and Fezf2 function
results in the reduction of vip-expressing cells (P<0.001; P<0.001; no P value, 100 %
loss), whereas the reduction of Foxb1.2 activity results in no changes of VIP cell number
(P=0.3973). Error bars indicate standard error of the means. The number of embryos
analyzed is shown in the graph. Abbreviations used: loss-of-function (LOF).
In the PO, Oxtl cell number is highly reduced in embryos lacking Otp, Sim1a and
Fezf2 function (no P value because loss of OTP function results 100 % loss of oxtl cells;
P<0.001; P<0.001)(Fig. 3.20A). In contrast the loss of Foxb1.2 function resulted in slight
changes in Oxtl cell number (P=0.0032) that could result from the delayed development
that the embryos injected with 8 ng of MO display. The embryos with reduced Otp
function showed a lack of avpl-expressing neurons (Fig. 3.20B), whereas the loss of Sim1a
and Fezf2 function resulted in a severe reduction in Avpl cell number (P<0.001; P<0.001)
and no changes were observed in embryos with reduced Foxb1.2 activity (P=0.8582).
Similar to Avpl cell number, vip-expressing neurons in the PO are highly reduced in
loss of Otp and Sim1a function (P<0.001; P<0.001)(Fig. 3.20C). The reduction of Fezf2
activity resulted in the the loss of all vip-expressing neurons, whereas foxb1.2 morphants
show no changes in VIP cell number (P=0.3973).
In the MA, Embryos with reduced Otp, Sim1a and Fezf2 activity showed a variable
reduction of vip expressing cells in the MA (Fig. 3.18K-N). To further assess this finding,
I analyzed the number of vip-expressing cells in wild-type embryos and embryos with
reduced Otp, Sim1a, Fezf2 and Foxb1.2 activity in the MA (Fig. 3.21A). The loss of
Otp, Sim1a and Fezf2 function resulted in a decreased number of vip-expressing cells in
the MA compared to wild-type embryos (Wilcoxon Signed rank test, P<0.001; P<0.001;
P<0.001), whereas the reduction of Foxb1.2 activity had no effect in vip-expressing cells
(P=0.7423). In contrast, the number of uts1 -expressing neurons is increased in loss of
Otp and Foxb1.2 function embryos (P<0.001; P<0.001) (Fig. 3.21B) and decreased in
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sim1a and fezf2 morphants (P<0.001; P<0.001).
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Fig. 3.21: Otp, Sim1a, Fezf2 and Foxb1.2 activity is necessary for the
formation of vip and uts1 expressing neurons in the MA
(A,B) Chart bars indicate the percent change in the number of (A) VIP- and (B)
Uts1-positive neurons in loss-of-function embryos compared to uninjected wild-type
embryos. The number of vip- and uts1 -expressing cells was compared using the medians
of wild-type embryos as a reference (Wilcoxon Signed rank test). At 2 dpf the number of
vip-expressing cells in wild-type embryos has median and mean (± s.e.m.) values of 14
and 14.6 (± 0.36), respectively. (A) The loss of Otp, Sim1a, and Fezf2 function leads to
a reduction in VIP cell number in the MA compared to the wild-type embryos (P<0.001;
P<0.001; P<0.001), whereas the loss of Foxb1.2 shows no difference compared to the
wild-type (P=0.7423). The number of uts1 -expressing cells in wild-type embryos has
median and mean (± s.e.m.) values of 8 and 8.5 (± 0.22), respectively. (B) Embryos
lacking Otp and Foxb1.2 activity have an increased number of Uts1-positive cells
(P<0.001; P<0.001), whereas the loss of Sim1a and Fezf2 leads to a reduction (P<0.001;
P<0.001). Error bars indicate standard error of the means. The number of embryos
analyzed is shown in the graph. Abbreviations used: loss-of-function (LOF).
In summary, these analyses of the cell numbers of distinct neuron types in
loss-of-function embryos shows the necessity of Otp, Sim1a and Fezf2 in the PO and
of Otp, Sim1a, Fezf2 and Foxb1.2 in the MA for the specification of neuronal subtypes.
Interestingly, the regulation of the specification of vip-expressing neurons in the PO
compared to the MA is different. To investigate the regulatory action of the transcription
factors on neuron type specification further and to detect which of the regulators
are sufficient to induce a distinct neuron type I performed a co-expression and a
gain-of-function analysis.
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3.2.3 Different MA and PO domains give rise to distinct
neuronal subtypes
The observed changes in the expression of the neuropeptides upon loss of Fezf2, Foxb1.2,
Otp and Sim1a function reveal the necessity of these transcription factors for the
specification of the neuronal subtypes. However, to what extent the variable interactions
among these transcription factors and the resulting subdomains within the PO and the
MA play a role in the specification of distinct neuron types remains unknown. To answer
this question, I first performed co-expression analyses using two color FISH with probes
of selected neuropeptides in combination with fezf2, foxb1.2, otp or sim1a.
In the MA penka and cck were expressed lateral to the otpa expression domain, which
marks the peripheral MA (Fig. 3.22A-B”). Hence, these neuropeptide are expressed
outside of the so far described MA and its regulatory network that they are therefore
excluded from following experiments. The regulatory action of Fezf2 on the expression
of both neuropeptides can be explained by the early regulatory interactions of Fezf2 in
the posterior hypothalamus at 1 dpf.
Fig. 3.22: penka and cck are expressed lateral to the peripheral MA
(A-B”) 2 dpf wild-type embryos subjected to two color FISH to reveal the spatial
relationship of otpa (A’,B’) and both penka (A) and cck (B) in the MA. The maximum
projections of 10-15 µm are shown in the dorsal view. (A-B”) penka (A-A”) and cck
(B-B”) are expressed lateral to the otpa expression domain. The scale bar represents 60
µm.
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Fig. 3.23: The co-expression of transcription factors with oxtl, avpl and vip
displays regulatory actions
(A-I) Two-color FISH with probes for otpb (A’,D’,G’), sim1a (B’,E’,H’), fezf2 (C’,F’,I’),
oxtl (A-C”), avpl (D-F”) and vip (G-I”) in 2 dpf wild-type embryos to reveal their spatial
relationship. Maximum projections of 10 µm in the dorsal view are shown. (A-B”) The
expression of oxtl is contained within the otpb (A-A”) and sim1a (B-B”) expression
domains. (C-C”) fezf2 and oxtl are mostly not co-expressed. (D-E”) Also the preoptic
avpl expression is contained within the otpb (D-D”) and sim1a (E-E”) expression domain
and (F-F”) avpl is mostly co-expressed with fezf2. (G-I”) vip is co-expressed with otpb
(G-G”), sim1a (H-H”) and mostly with fezf2 (I-I”). (J) A model summarizing the spatial
relationship among the transcription factors and oxtl, avpl and vip. The scale bar shows
60 µm.
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The co-expression analysis in the PO was performed using probes of oxtl, avpl and
vip in combination with probes of the transcription factors otpb (as representative of the
two otp paralogs), sim1a and fezf2. As expected from the loss-of-function analysis, oxtl
was co-expressed with otpb (Fig. 3.23A-A”) and sim1a (Fig. 3.23B-B”), consistent with
the fact that the loss of both Otpa and Sim1a activity led to a loss of oxtl-expressing
cells (Fig. 3.18P-R). Only a few oxtl-expressing cells were contained within the fezf2
expression domain (Fig. 3.23C-C”), although the loss of Fezf2 function resulted in an
absent oxtl domain (Fig. 3.18P,S). This suggests that Fezf2 regulates oxtl expression by
its effect on otp expression. Alternatively, Fezf2 might be present in oxtl progenitor cells.
avpl expression was contained within the otpb and sim1a expression domain (Fig.
3.23D-E”), consistent with the findings that the loss of Otp and Sim1a function resulted
in an absent preoptic avpl domain (Fig. 3.18U-W). The loss of Fezf2 function resulted in
a highly reduced preoptic avpl expression (Fig. 3.18U,X), which suggested co-expression.
Indeed, most of the avpl-positive neurons were fezf2 -positive (Fig. 3.23F-F”). Since vip
expression in the PO is absent in embryos with reduced Otp, Sim1a and Fezf2 activity
(Fig. 3.18K-N), I expected that vip is contained within all three expression domains. In
fact, vip was co-expressed with otpb (Fig. 3.23G-G”), sim1a (Fig. 3.23H-H”) and mainly
co-expressed with fezf2 (Fig. 3.23I-I”). The model in figure 3.23J summarizes the results
of the co-expression analysis of the PO. Consistent with the fact that foxb1.2 is not
expressed in the PO throughout embryonic development (Fig. 3.1E and Fig. 3.2) a loss
of Foxb1.2 function resulted in no apparent change of oxtl, avpl and vip expression at 2
dpf (Fig. 3.18K,O,P,T,U,Y).
In the MA the regulatory interactions of fezf2, foxb1.2, otp and sim1a formed
distinct subregions within the MA. To test whether these subregions and the defined
combination of transcription factors expressed there give rise to distinct neuronal
subtypes, I performed a co-expression analysis. The spatial relationship of vip and
uts1 with otpb, sim1a, fezf2 and foxb1.2 was investigated. Since the loss of Otp function
resulted in a complete loss of vip expression in the MA (Fig. 3.18K,L) I hypothesized
that vip is expressed in the otp expression domain and is therefore situated in the
peripheral MA. Indeed, vip was contained within the otpb expression domain at 2
dpf (Fig. 3.24A-A”) as well as within the sim1a expression domain (Fig. 3.24B-B”).
This finding is also consistent with the fact that embryos with reduced Sim1a activity
show a slightly reduced vip expression in the MA (Fig. 3.18K,M). Although vip is
not co-expressed with fezf2 (Fig. 3.24C-C”) the loss of Fezf2 function resulted in a
severe reduction of vip-expressing cells in the MA (Fig. 3.18K,N). This finding might
be explained by the earlier positive regulation of Fezf2 on the otp expression in the
MA, where fezf2 morphants display a severe reduction of otp expression at 1 dpf and
at 2 dpf (Fig. 3.6A,B,D,E and Fig. 3.8A,B,D,E). The loss of Foxb1.2 activity resulted
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in no changes of vip expression in the MA (Fig. 3.18K,T) which is consistent with the
finding that vip expression was found outside of the foxb1.2 expression domain (Fig.
3.24D-D”). In the case of uts1, loss of Sim1a and Fezf2 function embryos displayed a
reduced number of uts1 -expressing cells in the MA (Fig. 3.19A,C,D), which suggests
that uts1 is expressed in a sim1a- and fezf2 -positive domain. Indeed, the co-expression
analysis at 3 dpf revealed that uts1 is contained within the medially located sim1a (Fig.
3.24F-F”) and fezf2 expression domain (Fig. 3.24G-G”).
Fig. 3.24: VIP- and Uts1 positive neurons develop within different MA
domains
(A-H”) Two-color FISH of 2 dpf (A-D”) and 3 dpf wild-type embryos (E-H”) to detect
the relative expression of vip (A-D”) and uts1 (E-H”) in comparison to the expression of
otpb (A’,E’), sim1a (B’,F’), fezf2 (C’,G’) and foxb1.2 (D’,H’). (A-D”) vip is contained
within the otpb (A-A”) and the sim1a (B-B”) expression, while it is not co-expressed
with fezf2 (C-C”) and foxb1.2 (D-D”). (E-H”) In contrast, uts1 is not co-expressed with
otpb (E-E”), but is co-expressed with sim1a (F-F”), fezf2 (G-G”) and foxb1.2 (H-H”).
10-15 µm maximum projections in the dorsal view are shown. Scale bars represent 60
µm.
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In addition, otpb is expressed adjacent to the uts1 expressing cells with nearly no overlap,
showing that uts1 is expressed in the central MA that is surrounded by the lateral otpb
expression (Fig. 3.24E-E”). This finding together with the loss-of-function analysis
illustrates clearly the regulatory interactions between otp and fezf2 at 2 dpf, where the
loss of Otp function resulted in an expanded fezf2 expression domain (Fig. 3.1C,D), that
contains uts1 -expressing cells, and results in more uts1 cells (Fig. 3.19A,B). Although
the co-expression analysis revealed uts1 expressing cells to be expressed in the central
MA and to be foxb1.2 -positive (Fig. 3.24H-H”), the loss of Foxb1.2 function resulted in
an expanded uts1 expression domain in the MA. This result can be explained by the
genetic regulatory interaction of foxb1.2 and fezf2. The loss of Foxb1.2 function resulted
in an expanded fezf2 expression domain in the MA (Fig. 3.9C,D). Since Fezf2 activity
is important for the specification of uts1 -expressing cells in the MA (Fig. 3.19A,D), an
expanded fezf2 expression domain could lead to more uts1 cells.
otpa/otpb
sim1a
fezf2
foxb1.2
eye
eye
uts1
vip
central MA
Fig. 3.25: vip and uts1 are expressed in subregions of the MA
A model illustrating the co-expression of fezf2, foxb1.2, otp, and sim1a with vip and uts1
in different subregions of the MA. The white dashed line demarcates the central MA.
In summary, VIP and Uts1-positive cells develop in different subregions of the MA,
which reflect the requirement of the distinct transcription factors for the specification of
these neuropeptide producing cells. VIP cells are situated in the peripheral MA and are
otp+ and sim1+. Uts1 cells can be found in the central MA and are sim1a+, fezf2+
and foxb1.2+, although Foxb1.2 is not necessary for the specification of uts1 expressing
cells (Fig. 3.25).
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3.2.4 Transcription factor requirement for the specification of
Oxtl, Avpl, VIP and Uts1 neurons
3.2.4.1 Establishment of inducible transgenic lines over-expressing fezf2,
foxb1.2, otpa, otpb or sim1a cDNA
To test which of the transcription factors might be sufficient to induce the fate of a neuron
type I generated transgenic lines over-expressing the cDNA of fezf2, foxb1.2, otpa, otpb
and sim1a fused with either GFP or tdTomato fluorophores via the viral 2A peptide
(Tang et al., 2009) to allow easy identification of embryos carrying the transgenes. These
transgene cassettes are under the control of an inducible basal heat shock promoter
(Halloran et al., 2000). To test whether the transgenic lines do over-express the distinct
cDNAs I performed WISH of the lines with strongest fluorophore over-expression after
over night (ON) heat shock treatment. All of the analyzed transgenic lines showed a
strong over-expression of the cDNAs contained within the transgenic construct (Fig.
3.26A-J).
3.2.4.2 Otp, Sim1a, Fezf2 or Foxb1.2 are sufficient to induce distinct
neuronal subtypes
To test whether the transcription factors expressed in Oxtl, Avpl, VIP and Uts1 neurons
are sufficient to promote their fates I performed temporally controlled gain-of-function
(GOF) analyses. The ON heat shock was carried out either at 34 hpf for Oxtl, Avpl
and VIP or at 2,5 dpf for Uts1 in order not to interfere with early patterning of the
hypothalamus. Neurons expressing oxtl express otpa, otpb and sim1a while they do mostly
not express fezf2 (Fig. 3.23A-C”). Therefore, I hypothesized that the over-expression of
Otp and Sim1a might be sufficient to induce supernumerary oxtl-expressing cells. Indeed,
I found more oxtl-expressing cells in embryos over-expressing otpa (P<0.001, Wilcoxon
Signed rank test) and sim1a (P<0.001) while over-expression of fezf2 (P=0.6926) and
otpb (P=0.2105) had no effect on oxtl cell number when compared to wild-type embryos
that were heat-shocked (Fig. 3.27A). Similar to oxtl-expressing cells, avpl-expressing
cells are present within the otp and sim1a expression domains. In addition, avpl cells
also mostly co-express fezf2 (Fig. 3.23D-F”). The analysis of the avpl cells revealed
that only the over-expression of sim1a (P<0.001, Wilcoxon Signed rank test) and a
combination of otpa and fezf2 (P<0.001) was sufficient to induce supernumerary avpl
cells compared to heat-shocked wild-type embryos (Fig. 3.27B). In contrast, neither
the over-expression of otpa (P=0.3428), otpb (P=0.1293), fezf2 (P=0.6253) nor other
transcription factor combinations were sufficient. Similar to avpl-expressing cells, vip in
the PO is co-expressed with otp, sim1a and fezf2 (Fig. 3.23G-I”), which suggests that
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Fig. 3.26: Heat shock induces over-expression of the transgenes
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(A-J) After an overnight heat shock wild-type embryos (A,C,E,G,I) and embryos
containing (B) Tg(hsp70:otpa-2A-EGFP)hd7, (C) Tg(hsp70:otpb-2A-lyntdTomato)fd1,
(F) Tg(hsp70:sim1a-2A-lyntdTomato)hd8, (H) Tg(hsp70:fezf2-2A-EGFP)hd6 and
(J) Tg(hsp70:foxb1.2-2A-EGFP)hd9 have been subjected to WISH to detect the
over-expression of otpa (A,B), otpb (C,D), sim1a (E,F), fezf2 (G, H) or foxb1.2 (I,J).
Transgenic lines expressing otpa (A, B, n=24/24), otpb (C,D, n=21/29), sim1a (E,F,
n=29/29), fezf2 (G,H, n=37/37) or foxb1.2 (I,J, n=34/34) showed an over-expression
of the specific transgenes. Lateral views are shown. The scale bar is 200 µm.
the over-expression of these three transcription factors individually or in combination
might be sufficient to induce supernumerary vip cells. Interestingly, while the
over-expression of otpa (P=0.0331, Wilcoxon Signed rank test) and fezf2 (P=0.0016)
resulted in fewer preoptic vip cells the over-expression of otpb led to ectopic vip expression
throughout the brain (Fig. 3.29A,B), only the over-expression of sim1a resulted in
a higher vip cell number compared to heat-shocked wild-type embryos (P=0.0116).
Different combinations of the transcription factors had no effect on vip cell number (Fig.
3.27C).
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Fig. 3.27: Otp and Sim1a are sufficient to induce supernumerary oxtl, avpl
and vip cells in the PO.
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(A-C) Chart bars indicate the percent change in the number of Oxtl- (A) and Avpl-
(B) and VIP-positive (C) neurons in transgenic embryos over-expressing cDNAs for
otpa, sim1a or fezf2 in comparison to wild-type embryos. Cell number changes were
compared to the theoretical median cell number of wild-type embryos and analyzed
using Wilcoxon Signed rank test. Heat-shocked wild-type embryos have median and
mean (± s.e.m.) values of 13 and 13.2 (± 0.18) Oxtl-positive cells, respectively. (A)
Over-expression of otpa (P<0.001) and sim1a (P<0.001) results in a higher oxtl cell
number whereas over-expression of otpb (P=0.2105) and fezf2 (P=0.6926) leads to no
changes in oxtl cell number. Wild-type embryos subjected to ON heat shock displayed
median and mean (± s.e.m.) values of 4 and 4.1 (± 0.12) Avpl-positive cells, respectively.
(B) Over-expression of sim1a (P<0.001) and combined over-expression of otpa and fezf2
(P<0.001) results in a higher number of avpl-expressing cells while the over-expression
of otpa (P=0.3428), otpb (P=0.1293), fezf2 (P=0.6352), sim1a plus fezf2 (P=0.4083)
and otpa plus sim1a (P=0.5287) has no effect. Heat-shocked wild-type embryos showed
median and mean (± s.e.m.) values of 3 and 3.1 (± 0.11) VIP-positive cells, respectively.
(C) While only the over-expression of sim1a (P=0.0116) leads to supernumerary vip cells
the over-expression of otpa (P=0.0331) and fezf2 (P=0.0016) results in a reduction of vip
cells. The combination of otpa plus fezf2 (P=0.0607) and otpa plus sim1a (P=0.5024)
has no effect on vip cell number. Error bars indicate standard error of the means. The
number of embryos analyzed is shown in the graph.
In summary, the co-expression and loss- and gain-of-function experiments
demonstrate that Oxtl-positive neuron specification requires Otp and Sim1a,
Avpl-positive neurons require Otp, Sim1a and Fezf2 and the preoptic VIP cells require
Sim1a activity. In addition, Otp and Fezf2 function seems to be crucial demonstrated by
the strong reduction of VIP-positive cells in loss of Otp and Fezf2 function embryos.
In contrast to the PO, in the MA vip is co-expressed with otp and sim1a but not
with fezf2 and foxb1.2 (Fig. 3.24A-D”). Hence, I hypothesized that the over-expression
of otpa, sim1a and/or a combination of both may lead to supernumerary VIP-positive
cells. Indeed, I found more VIP-positive cells in embryos over-expressing otpa (P<0.001,
Wilcoxon Signed rank test), sim1a (P<0.001) or a combination of both (P<0.001)
compared to wild-type embryos that were heat-shocked (Fig. 3.28A). Notably, the
over-expression of fezf2 (P=0.2170) or foxb1.2 did not lead to an increase in the number
of VIP-positive cells consistent with the fact that vip cells are not co-expressed with
fezf2 and foxb1.2 at this stage. Moreover, the over-expression of foxb1.2 led to a
reduction in vip cell number (P<0.001). Since uts1 was co-expressed with sim1a, fezf2,
and foxb1.2 in the central MA (Fig. 3.24F-H”), I tested the effect of over-expression
of these factors on the number of uts1 -expressing cells. Although the over-expression
of sim1a (P=0.5645, Wilcoxon signed rank test) alone had no effect on the number of
Uts1-positive cells, over-expression of fezf2 (P=0.0137), sim1a plus fezf2 (P=0.0099),
and of foxb1.2 (P<0.001) led to an increase in the number of uts1 -expressing cells.
Consistent with the fact that uts1 is not co-expressed with otp the over-expression of
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otpa did not change uts1 cell number (P=0.4485) (Fig. 3.28B). The increase in the
number of Uts1-positive cells was relatively small, which was likely due to the fact
that I performed the heat shock induction at 2.5 dpf, when most of the neurons are
already specified. However, the increase was nonetheless significant and consistent across
multiple experiments. Thus taken together, the loss-of-function and over-expression
analyses demonstrate that VIP-positive neuron specification requires Otp and Sim1a
whereas Uts1-positive neurons require Fezf2, Sim1a and Foxb1.2 activity. In addition,
although not expressed in VIP-positive neurons in later developmental stages, Fezf2 is
crucial for their development, shown by the strong reduction of vip expressing cells in
fezf2 morphants.
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Fig. 3.28: Otpa and Sim1a are sufficient to induce VIP neurons and Fezf2
and Foxb1.2 are sufficient to induce Uts1 neurons
(A,B) Chart bars indicate the percent change in the number of VIP- (A) and Uts1 (B)
-positive neurons in transgenic embryos over-expressing cDNAs for otpa, sim1a, fezf2 or
foxb1.2 in comparison to wild-type embryos. Cell number changes were compared to the
theoretical median cell number of wild-type embryos and analyzed using the Wilcoxon
Signed rank test. Heat-shocked wild-type embryos have median and mean (± s.e.m.)
values of 13 and 12.8 (± 0.17) VIP-positive cells, respectively. (A) Over-expression of otpa
(P<0.001) and sim1a (P<0.001) leads to a higher number of VIP-positive cells. Combined
over-expression of otpa and sim1a also leads to a higher number of VIP-positive cells
(P<0.001) whereas over-expression of foxb1.2 results in a lower number of VIP-positive
cells (P<0.001). Over-expression of fezf2 leads to no change in the number of VIP-positive
cells (P=0.2170). The number of Uts1-positive cells in heat-shocked wild-type embryos
has median and mean (± s.e.m.) values of 9 and 8.8 (± 0.19), respectively. (B) The
over-expression of fezf2, a combination of fezf2 and sim1a, and of foxb1.2 leads to a higher
number of Uts1-positive cells at 3 dpf in the MA compared to the wild-type (P<0.05;
P<0.01; P<0.001) whereas over-expression of sim1a showed no changes in the number
of Uts1-positive cells (P=0.5645). Error bars indicate standard error of the means. The
number of embryos analyzed is shown in the graph.
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3.2.4.3 Otpb is sufficient to induce ectopic vip expression
The over-expression of otpb resulted in ectopic expression of vip broadly in the brain at
34 hpf before the onset of endogenous vip expression and also at 48 hpf (Fig. 3.29A-D,
n=27/27, n=112/112). Interestingly, in addition embryos over-expressing sim1a displayed
an ectopic vip expression domain at 34 hpf before endogenous vip starts to be expressed
(Fig. 3.29E,F, n=25/25) and also at 48 hpf (data not shown) in the hindbrain.
Fig. 3.29: Over-expression of otpb is sufficient to induce ectopic vip
expression
(A-F) WISH to detect the expression of vip in heat-shocked wild-type embryos (A,C,E),
in heat-shocked Tg(hs:otpb-2A-tdTomato)fd1 embryos (B,D) and in heat-shocked
Tg(hs:sim1a-2A-tdTomato)hd8 embryos at 34 hpf (A,B,E,F) and at 2 dpf (C,D). (A-D)
Ectopic vip expression can be induced by otpb over-expression at 34 hpf (n=27/27) and
at 2 dpf (n=112/112). (E,F) Over-expression of sim1a induces an extra vip expression
domain in the hindbrain (n=25/25). The Scale bar represents 200 µm.
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Embryos over-expressing sim1a displayed a higher degree of over-expression of the
transgene in a domain in the hindbrain (Fig. 3.30A,B, arrow, n=29/29), this domain also
showed ectopic expression of otpb (Fig. 3.30C,D, arrow, n=20/20). This suggests that the
ectopic otpb expression in turn led to ectopic expression of vip in this hindbrain domain
at 2 dpf (data not shown, n=129/129) and at 3 dpf (Fig. 3.30E,F, arrow, n=70/70).
Thus, a high over-expression of sim1a induces ectopic expression of otpb, which in turn
induces ectopic expression of vip.
Fig. 3.30: High-level over-expression of sim1a induces ectopic otpb
expression that subsequently results in ectopic vip expression
(A-F) The expression of sim1a (A,B), otpb (C,D) and vip (E,F) was detected
after ON heats shock in wild-type embryos (A,C,E) and embryos containing
Tg(hsp70:sim1a-2A-lyntdTomato)hd8 (B,D,F) at 2 dpf (A-D) and 3 dpf (E,F) by
using WISH. (A,B) Short staining of embryos over-expressing sim1a revealed a
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high-level over-expression domain of sim1a in the hindbrain (arrow, n=29/29). (C,D)
Over-expression of sim1a results in ectopic expression of otpb in the hindbrain (arrow,
n=20/20). (E,F) A comparable hindbrain domain shows ectopic vip expression upon
sim1a over-expression (n=70/70). Dorsal views are shown. The scale bar represents 200
µm.
To determine if the over-expression of the transcription factors results in the
upregulation or downregulation of other transcription factors as well, I performed a
gain-of-function analysis. I found that none of the over-expressed transcription factor
was sufficient to change the expression of another one (Fig. 3.31A-B2) except of sim1a,
which showed ectopic otpb expression in the hindbrain (Fig. 3.30C,D).
Fig. 3.31: Over-expression of otpa, otpb, sim1a, fezf2 and foxb1.2 revealed
nearly no genetic regulatory interactions among those
transcription factors
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(A-B2) WISH to detect the expression of otpa (A-E), otpb (F-J), sim1a (K-P),
fezf2 (Q-V) and foxb1.2 (W-B2) in 2 dpf wild-type embryos and embryos
containing Tg(hsp70:otpa-2A-EGFP)hd7 (G,L,R,X), Tg(hsp70:otpb-2A-lyntdTomato)fd1
(B,M,S,Y), Tg(hsp70:otpa-2A-EGFP)hd7 plus Tg(hsp70:otpb-2A-lyntdTomato)fd1
(N,T,Z), Tg(hsp70:sim1a-2A-lyntdTomato)hd8 (C,H,U,A2), Tg(hsp70:fezf2-2A-EGFP)
hd6 (D,I,O,B2) and Tg(hsp70:foxb1.2-2A-EGFP)hd9 (E,J,P,V) after ON heat shock to
detect alterations in transcription factor expression patterns. Lateral views are shown.
(A-E) Neither the over-expression (OE) of otpb (B, n=16), sim1a (C, n=27), fezf2
(D, n=16) nor of foxb1.2 (E, n=30) results in a change in otpa expression. (F-J) The
expression of otpb is not affected by over-expression of otpa (G, n=17), fezf2 (I, n=20) or
foxb1.2 (J, n=36), while the over-expression of sim1a results in an ectopic otpb domain
in the hindbrain (H, arrow, n=20/20). (K-P) sim1a expression is not changed upon
over-expression of otpa (L, n=18), otpb (M, n=19), a combination of otpa and otpb
(N, n=25), fezf2 (O, n=22) and foxb1.2 (P, n=33). (Q-V) Over-expression of otpa (R,
n=18), otpb (S, n=17), a combinatorial over-expression of otpa and otpb (T, n=24),
sim1a (U, n=35) and foxb1.2 (V, n=27) results in no alteration of fezf2 expression.
(W-B2) No effect on foxb1.2 expression is achieved by over-expressing otpa (X, n=13),
otpb (Y, n=12), a combination of otpa and otpb (Z, n=22), sim1a (A2, n=32) and fezf2
(B2, n=24). The scale bar shows 200 µm.
The fact that there was no detectable upregulation or downregulation of other
transcription factors in the gain-of-function analysis might be due to the fact that the
level of over-expression is very low. A real-time PCR analysis to detect the fold change
of otpa expression in the F1 and F2 generation of Tg(hsp70:otpa-2A-EGFP)hd7 embryos
showed no significant increase in otpa expression (Chen-Min Yeh, unpublished data). In
addition, the low level of over-expression is further decreasing in the following generation
(Fig. 3.32).
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Fig. 3.32: ON activation of Tg(hsp70:otpa-2A-EGFP)hd7 results in a slight
increase in otpa mRNA
Chart bars indicate the fold change of otpa mRNA after ON heat shock of wild-type
and Tg(hsp70:otpa-2A-EGFP)hd7 embryos of the F1 and F2 generation. Four individual
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samples of each genotype have been analyzed and compared using paired t-test. In the F1
generation a 1.6 fold non-significant increase in otpa mRNA compared to heat-shocked
wild-type embryos could be detected (P=0.1902) while the F2 generation only shows an
increase of 1.3 fold (P=0.3704). Error bars indicate standard error of the means.
3.3 In vivo analysis of regulatory interactions in preoptic and
posterior hypothalamus neurons
3.3.1 Generation of stable transgenic lines labeling
transcription factor expression domain
One of the advantages of zebrafish is the transparency of its embryos. Using this
advantage one can utilize in vivo time-lapse imaging to observe even slight differences in
the birthdates of distinct neurons and to track a labeled lineage at single cell resolution.
To further investigate the hypothalamic cell lineages, it is necessary to induce the
expression of a fluorophore in distinct sub-lineages of the developing hypothalamus.
Otp in zebrafish is one of the key transcription factors for the development of the
neuroendocrine hypothalamus (Blechman et al., 2007; Eaton and Glasgow, 2007; Eaton
et al., 2008; Ryu et al., 2007). Reflecting its complex function for the specification
of several neuronal sub-types, Otp is broadly expressed from 2 days post fertilization
(dpf) onwards in the zebrafish diencephalon, including parts of the PO, the posterior
tuberculum (PT), the ventral hypothalamus (vHyp) and the posterior hypothalamus
(pHyp) (Fig. 3.33A-D). Therefore, the regulatory region of otp should contain enhancers
specific for distinct Otp-positive regions and for several neuron types. Contrary to Otp,
fezf2 has a broad expression in the diencephalon at 1 dpf but a more specific expression
from 2 dpf onwards. The diencephalic expression of fezf2 at 2 dpf is restricted to the PO
and to the posterior hypothalamus (Fig. 3.33E,F). Therefore, also the fezf2 regulatory
region should contain enhancers specific for distinct Fezf2 positive regions and neuron
types.
It is already known that some cells are Fezf2- and Otp-positive until they are fully
differentiated. fezf2 for example is expressed in Oxtl neurons (Blechman et al., 2007) in
the preoptic area, which suggests that Fezf2 may defines distinct lineages of differentiated
neurons. Furthermore, otp is expressed in progenitors as well as in differentiated neurons
(Ryu et al., 2007). This suggests that early otp is expressed broadly in progenitor cells
and may define a specific hypothalamic lineage. To investigate the relationship between
Otp-positive and Fezf2-positive neurons as well as their final fates I generated constructs
containing the regulatory region of these transcription factors controlling the expression
of a fluorescent protein.
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Fig. 3.33: The expression of otpa, otpb and fezf2 at 1 and at 2 dpf
(A-F) WISH of the expression of otpa (A,B), otpb (C,D) and fezf2 (E,F) at 1 dpf (A,C,E)
and at 2 dpf (B,D,F) to reveal their expression pattern in wild-type embryos. (A-D) At
1 dpf the expression of otpa and otpb is spatially restricted to a small telencephalic
(Tel) domain, diencephalic (Di) domains and a hindbrain domain (not shown). Both
factors show a broad expression at 2 dpf including the preoptic area (PO), the posterior
tuberculum (PT), the ventral hypothalamus (vHyp) and the posterior hypothalamus
(pHyp). (E,F) In contrast, fezf2 has a broad expression at 1 dpf and spatially restricted
expression at 2 dpf including a small domain in the PO and a bigger domain in the vHyp.
Dorsal views are shown and the scale bar represents 200 µm.
Due to a genome duplication event there are 2 paralogs of the otp gene in zebrafish,
otpa and otpb. Since both regulators have a similar expression pattern except for a
domain in the posterior hypothalamus (Ryu et al., 2007) (Fig. 3.33D, arrow), the
regulatory region of one of the paralogs should be sufficient to identify enhancers specific
for distinct Otp-positive domains. The upstream regulatory region of otpa contains a
region highly conserved among human, mouse, chicken, frog and zebrafish (hs 262) with
the size of approximately 400 bp (Visel et al., 2007). In a mouse embryo, this non-coding
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DNA fragment induces a lacZ expression specific to the hypothalamus and no additional
lacZ expression in other brain regions known to express Otp in mouse. Based on this
finding I used this highly conserved regulatory region flanked by neighboring 100 bp
or 1300 bp to generate approximately 600 bp or 3 kb DNA fragments. These two
fragments were cloned into a vector, containing a basal heat shock promoter from the
hsp70 gene (Halloran et al., 2000) (obtained from Laurence Ettwiller, Ettwiller Lab) and
GFP, membrane-bound Dendra or membrane-bound Cerulean (MbmCerulean). Dendra
is a green-to-red photoconvertible fluorescent protein (Gurskaya et al., 2006), whose
photoconversion is not reversible making it possible to trace photoconverted single
cells or a group of cells. The constructs were injected into single-cell stage zebrafish
embryos and subsequently screened for germ-line integration of the transgene. I analyzed
the obtained transgenes Tg(600bp-otpa:hsp-egfp)Fd13 and the Tg(3kb-otpa:hsp-egfp)Fd2
using αOtpa, αOxtl and αAvpl antibodies generated in the laboratory in combination
with a commercial GFP antibody. Both constructs label specific neurons within the
PO but not neurons in the posterior hypothalamus. Additionally, I observed that the
3 kb-otpa constructs reliably labels the majority of Otpa-positive cells in the PO (Fig.
3.34A-A”).
Fig. 3.34: The 3 kb fragment of the otpa regulatory region induces GFP
expression in the majority of Otp-positive neurons
(A-A”) Immunohistochemistry of Tg(3kb-otpa:hsp-egfp)Fd2 embryos at 3 dpf with
antibodies against GFP (A) and Otpa (A’) to investigate the specificity of the GFP
labeled cells. A major proportion of the Otpa-positive cells are GFP positive as well. A
single plane in the dorsal view is shown and the scale bar represents 60 µm.
In Contrast, the 600 bp-otpa construct labels only a subset of the Otpa-positive
cells in the PO. Interestingly, these few GFP-positive cells include nearly all Oxtl
neurons and nearly all Avpl neurons (Fig. 3.35A-B”), suggesting that a part of the otpa
promoter region can label different neuronal subtypes within this area. In order to label
other subsets of Otp-positive neurons, I generated 4 additional constructs containing
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fragments of the 3kb promoter region combined with MbmCerulean. Since the 600 bp
promoter fragment labels mainly Oxtl and Avpl neurons, I reasoned that remaining parts
of the 3kb fragment might label other neuronal subtypes within the PO. Several stable
transgenic lines generated from these four constructs were analyzed, but none of them
showed specific expression in the hypothalamus.
Fig. 3.35: The 600 bp-otpa fragment is sufficient to induce GFP expression
in Oxtl- and Avpl-positive cells
(A-B”) Immunohistochemistry on Tg(600bp-otpa:hsp-egfp)Fd13 3 dpf old embryos using
antibodies against GFP (A,B), Oxtl (A’) and Avpl (B’) to determine the identity of the
GFP-positive cells. The 600 bp otpa promoter region induces GFP expression mainly
in Oxtl- (A-A”) and Avpl-positive cells (B-B”). White arrows point to examples of
co-expressing cells. Single planes in the dorsal view are shown and the scale bar represents
60 µm.
To generate transgenic lines labeling Fezf2-positive neurons I used a 3 kb promoter
region obtained from Dr. Josh Bonkowski (University of Utah) driving membrane-bound
Dendra. Analysis of transgenic lines with three different insertions showed a strong
expression at 1 dpf similar to the observed fezf2 expression at 1 dpf. However, there
3.4 Summary 69
was no detectable Dendra signal at later stages of development. Therefore, none of the
obtained lines are useful for lineage analysis of Fezf2-positive neurons.
These results show that the regulatory regions of otpa and fezf2 are sufficient to mimic
their endogenous specific expression. Since the fezf2 promoter element is only active
until 1 dpf and the otpa fragments are only labeling parts of the PO a comprehensive
lineage and birthday analysis of different hypothalamic cell lineages especially within the
posterior hypothalamus was not possible.
3.4 Summary
In this thesis, I showed that the genetic regulatory interactions of Fezf2 are crucial
for the regionalization of the hypothalamus at 1 dpf and that at 2 dpf a variable
regulatory network of fezf2 together with otp, sim1a and foxb1.2 is important for the
regionalization of the preoptic and the mammillary area in zebrafish embryos leading
to defined subregions. I also to showed that this variable regulatory network and the
resulting subregions are crucial for the formation of distinct neuronal subtypes. Lastly, I
showed that a highly conserved regulatory region upstream of the otpa gene is sufficient
to induce reliably specific expression in the preoptic area.
I demonstrated that Fezf2 at 1 dpf is crucial for the regionalization of the
hypothalamus. fezf2 is expressed in the posterior hypothalamus where is positively
regulates the expression of emx2, a marker of the posterior-ventral hypothalamus.
Further, the repressive interactions to shh in the ZLI appears to subsequently influence
the regionalization of the anterior-dorsal hypothalamus. Fezf2 negatively regulates the
expression of foxb1.2, which is present in the posterior-dorsal hypothalamus. Together
these results show the crucial role of Fezf2 at 1 dpf for the regionalization of the
hypothalamus and demonstrate the existence of distinct subregions within the early
hypothalamus that have not been described so far. Furthermore, at 1 dpf Fezf2 positively
regulates the expression of the transcription factors otp and sim1a that are important
for the specification of neuronal subtypes. A summary of the observed genetic regulatory
interactions and the anatomy of the hypothalamus at 1 dpf is shown in figure 3.36.
Moreover, 3 kb including a highly conserved regulatory region upstream of the otpa
gene together with a basal heat shock promoter are sufficient to induce the expression of a
fluorophore reliably and specific in the preoptic area of zebrafish. Since a smaller construct
that contains the 400 bp highly conserved regulatory region labels mainly magnocellular
neurosecretory neurons, this regulatory region might be helpful for further functional
characterization of these neurons.
At 2 dpf Fezf2 is important for the formation of the preoptic area, the homologous
structure to the mammalian PVN and SON, and the posterior most region of the
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Fig. 3.36: A map summarizing the interaction and expression of fezf2,
foxb1.2, emx2, shh and otp at 1 dpf
A schematized map displaying the relative expression patterns of the transcription
factors at 1 dpf and a summary of their genetic interactions. Red bars indicate
negative regulation while green arrows indicate positive regulation. The white dashed
line delineates the prospective hypothalamus demarcated by nkx2.1a expression.
hypothalamus, the mammillary area. To my knowledge, this is the first study describing
the mammillary area in zebrafish embryos and providing a molecular map of mammillary
subregions.Similar to mouse, where FOXB1 is the marker for the mammillary body (MB),
foxb1.2 was found to be expressed in the central MA of zebrafish. Together with the
expression domains of fezf2, otp and sim1a, foxb1.2 delineates distinct subregions of the
MA in zebrafish. Loss-of-function analyses showed that these subregions of the MA may
results from the complex regulatory interactions of fezf2, foxb1.2, otp and sim1a. In a
temporally- and spatially-controlled manner these factors negatively regulate each other
contributing to the formation of the separated subregions. Similarly, in the preoptic area
the positive regulatory interactions of otp, sim1a and fezf2 are reflected in the anatomy,
which shows mostly co-expression. Interestingly, while at 1 dpf Fezf2 acts upstream of
otp at 2 dpf Otp also regulates fezf2 positively in the PO and negatively in the MA.
Further, in this study I investigated the specification of Oxtl-, Avpl-, VIP-
and Uts1-positive neurons. By combining the information about genetic regulatory
interactions of the transcription factors and their co-expression, I identified necessary
transcription factors for the formation of these neuronal subtypes. Taking advantage
of the transgenic heat shock lines, which over-express temporally controlled cDNAs of
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fezf2, foxb1.2, otp and sim1a, I demonstrated which transcription factors are sufficient
for the specification of Oxtl-, Avpl-, VIP- and Uts1-positive neurons. I found that key
transcription factors sufficient for the formation of Oxtl-positive neurons, are Otpa and
Sim1a, whereas for Avpl-positive neurons in the PO a combination of Otpa, Sim1a and
Fezf2 appears to be crucial. Further, my studies revealed that, although Otp, Sim1a and
Fezf2 are necessary for the specification of VIP-positive neurons in the PO, only Sim1a
activity induces a higher amount of vip-expressing cells. Remarkably, Otpb activity is
sufficient to induce ectopic vip expression broadly in the brain. In addition, in the MA
Otpa and Sim1a activity is sufficient to induce supernumerary VIP-positive cells. Notably,
since the loss of Fezf2 function results in a severe reduction of vip expressing cells also this
transcription factors appears to play a crucial role for VIP-neurons specification. Lastly,
for the Uts1-positive neurons my results show that consistent with the co-expression
data, Fezf2 alone and in combination with Sim1a or Foxb1.2 are sufficient to induce
supernumerary Uts1-positive neurons in the central MA. A summary of the observed
genetic regulatory interactions and the resulting complex anatomy important for the
formation of the discussed neuronal subtypes is shown in figure 3.37.
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Fig. 3.37: A summary of the relative expression and interaction of the
transcription factors and neuropeptides at 2 dpf
A schematized map showing the relative expression of the transcription factors and the
neuropeptides in the PO and the MA at 2 dpf and a summary of the genetic interactions of
the transcription factors. Red bars indicate negative regulation and green arrows indicate
positive regulation. The white dashed line delineates the central MA.
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4 Discussion
4.1 A molecular map of the posterior hypothalamus
To my knowledge, this is the first study to define a comprehensive molecular map of the
MA based on the underlying genetic regulatory interactions. This genetic regulatory
network involving fezf2, foxb1.2, otp and sim1a leads to the delineation of distinct
subdomains within the MA where subsequently distinct neuronal subtypes are specified.
The posterior most region of the hypothalamus, the mammillary area is an evolutionary
highly important and conserved hypothalamic area, whose existence is even discussed in
lamprey (Nieuwenhuys et al., 1998). It is a crucial hypothalamic region in the control of
spatial memory and cognitive behavior in mammals (Pan and McNaughton, 2004; Vann,
2010). Although anatomists distinguished 5 different nuclei within the MA since decades
(Swanson, 1987), the role of these nuclei or neuron types within them have been difficult
to analyze. This difficulty persists, because lesions studies (Beracochea, 2005; Canteras
et al., 2001; Pan and McNaughton, 2004; Vann, 2010; Vann and Aggleton, 2004) and
mutants affecting MA formation (Alvarez-Bolado et al., 2000a; Marion et al., 2005; Wehr
et al., 1997) mostly affect more than one defined nucleus. So far the MA has been regarded
as a homogenous non-laminar region with few cell types with different morphology and
electrophysiological properties (Allen and Hopkins, 1988; Alvarez-Bolado et al., 2000a;
Vann, 2010; Veazey et al., 1982). This study revealed an unexpected complexity of the MA
and provides molecular marker to distinguish its subregions. A recent study provided a
list of markers for different hypothalamic nuclei in the developing mouse brain (Shimogori
et al., 2010). In future studies these marker can be incorporated to the molecular map
defined in this study in order to generate an even higher resolution molecular map and
more defined regulatory codes for the specification of distinct neuron types. Based on
Shimogori et al. (2010) and my preliminary results, these additional markers include
dbx1a, dlx1a, dlx2a, dlx5a, isl1, tbx2b, arx and lhx6. Since the tuberomammillary area
is the sole seat of histaminergic neurons (Haas and Panula, 2003) the expression of
histidine decarboxylase (hdc) would serve as a perfect marker to delineate the position
of the tuberomammillary area in zebrafish embryos.
These subdomains, which have been identified in this thesis and that express a defined
combination of transcription factors might reflect the functionally different nuclei of
the MA known from mammals. In addition, the knowledge gained in this thesis may
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allow a more precise manipulation for a functional analysis of these different posterior
hypothalamic nuclei or even distinct neuron types.
4.2 The mammillothalamic tract in zebrafish?
The principal mammillary tract is the major axon bundle from the MB, sprouting at
a specific point to become the mammillotegmental and the mammillothalamic tract
(Szabo et al., 2011). As the name indicates, the mammillothalamic tract connects the
MB with the thalamus, which makes it important in spatial and working memory and in
object and scene discrimination (Radyushkin et al., 2005; Vann, 2010). Studies showed
that the mammillothalamic tract fails to develop in mutants for Foxb1 and Sim1/Sim2
(Alvarez-Bolado et al., 2000b; Marion et al., 2005). This thesis showed that the activity
of Foxb1.2 and Sim1a is crucial for the formations of the MA or neuron types of the
MA in zebrafish. Further in the lateral view an extension of the mammillary foxb1.2 and
also sim1a expression domain towards the thalamus is clearly detectable. Therefore,
I hypothesize that this stripe of transcription factor expression might delineate the
mammillothalamic tract in zebrafish, but further experiments are necessary to confirm
this. This could represent the first description of such an important connection in a
non-mammalian species.
4.3 Conserved regulatory interactions in the PO and in the MA
It has been known that the function of distinct transcription factors important for the
formation of the preoptic area is evolutionary conserved (Caqueret et al., 2005; Machluf
et al., 2011; Ryu et al., 2007). In this study I showed that transcription factors important
for the formation of the mammillary area, the putative homologue to the mammalian MA,
are also highly conserved. The transcription factor FOXB1 in rodents is crucial for the
proper formation of the MB (Wehr et al., 1997). This thesis shows that in zebrafish the
orthologous transcription factor Foxb1.2 is important for the formation of the central MA.
Furthermore, it was found that SIM1/SIM2 is expressed in the MB of rodents and that
these regulators are necessary for the formation of the mammillothalamic tract, although
the formation of the MB itself in Sim1/Sim2 mutants is not altered (Marion et al., 2005).
Consistent with the data in rodents, Sim1a is expressed in the MA in zebrafish. A loss of
Sim1a function did not alter the expression of other transcription factors, which suggests
that there is no alteration of the development of the MA. Sim1a in zebrafish might be
important for the formation of an equivalent to the mammillothalamic tract of rodents.
A recently published study, which provides a list of markers expressed in distinct
hypothalamic nuclei in the developing mouse brain (Shimogori et al., 2010) shows that
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Otp is expressed in several mammillary nuclei like the premammillary nucleus, the
mammillary body and the tuberomammillary area at different stages of the development
of the mouse brain. This thesis showed that the posterior hypothalamic otp expression in
zebrafish (Ryu et al., 2007) is found in the peripheral MA, where it plays an important
role for the proper formation of the MA of zebrafish. In rodents the activity of SIM1/SIM2
in the MA is independent of ARNT2 function (Marion et al., 2005). Consistent with
this finding, in zebrafish arnt2 is not expressed in the posterior hypothalamus (Löhr,
2009). All these observations argue for the existence of conservation of the regulatory
actions of transcription factors in the hypothalamus development. One exception might
be represented by SIM1/SIM2. In mouse SIM1/SIM2 appear to be acting upstream
of Foxb1 because a mutation of SIM1/SIM2 is leading to a reduced Foxb1 expression
(Marion et al., 2005). However in zebrafish, sim1a morphants display no change in foxb1.2
expression.
In summary, most of the transcription factor activities appear to be highly conserved
between rodents and zebrafish. Therefore, findings obtained in zebrafish like the molecular
map of the MA or the transcription factors contribution to the specification of distinct
neuron types will be worthwhile to analyze in rodents in order to gain insight in the
hypothalamus development in mammals.
4.4 Evolutionary conservation of VIP- and Uts1 positive
neurons in zebrafish
To the best of my knowledge this is the first study analyzing the expression pattern
of vip and uts1 cells in the embryonic zebrafish hypothalamus. In mammals VIP is
broadly expressed and has pleiotropic regulatory functions throughout the whole body.
In the central nervous system regions of highest VIP expression are the suprachiasmatic
nucleus where it is implicated in the generation and synchronization of the circadian
oscillation clocks (Vosko et al., 2007) and another site of strong VIP expression is the
PVN where it is co-expressed with CRH (Ceccatelli et al., 1989; Hokfelt et al., 1987)
and can enhance ACTH secretion in the pituitary (Nussdorfer and Malendowicz, 1998).
Other VIP-immunoreactive as well as VIP-binding sites in the mammalian hypothalamus
are situated in the mammillary nuclei (Saper, 2000; Sarrieau et al., 1994). However, the
function of those neurons in the MA is poorly understood. In zebrafish, I observed mainly
two sites of VIP expression in the embryonic zebrafish hypothalamus: in the PO and
in the MA, suggesting an important and evolutionary conserved function of VIP within
these hypothalamic areas.
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Uts1 is the teleost ortholog of the mammalian urocortin 1 (UCN1) (Vaughan
et al., 1995) that belongs to the urocortins, which are structurally related to CRH
and consist of UCN1, UCN2 and UCN3 (Hsu and Hsueh, 2001; Lewis et al., 2001;
Reyes et al., 2000; Vaughan et al., 1995). UCN1 is widely distributed in the brain
and also in the periphery where it has important physiological functions in various
tissues. In the central nervous system it is implicated in the modulation of energy and
water homeostasis as well as in stress adaptation while in the periphery it associated
with immunomodulation and cardioprotection (Oki and Sasano, 2004). A low-level
expression of Ucn1 in colchicine-treated rats was found in the lateral mammillary and
in the supramammillary nuclei (Bittencourt et al., 1999), whereas in adult zebrafish a
homogeneously distributed expression of uts1 was detected within the corpus mamillare
(Alderman and Bernier, 2007). Although the function of UCN1 in the MA of rats
and of Uts1 in the MA of zebrafish is not known, this conserved expression indicates
an important evolutionary conserved function, which still needs to be investigated. In
contrast to the high conservation of Uts1 expression domains among mammals and
zebrafish, a substantial number of descending Uts1-ir fibers but no or very few CRH-ir
fibers form in the spinal cord of teleosts. In contrast, in mammals the opposite it true
(Pepels et al., 2002).
4.5 Molecular mechanism of VIP- and Uts1-positive neuron
specification
In this thesis I showed for the first time transcription factor requirements for the
specification of VIP and Uts1-positive neurons. Fezf2 was already known to be required
for the formation of several neuron types both in mouse and in zebrafish. In mouse,
early in development Fezf2 is broadly expressed throughout the dorsal telencephalon but
becomes restricted to the cortical deep layers later in development where it is important
for the specification of subcerebral neurons (Chen et al., 2005a,b; Molyneaux et al.,
2005; Shimizu and Hibi, 2009). In zebrafish, Fezf2 is important for the specification of
5-Hydroxytryptamine (5-HT), DA and Oxtl neurons (Blechman et al., 2007; Guo et al.,
1999; Jeong et al., 2006; Levkowitz et al., 2003). In this thesis I showed that Fezf2
is also crucial for the development of VIP- and Uts1 positive neurons. Since fezf2 is
only co-expressed with uts1 but not with vip in the zebrafish MA the mechanism by
which Fezf2 affects their specification is likely to be different. Fezf2 controls neuron type
specification non-cell-autonomously for the development of 5-HT and DA neurons since
fezf2 is not expressed in these cell types (Levkowitz et al., 2003). It might be possible that
for VIP neuron specification Fezf2 also acts non-cell-autonomously. Alternatively, Fezf2
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might affect development of the early VIP progenitor cells either directly or by regulating
otp expression. I consider the latter possibility to be more likely because fezf2 is broadly
expressed in the posterior hypothalamus at earlier stages and it down-regulates the
expression of otp. Also in the PO where vip is co-expressed with fezf2, the over-expression
of fezf2 resulted in no supernumerary VIP cells while fezf2 morphants display a severe
reduction of VIP cells in the PO and the MA. In contrast, for the Uts1-positive neurons
the loss of Fezf2 function caused fewer uts1 -expressing cells while the gain of Fezf2
function resulted in more uts1 -expressing cells. Therefore, it is likely that Fezf2 directly
regulates the late aspects of specification of uts1 -expressing cells.
The regulatory action of Otp and Sim1a on the specification of VIP-positive neurons
appears to be directly linked. The loss of Sim1a and Otp function caused a reduction
of vip-expressing cells in the PO and an increase in vip-expressing cells in the MA.
In contrast, Foxb1.2 appears to regulate vip expression indirectly because they are not
co-expressed and the over-expression of foxb1.2 results in a decrease in the number
of vip-expressing cells whereas foxb1.2 morphants display no change in the number of
vip-expressing cells. Since foxb1.2 and otp appear to negatively regulate each other, a
gain of Foxb1.2 function could result in a decreased activity of Otp, which is a key
regulator for VIP neuron specification, and therefore in a fewer VIP cell number.
This negative cross-regulatory interaction of otp and foxb1.2 might also play a role in
the specification of uts1 -expressing neurons. In loss of Otp function embryos the number
of uts1 -expressing neurons increases whereas the over-expression of otp causes no change
in uts1 cell number. Since the gain of Foxb1.2 functions results in more uts1 -expressing
neurons and the loss of Otp function results in an expanded foxb1.2 domain, the increase
of uts1 neurons in loss of Otp function embryos might be indirect through the negative
genetic interaction of otp and foxb1.2. Interestingly, also foxb1.2 morphants display an
increase in uts1 -expressing neurons. Foxb1.2 appears to have an early and a late role in
forebrain development similar to other transcription factors (Baumgardt et al., 2007).
Early in development it is important for the regionalization of the forebrain (Staudt and
Houart, 2007; Toro and Varga, 2007) but this thesis showed that later in development it is
important for the formation of the central MA and for the specification of neuron types.
Since the loss-of-function analysis with morpholinos results in the loss of the protein
activity from one-cell stage onwards both early and late functions are disrupted and
it might be impossible to detect the late function of this transcription factor. Increase
in Uts1 cell number both in loss and in gain of Foxb1.2 function might be due to the
fact that the loss-of-function experiment reveals the effects on the regionalization of the
posterior hypothalamus while the gain-of-function experiment shows the effects on cell
type specification.
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4.6 Molecular mechanism of the specification of magnocellular
neurosecretory neurons
Several studies (Blechman et al., 2007; Eaton and Glasgow, 2006, 2007; Eaton et al.,
2008) together with this thesis revealed the necessity of Otp, Sim1a and Fezf2 for the
formation of Oxtl- and Avpl-positive neurons. The co-expression analysis suggested that
Fezf2 might directly regulate Avpl neuron specification and indirectly the specification
of Oxtl neurons, because avpl is mainly co-expressed with fezf2 while oxtl is not. With
the gain-of-function analysis I was able to confirm this hypothesis that oxtl is indirectly
regulated by fezf2, because the over-expression of fezf2 resulted in no changes in oxtl cell
number. Another possible mechanism for the regulatory action of fezf2 on oxtl-expressing
cells is that fezf2 acts on early progenitors of oxtl-expressing neurons. In addition, the
gain-of function analysis shows that Fezf2 does not act non-cell-autonomously in the
specification of the preoptic and the mammillary neuron types. Interestingly, the ectopic
over-expression of fezf2 in this study does not induce phenotypes in neurons, which
do not express fezf2. However, this thesis did not identify key transcription factors
similar to a terminal selector gene known from C. elegans (Hobert, 2008), which are
exclusively sufficient for the formation of Oxtl- or Avpl-positive neurons in the zebrafish
hypothalamus. Otp, Sim1a and Fezf2 are important for the formation of several neuronal
subtypes, making it likely that a underlying regulatory network is important for the
formation of avpl- or oxtl-expressing neurons.
4.7 Fezf2 is a key transcription factor for early hypothalamus
patterning
This study provides the first insight into the importance of Fezf2 on the patterning of
the hypothalamus is zebrafish. Although it was known already that fezf2 is expressed in
the hypothalamus early on, the function of Fezf2 in this area has not been clear so far. A
previous study assumed that the patterning of the hypothalamus in fezf2 morphants
is largely normal, because fezf2 morphants display no change in nkx2.1a expression
(Jeong et al., 2007). In this study, I found that although nkx2.1a expression was not
changed in fezf2 morphants, Fezf2 has important functions for the patterning of the
hypothalamus at 1 dpf. fezf2 is expressed in the posterior half of nkx2.1a expression
domain, perfectly abutting but not overlapping with the expression of shh in the anterior
hypothalamus. The fezf2 expression domain contains the smaller expression domain
of emx2, the posterior-ventral hypothalamic marker (Mathieu et al., 2002) indicating
that fezf2 is labeling a larger proportion of the posterior hypothalamus, whereas emx2
delineates the posterior-ventral hypothalamus. In fezf2 morphants the expression of emx2
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in the posterior-ventral hypothalamus is severely reduced. In addition, the anterior-dorsal
hypothalamic shh expression domain is more dorsal and more compact (Jeong et al.,
2007), which might be an indirect effect of the observed shift of the ZLI shh expression
because fezf2 is not co-expressed with shh.
Another factor highly important for the formation of the posterior hypothalamus
is Nodal. Mutants of the Nodal pathway display a severe reduction of emx2 expression
while shh expression is retained (Mathieu et al., 2002). Therefore, it is possible that
fezf2 is affected by the Nodal pathway and represses shh, which is known to suppress
the posterior-ventral hypothalamic fate by promoting the anterior-dorsal hypothalamus
(Wilson and Houart, 2004). Interestingly, mutant of the nodal pathway display a highly
reduced otp expression in the PO and no otp expression in the posterior hypothalamus
comparable but weaker than what is observed in fezf2 morphants (Del Giacco et al.,
2006).
Fezf2 was originally identified as a gene upregulated upon Dkk1 over-expression,
indicating that fezf2 expression is repressed by canonical wnt/β-catenin pathway
(Hashimoto et al., 2000). More recent studies indeed found Fezf2 to be part of the
canonical Wnt signaling of Wnt8b mediated by Lef1 (Jeong et al., 2007; Lee et al., 2006;
Russek-Blum et al., 2008). In the case of DA neuron specification, it was found that fezf2
is downstream of Wnt8b, a key regulator for DA neuron development. These findings
suggests that a balanced activity of Wnt8b and Fezf2 is needed to form the correct
number of DA neurons (Russek-Blum et al., 2008). Since wnt8b has been reported to be
expressed in the mammillary and the retromammillary hypothalamus in mice and humans
(Lako et al., 1998) this upstream regulatory function of Wnt8b on fezf2 expression might
also be important for the formation of the MA in zebrafish.
As it was already proposed in recent studies (Eaton and Glasgow, 2006, 2007) this
thesis showed no evidence that Otp or Sim1a are involved in the patterning of the
hypothalamus. Therefore, I concluded that Otp and Sim1a regulate differentiation and
cell fate rather than patterning. Supporting this statement, is the fact that Otp is only
expressed in non-proliferating progenitor cells (Ryu et al., 2007) and that my initial
screen to find transcription factors regulated by Otp only revealed three factors out of
more than 80 different transcription factors.
4.8 Variable regulatory interactions of a common transcription
factor set generates hypothalamic neuronal diversity
Neuronal subtype specification is thought to involve combinatorial usage of a limited
repertoire of transcription factors (Shirasaki and Pfaff, 2002). To explain how such an
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amazing neuronal diversity can be achieved by using a small set of common transcription
factors several mechanisms have been suggested. For example, feed-forward regulatory
loops segregate the fate of motor neurons and interneurons in the developing spinal
cord although they are specified by related LIM-complexes (Lee et al., 2008). In the
Drosophila nervous system in contrast, the progenitor competence is limited over time by
a temporal cascade of transcription factors (Baumgardt et al., 2009). Although several
transcription factors have been identified, which are implicated in the development of
the hypothalamus and its contained neuronal subtypes it remains unknown how these
regulators interact to generate distinct neuron types. In this study I found that one
mechanism for the generation of neuronal diversity with a limited set of transcription
factors is their dynamic interaction. Transcription factors can act as an activator or a
repressor (Babu et al., 2004). I demonstrate that the genetic cross-regulatory network
composed of fezf2, foxb1.2, otp and sim1a changes in spatially and temporally dependent
manner. At 1 dpf, Fezf2 acts upstream of otpb (Blechman et al., 2007), otpa, sim1a and
emx2, controlling thereby the regionalization, neurogenesis and/ or the initial steps of
neuronal differentiation in the hypothalamus. Strikingly at 2 dpf, the genetic regulatory
interactions of the transcription factors changes at multiple levels. First, the fezf2 -otp
interactions become cross-regulatory, now Otp positively regulates the expression of fezf2
in the PO while it negatively regulates the expression of fezf2 in the MA. Sim1a that
is proposed to work in parallel to Otp (Löhr et al., 2009) remains downstream of Fezf2.
Second, Fezf2 positively regulates the expression of sim1a in the PO while in contrast,
it negatively regulates it in the MA. Third, fezf2 and foxb1.2 interactions as well as otp
and foxb1.2 interactions become cross-repressive in the MA. The functional consequences
of these dynamic genetic regulatory interactions are the definition of the subdomains
in the PO and in the MA that are important for the generation of distinct neuronal
subtypes. Although Otp and Sim1a are proposed to work in a parallel pathway, they are
regulated differentially and their sufficiency to induce neuropeptide expression is different
as well. Further, Otp and Sim1a are not completely co-expressed which allows Sim1a and
Otp to exert different effects on Uts1 cell number. Taken together, these results do not
support the existence of completely parallel functions of Otp and Sim1a. In addition,
SIM1 heterozygous mutant mice display a dosage dependent obesity phenotype (Duplan
et al., 2009) whereas OTP mutant mouse do not show such a phenotype.
This study provides important mechanistic insights into the generation of neuronal
diversity in the hypothalamus. In hypothalamus development early regulators such as
Fezf2 and Foxb1.2 are important for the regionalization and then later in development
become re-deployed in the generation of different neuronal subtypes. This economical
way of using transcription factors has the disadvantage that the loss-of-function analysis
with Morpholinos interferes with both functions and the effects of the earlier function
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might still have impact on the detection of the later function. Hence it might be possible
that Fezf2 at 2 dpf does not positively regulate the expression of otp in the MA. It
is more likely that the otp-fezf2 interactions becomes cross-repressive since their two
expression domains separate beginning at 1 dpf. This statement is supported by the fact
that cross-repressive regulatory interactions are used to sharpen boundaries of domains
(Shirasaki and Pfaff, 2002).
4.9 The limitations of gain-of-function analyses
The usage of gain-of-function analysis has clear advantages. Using an inducible promoter
like a heat shock shock promoter the time when the gene of interest should be
over-expressed is controlled. Especially with transcription factors that have early and
late functions in development, the investigation of the later roles with loss-of-function
analysis remains difficult. So far, only the usage of techniques like the usage of
PhotoMorphs (Tomasini et al., 2009) makes it possible to achieve an temporal controlled
loss-of-function situation. Another advantage of gain-of-function experiments is the fact
that the sufficiency of the gene of interest can be investigated. Loss-of-function studies
only provide information on the necessity of the gene of interest for the investigated
processes. Despite its advantages, the temporal control of the gain-of-function constructs
using an inducible heat shock promoter has disadvantages. Several studies showed that
the time point of giving the heat shock is critical to induce an over-expression phenotype
(Blechman et al., 2007; Jeong et al., 2007). To find this time point extensive tests using
different induction times are necessary. In addition, knowledge about the earlier roles
of the investigated transcription factors are necessary to avoid interference with this
function.For example, the relatively mild effect of fezf2 over-expression on Uts1 cell
number is likely due to the heat shock that was performed at 2.5 dpf. At this time point
much of the hypothalamic differentiation processes have been initiated already, making
it more difficult to induce significant changes than at earlier stages. Furthermore the
expression level of the induced transgene is of high importance. The expression level
of Fezf2 transgenic line established in this study is likely to be significantly lower than
in fezf2 over-expression systems published earlier, where the Gal4-UAS system has been
used for a strong transgene induction (Jeong et al., 2007). Additionally, the real-time PCR
analysis performed by Chen-Min Yeh (Ryu Laboratory) testing the expression level of the
established otpa over-expression line revealed a very low fold change of the mRNA level
of the induced gene. Another issue to take into consideration is the question whether the
investigated transcription factors act together with other proteins in protein complexes
or whether they need other factors to bind to the distinct DNA binding site to induce
the investigated phenotype. It might be possible that only so called terminal selector
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genes (Hobert, 2008) are able to induce a broad or ectopic expression of a marker for a
distinct neuronal subtype when over-expressed alone. So far, to my knowledge, terminal
selector genes in vertebrates as such have not been described. If the fact that cell identity
is achieved by the active repression of other possible neuronal fates (Shirasaki and Pfaff,
2002) is true in the brain as well then the induction of other cell types needs to overcome
the repressors of the distinct cell types that should be achieved by over-expression of a
distinct transcription factor. Therefore, over-expression of a distinct transcription factor
might only induce a neuronal fate in a very small subset of neurons where this active
repression does not take place and the neurons are still competent for the induction of
another fate. This hypothesis is supported by the fact that I achieved only very slight
changes of cell number in the gain-of-function experiments.
4.10 Ectopic vip expression reveals different roles of Otpa vs.
Otpb
In this study I showed for the first time that the over-expression of otpb is sufficient
to induce the ectopic expression of vip broadly in the brain. So far studies utilizing
over-expression of transcription factors in the zebrafish hypothalamus usually showed
a limited number of extra cells observed very close or within the original cell cluster
(Blechman et al., 2007; Löhr et al., 2009; Ryu et al., 2007). Only very high levels of
over-expression of cmv-otpa transiently induced a limited amount of ectopic expression
of th in areas where no th expression is usually found (Ryu et al., 2007). In this study I
showed that a long induction of low-level over-expression of otpb is sufficient to induce
ectopic vip expression broadly in several areas in the brain that do not normally express
vip. This effect might be due to of the fact that neurons are competent to express vip in
addition to their normal fate. Alternatively otpb might be a terminal selector gene that is
able to induce the specification of VIP neurons in the whole brain. I think the first option
is more likely because VIP has very broad functions including its neurotrophic properties.
This neurotrophic or neuroprotection function includes the stimulation of astrocytic
mitosis, the increase in neuronal survival and the neuronal differentiation of embryonic
stem cells (Passemard et al., 2011). Therefore, it is very likely that neurons are capable
of producing VIP in addition to their original expression profile. Interestingly, only the
over-expression of otpb is sufficient to induce this phenotype although its expression is
limited to distinct regions in the brain. This implies that otpa and otpb are not only
working in parallel but that their functions differ from each other where one is more
important for the neuron type specification and the other one might be more important
for the neuronal survival.
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5 Conclusion
Although several transcription factors important for hypothalamus development are
known, one big question remains. How do these transcription factors act in concert to
form the specific nuclei of the hypothalamus and the various neuron types within them? In
order to contribute to our understanding of the development of the hypothalamus, the aim
of this thesis was to identify mechanisms important for the formation of distinct neuron
types in the preoptic area and the posterior hypothalamus. In this thesis, I identified
that a limited set of transcription factors and their dynamic interactions are crucial
for the formation of these two functionally different nuclei. I found that the regulatory
interactions involving Fezf2, Otp, Sim1a and Foxb1.2 vary between anterior and posterior
hypothalamus resulting in subdomains with distinct transcription factor expression.
Within each of these subdomains different neuron types with defined transcription factor
co-expression form. Therefore, this study provides an important mechanistic insight
into the formation of neuronal diversity in the developing hypothalamus. Further, the
subdomains defined by the TF expression allow for the first time the generation of a
regulatory and a molecular map of the mammillary area. These maps will contribute
significantly to the assignment of distinct functions to different mammillary nuclei and
cell types by aiding future functional investigations or interference.
The assigned genetic regulatory interactions in this thesis are based on the observed
changes in the expression of the transcription factors. Therefore, it not known whether
these interactions are direct or indirect. Further studies are needed to show if other
transcription factors or signaling pathways are involved in these regulatory networks.
Similarly, the precise mechanism by which the transcription factors regulate the
specification of the neuron types need to be further investigated. Nevertheless, with
this thesis, important first steps are made to define the transcription network governing
the spatio-temporal development of the mammillary area. In addition, it provides an
important entry point for further investigation of the hypothalamic transcription factor
interactions, the role of different signaling pathways and the functional relevance of the
investigated neuropeptides.
In conclusion, this thesis achieved the following major findings: First, it defined for the
first time the transcriptional network that regulates the mammillary area development.
Second, it identified hitherto uncharacterized regulatory interactions of the hypothalamic
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regulators. Third, it identified that one important mechanism underlying the generation
of hypothalamic neuronal diversity is the temporally and spatially dynamic regulatory
interactions of a common transcription factor set.
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6 Material and Methods
6.1 Materials
6.1.1 Buffers
Buffer Composition
AP staining buffer 100 mM Tris-HCL pH 9.5, 50 mM MgCl2, 100 mM NaCl,
0.1 % Tween20
Danieau’s Solution (30x) 1.74 M NaCl, 21 mM KCl, 12 mM MgSO4, 18 mM
Ca(NO3)2x4(H2O), 150 mM Hepes, adjust to pH 7.6
Egg water 3 g Red Sea Salt in 10 l dd H2O
Gel loading buffer 50 % (v/v) Glycerin, 50 mM EDTA pH8.0, 10 mM
Tris/HCl pH8.0, bromophenol blue
Hybridization mix 50 % Formamide, 5x SSC, 5 mg/ml torula RNA, 50
µg/ml heparin, 0.1 % Tween 20
Hybridization mix +D Hybridization mix, 5 % Dextran sulfate
Lysis buffer (10x) 100mM Tris pH 8, 10 mM EDTA pH 8, 50 0mM KCl, 3
% Tween 20, 3 % NP-40
Maleic acid buffer 100 mM Maleic acid, 150 mM NaCl, adjust to pH 7.5
(with NaOH)
PBS (20x) 160 g/l NaCl, 4 g/l KCl, 28,8 g/l Na2HPO4, 4.8 g/l
KH2PO4
PBT 1x PBS, 0.1 % Tween20
PBTX 1x PBT, 0.1 % Tween20, 0.1 % TritonX100
4 % Paraformaldehyd
(PFA)
40 g PFA in 1 l PBS
PTU 0.03 % 1-phenyl-2-thiourea in egg water
Roche blocking solution 10 % (w/v) blocking reagent in maleic acid buffer
SSC (20x) 175.3 g/l NaCl, 88.2 g/l NaCitrate, adjust to pH 7.0
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SSCT 1x SSC, 0.1 % Tween20
TAE-buffer (50x) 242 g/l Tris Base, 57.1 ml/l glacial acetic acid, 0.05 M
EDTA (pH 8)
Tricaine Solution 4 g/l Tricaine powder, 25 ml 1 M Tris-HCL (pH 9), adjust
to pH 7
TSA Reaction buffer 100 mM borate, 2 % dextran sulfate, 0.1 % Tween, 0.003
% H2O2, 150-450 µg/ml 4-Iodophenol, adjust to pH 8.5
Table 6.1: Buffers
6.1.2 Computer software
Software Company
EndNote X5 Thomson Scientific, USA
Fiji Max Planck Society, Germany
Generunner Hastings Software, Inc.
Lasergene DNASTAR, USA
Leica LAS AF Leica Microsystems, Germany
Leica Application Suite V3.7 Leica Microsystems, Germany
Prism 5 GraphPad Software, Inc., USA
Table 6.2: Software
6.1.3 Bacterial strains
Bacterial strains used in this thesis are Top10 cells from Invitrogen.
6.1.4 Bacterial media
Medium Composition
Luria Bertani (LB) Medium Recipe according to Sambrook and Russel (2001)
SOC Medium 10 g/l bacto-tryptone, 5 g/l yeast extract, 0.5 g/l NaCl,
0.186 g/l KCl, 12.5 ml/l 1M MgCl2, 12.5 ml/l 1M
MgSO4, after autoclaving add 20 ml/l 1 M Glucose
(sterile filtered)
Table 6.3: Bacterial media
86 6 Material and Methods
All media were autoclaved prior to use. Media for the plates contained in addition
20 g agar per liter. Antibiotics were added if necessary (50 mg/l Ampicillin, 25 mg/l
Kanamycin).
6.1.5 Enzymes
Enzyme Company
Big Dye Terminator V3.01 ABI Prism
DNase I New England Biolabs
Phusion DNA Polymerase NEB
Proteinase K Sigma-Aldrich
Restriction Enzymes New England Biolabs
RNA Polymerases (T7, Sp6) Roche
RNA Polymerase (T3) Fermentas
RiboLock RNase Inhibitor Fermentas
T4 DNA Ligase New England Biolabs
Taq DNA Polymerase New England Biolabs
Table 6.4: Enzymes
6.1.6 Reaction kits
Kit Company
ABI PRISM Big Dye Terminator v3.1 Cycle Sequencing Kit Applied Biosystems
DIG RNA labeling mix Roche
GenElute PCR Clean-Up Kit Sigma-Aldrich
GenElute Plasmid Miniprep Kit Sigma-Aldrich
mMessage mMachine Sp6, T7 Ambion
Qiagen Plasmid Midi Kit Qiagen
Qiaquick Gel extraction Kit Qiagen
Rneasy Mini Kit Qiagen
PureLink RNA Mini Kit Invitrogen/Ambion
Superscript III Reverse Transcriptase Invitrogen
Dual Promoter TA Cloning Kit, pCRII vector Invitrogen
Power SYBR Green RNA-to-CT Applied Biosystems
Table 6.5: Kits
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6.1.7 Instruments and special equipment
Equipment Supplier
Bacterial incubator Heraeus Brutschrank B 6060
Cameras Leica DFC500
Centrifuges Eppendorf Centrifuge 5417R, Heraeus Labofuge 400R,
Beckman Avanti J-25
DNA sequencer ABI Prism 3100-Avant Genetic Analyzer
Fish incubator Rubarth Apparate GmbH RuMed 3101
Gel documentation system Intas Gel iX Imager
Microinjector Eppendorf Femto Jet, Transjector 5246
Microscopes Leica SP5, Leica DM5500B, Leica MZ16
Needle puller Flaming/Brown Micropipette Puller
PCR machines Eppendorf Mastercycler epgradient, Applied Biosystems
7500 Real-Time PCR System
PH-meter Knick pH-Meter 766 Calimatic
Spectrophotometer Eppendorf BioPhotometer
Stereomicroscope Leica MZ6, M3Z, Zeiss Stemi DV4
Table 6.6: Equipment
6.1.8 Fish strains
Fish strains that have been used in this study despite of the wild-type strain ABTL:
Fish strain Reference
Tg(3kb-otpa:hsp70-EGFP)fd2 this thesis
Tg(600bp-otpa:hsp70-EGFP)fd13 this thesis
otpam866 Ryu et al. (2007)
Tg(hsp70:fezf2-2A-EGFP)hd6 this thesis
Tg(hsp70:otpa-2A-EGFP)hd7 this thesis
Tg(hsp70:otpb-2A-lyntdTomato)fd1 this thesis
Tg(hsp70:sim1a-2A-lyntdTomato)hd8 this thesis
Tg(hsp70:foxb1.2-2A-EGFP)hd9 this thesis
Table 6.7: Fish strains
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6.1.9 Morpholinos
Morpholino based antisense oligonucleotides were synthesized by Gene Tools LLC
(Philomath, OR, USA). Names, Sequences and binding sites are shown in the table
below.
Morpholino Sequence Reference
otpb (e2i2) splice MO 5’-GAGCAAGTTCATTAAG
TCTCACCTG-3’
Ryu et al. (2007)
sim1a (e2i2) splice MO 5’-TGTGATTGTGTACCTG
AAGCAGATG-3’
Löhr et al. (2009)
fezf2 / sp3 (e2i2) splice MO 5’-TATTTTAACCTACCTG
TGTGTGAAT-3’
Jeong et al. (2006)
foxb1.2 ATG MO 5’-TCTGGGCATCCTGTC
CTAATCGCGT-3’
this thesis
Standard control MO 5’-CCTCTTACCTCAGTTA
CAATTTATA-3’
Gene Tools LLC
Table 6.8: Morpholinos
6.1.10 Vectors
Standard cloning vectors:
Vector Company
pCRII Invitrogen
pCS2+ Rupp et al. (1994)
Table 6.9: Vectors
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6.1.11 Constructs generated and/or used in this thesis
Construct Reference
Hsp339-3kb-otpa:hsp70 -EGFP Ettwiller laboratory and this thesis
Hsp339-600bp-otpa:hsp70 -EGFP Ettwiller laboratory and this thesis
Hsp339-fezf2 :hsp70 -Dendra-ras Dr. Josh Bonkowski and this thesis
pCS2+-ATG-EGFP Wittbrodt Laboratory
pCS2+-foxb1.2MO-EGFP this thesis
pCS2FA-transposase Kwan et al. (2007)
pSceIn-hsp70 :otpb-2A-lyntdTomato Arturo Gutierrez-Triana, Ryu laboratory and
this thesis
pSceIn-hsp70 :sim1a-2A-lyntdTomato Arturo Gutierrez-Triana, Ryu laboratory and
this thesis
pT2G12A-hsp70 :fezf2 -2A-EGFP Arturo Gutierrez-Triana, Ryu laboratory and
this thesis
pT2G12A-hsp70 :foxb1.2 -2A-EGFP Arturo Gutierrez-Triana, Ryu laboratory and
this thesis
pT2G12A-hsp70 :otpa-2A-EGFP Arturo Gutierrez-Triana, Ryu laboratory and
this thesis
Table 6.10: Constructs
6.1.12 Constructs for RNA Probe synthesis
Constructs for transcription factor probes:
Gene Enzyme RNA Pol. Reference
pCRII-a2bp1 EcoRV Sp6 this thesis
pZL-arx SalI Sp6 Miura et al. (1997)
pCRII-ascl1a EcoRV Sp6 this thesis
pCRII-barhl1.1 EcoRV Sp6 this thesis
barhl2 SalI Sp6 Colombo et al. (2006)
pCRII-creb1 EcoRV Sp6 this thesis
pCRII-dact1 EcoRV Sp6 this thesis
pCRII-dbx1a NotI Sp6 this thesis
pCRII-dxb1b BamHI T7 this thesis
pCRII-dlx1a BamHI T7 this thesis
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pBSKS-dlx2a BamHI T7 Akimenko et al. (1994)
pBSKS-dlx5a BamHI T7 Akimenko et al. (1994)
pCRII-dmrt3a NotI Sp6 this thesis
pCRII-dnmt4 EcoRV Sp6 this thesis
pBSKS-emx2 XhoI T7 Morita et al. (1995)
pBSKS-emx3 AccI T7 Morita et al. (1995)
pCRII-erm BamHI T7 this thesis
pCRII-esr2b EcoRV Sp6 this thesis
pCRII-fezf2 EcoRV Sp6 this thesis
pCRII-foxa1 BamHI T7 this thesis
pCRII-foxb1.1 EcoRV Sp6 this thesis
pBSSK-foxb1.2 EcoRI T7 Thisse et al. (2001)
pCRII-foxp2 EcoRV Sp6 this thesis
pBSSK-gli3 NotI T7 Tyurina et al. (2005)
pCRII-grhl1 EcoRV Sp6 this thesis
pCRII-gsh1 BamHI T7 this thesis
pCRII-her8a BamHI T7 this thesis
pCRII-hmx3 NotI Sp6 this thesis
pCRII-id3beg EcoRV Sp6 this thesis
pCRII-id3end BamHI T7 this thesis
pBSKS-isl1 XbaI T3 Inoue et al. (1994)
pCRII-lcorl BamHI T7 this thesis
pCRII-lef1 EcoRV Sp6 this thesis
pCRII-lhx1 XhoI Sp6 this thesis
pCRII-lhx5 BamHI T7 this thesis
pCRII-lhx6 BamHI T7 this thesis
pCRII-lhx7 NotI Sp6 this thesis
pCRII-lhx9 KpnI T7 this thesis
pCRII-lmo1 EcoRV Sp6 this thesis
pCRII-lmx1b NotI Sp6 this thesis
pCRII-mbd3b NotI Sp6 this thesis
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mcm5 Ryu et al. (2005)
pCRII-neurod4 BamHI T7 this thesis
ngn1 XhoI T7 Blader et al. (1997)
pCRII-ngn3 XbaI Sp6 Wang et al. (2001)
pBSSK-nkx2.1a SacII T3 Rohr and Concha (2000)
pCRII-nkx2.1b BamHI T7 this thesis
pCRII-nkx2.2a EcoRV Sp6 this thesis
pCRII-nr2e1 EcoRV Sp6 this thesis
pCRII-nr2f1a BamHI T7 this thesis
pCRII-nr2f1b BamHI T7 this thesis
pCRII-nr4a2a XhoI SP6 Filippi et al. (2007)
pCRII-nr4a2b SacI T7 this thesis
pCRII-nr5a1a EcoRV Sp6 this thesis
pCRII-nr5a2 NotI Sp6 this thesis
pCRII-nr6a1b EcoRV Sp6 this thesis
olig2 Park et al. (2002)
pCRII-otpa XhoI Sp6 Ryu et al. (2007)
pCRII-otpb KpnI T7 Ryu et al. (2007)
otx1 EcoRI T7 Li et al. (1994); Mori et al. (1994)
pCRII-otx1l NotI Sp6 this thesis
otx2 EcoRI T7 Li et al. (1994); Mori et al. (1994)
pCRII-pax3b BamHI T7 this thesis
pCRII-pax6a BamHI T7 this thesis
pCRII-pax6b NotI Sp6 this thesis
pCMVSport-pcna SalI Sp6 Koudijs et al. (2005)
pBSKS-pitx3 NotI T7 Dutta et al. (2005)
pou12 Spaniol et al. (1996)
pBSKS-prox1 XbaI T3 Glasgow and Tomarev (1998)
pCRII-rfx2 EcoRV Sp6 this thesis
pCRII-roraa EcoRV Sp6 this thesis
pBSSK-rx3 XbaI T3 Chuang et al. (1999)
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pCRII-sall1a EcoRV Sp6 this thesis
pCRII-satb2 EcoRV Sp6 this thesis
pCRII-sb:cb306 EcoRV Sp6 this thesis
pCRII-sb:cb382 BamHI T7 this thesis
pCRII-sb:cb458 EcoRV Sp6 this thesis
pCRII-sb:eu863 BamHI T7 this thesis
pUC18-shha HindIII T7 Krauss et al. (1993)
pCRII-sim1a XhoI Sp6 recloned from Löhr et al. (2009)
pCMVSport-sim2 EcoRI T7 RZPD clone (IRBOp991C0138D)
six3b BamHI T3 Kobayashi et al. (1998)
sox2 EcoRI T7 Adolf et al. (2006)
sox3 SalI SP6 RZPD clone (IRBOp991G0461D)
pCRII-sox11a EcoRV Sp6 this thesis
pCRII-sox14 EcoRV Sp6 this thesis
pCRII-sp8 EcoRV Sp6 this thesis
pCRII-spon1b NotI Sp6 this thesis
pCRII-tbx2b BamHI T7 this thesis
pCRII-tcfcp2l1 NotI Sp6 this thesis
pCRII-tcf7l1a BamHI T7 this thesis
pCRII-vgll2b EcoRV Sp6 this thesis
pCRII-zgc:103720 EcoRV Sp6 this thesis
pCRII-zic2a BamHI T7 this thesis
pCRII-znf536 EcoRV Sp6 this thesis
pBSSK-zp50 (pou50 ) SpeI T7 Hauptmann and Gerster (1996)
Table 6.11: Transcription factor probes
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Constructs for neuropeptide probes:
Gene Enzyme RNA Pol. Reference
pCRII-aanat1 BamHI T7 this thesis
pCRII-adra2a NotI Sp6 this thesis
pCRII-agouti BamHI T7 this thesis
pCR-BluntII-agt EcoRV Sp6 this thesis
pCRII-ak5l NotI Sp6 this thesis
pCRII-apelin NotI Sp6 this thesis
pCRII-ar NotI Sp6 this thesis
zVasotocin (avpl) EcoRI Sp6 Eaton et al. (2008)
pCRII-bombesin NotI Sp6 this thesis
pCR-BluntII-cck1
(now wu:fq26c12-201 )
EcoRV Sp6 this thesis
pCR-BluntII-cck EcoRV Sp6 this thesis
pCRII-chat NotI Sp6 this thesis
pCRII-CRH NotI Sp6 Löhr et al. (2009)
pCRII-cyp19a1a BamHI T7 this thesis
pCRII-gad1 BamHI T7 this thesis
pCRII-gastrin NotI Sp6 this thesis
pCRII-hdc BamHI T7 this thesis
pCRII-lin7a NotI Sp6 this thesis
pCRII-mmp23al BamHI T7 this thesis
pCR-BluntII-nts EcoRV Sp6 this thesis
zIsotocin (oxtl) SalI Sp6 Eaton and Glasgow (2006)
pCRII-pDYN BamHI T7 this thesis
pCR-BluntII-penk BamHI T7 this thesis
pCR-BluntII-penkl EcoRV Sp6 this thesis
pCRII-plcxd3 NotI Sp6 this thesis
pCRII-relaxin3c BamHI T7 this thesis
pCRII-rhbdf1 NotI Sp6 this thesis
pCRII-slc6a3 NotI Sp6 this thesis
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pCRII-slc18a2 BamHI T7 this thesis
pCRII-slit2 BamHI T7 this thesis
pCMVSport-sst1 SalI Sp6 Löhr et al. (2009)
pCRII-tafa5 NotI Sp6 this thesis
pBS-zTH XhoI T3 Holzschuh et al. (2001)
pCRII-zTRH BamHI T7 Löhr et al. (2009)
pCRII-Uts1 NotI Sp6 this thesis
pCR-BluntII-vip SacI T7 this thesis
Table 6.12: Neuropeptide probes
6.1.13 Primers
6.1.13.1 Primers for genotyping
Primer Sequence
net1a_4F ACCATTCAGAGCTGGACAGAA
net1a_4R ATGTATCTGAAACGTGACGCC
MD_WT4F GTAGCGGTCAACAGTAAGGATCAATA
MD_MUT3F GTAGCGGTCAACAGTAAGGATCAACG
geno_2A_B GTCACCGCATGTTAGCAGACTTCC
geno_2A_2B CTTCCTCTGCCCTCTCCACTGC
geno_otpa_F CTCTCCGGCCCCACCAATGT
geno_otpa_2F CAGCTGTGTAGCTCCCCGGAC
geno_sim1a_F CCTTGGGTGCTCTGGTTCCTCTC
geno_otpb_F CGGTCTTCAGTCGCATCTCTATCAAC
geno_fezf2_F CGGGAAAGGCTTTTGCAGGAAC
geno_fezf2_2F CACATACGGAAATTGCACGATAACG
Table 6.13: Primers for genotyping
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6.1.13.2 Primers for Probe synthesis constructs
Primers for probes detecting transcription factors:
Primer Sequence
a2bp1_F GCAACAGCACGGGTAATGACGAAT
a2bp1_B GCGCGAAACGACTGTATCCACCT
ascl1a_F CAAGATGGAAATAAGCGTAAACCAGCAG
ascl1a_R GTTCTCTCTCGTTCCGTCTGGCC
barhl1.1_F CAGCAGTGTGGAGATGGAAGCGT
barhl1.1_B ACCTGCGGGCTGTCTCTGCTG
creb1_F CTCCACTCCAGCCATAACAACCGTT
creb1_B GGGCAGTGCTGGGGAAGAGG
dact1_2F GAGACACCATGGTCATCACCGACA
dact1_2B CTGTGCTGACGTCATTCCATGGG
dbx1a_F TCATCTTTTAATAGCCGGGACCATG
dbx1a_B AATGGGCACGACCGATGAAGG
dbx1b_F GCCACCTGCCATGTATCCGAG
dbx1b_B CCTCGGCTTCCCTCGTGCTG
dlx1a_F TGACCATGTCTACAATACCAGAGAGTCTAAACA
dlx1a_B TCTGACTCCGGTGCTGGGTCC
dmrt3a_F CCCACTGGAGGTCCTGAAGAAGAT
dmrt3a_B CGATGCTCCTCACTGGGTCTGC
dnmt4_F AGTCGACTGAAATAGTGATGCCATCCA
dnmt4_R TCAGTAGTGGAGGTGGATGTGGTGC
erm_F CTCCAAATAAGTCTCACATGCAGGAACC
erm_R CGATGGAACCTGTGGTCTGTGCTG
esr2b_F TGGACTCCAGCAAGGCCGATC
esr2b_B CTCCTTTACCCACAATGCTCGCG
fezf2_F ACAGTGATGTCCTGCCCGAGACTAGAC
fezf2_B TGTGGTTCTCCCGCACGATTTG
foxa1_F CCAGGCCTGTTCTCAATACATCGTAGTC
foxa1_B ATACATATTTTATTCACAATGCATTTCCACC
foxb1.1_F TACCTCCAACAACAAGCAAAACTCCG
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foxb1.1_B TCTTGGGCAGTGCACGGCG
foxp2_F GGAGTCGGCCAATGAGACAATAAGC
foxp2_R CCAGCTGGCGGCAGAGTCTGT
grhl1_F TGCCCAATGATCCTGCGTACAAC
grhl1_B GGTTGTGGGGCAGCTGGCG
gsh1_F CATTTGGTACACGAGCGAGACTGA
gsh1_B GCTGCTCTGAAGTTGACTGCTGCTAT
her8a_F GCCCTCTCCCTCTGTCCCCG
her8a_B TTGGTGTCATCTGTGTTCATGCCC
hmx3_F CGAATATCAAGCCAACATGCCC
hmx3_B TCGTCTTCATCGTCCTTGGCG
id3_beg_F AGACCCAGAATGAAGGCGATCAGTC
id3_beg_R CTCGGAAGGACTCTTGCAGCGG
id3_end_F GATAGCGCTGGAAAACGAGACAGACA
id3_end_R CATTCATCCATCCTAATGGCACATAGCT
lcorl_F CGACCCAGTGCCGGAGCTC
lcorl_B ACAGTGAGGTCCAGAGGCCCATC
lef1_F CAGGATGGTCTGCCAGAGACAATTATG
lef1_B GCAAGTGAGCGAGTGGACATAGTGAAC
lhx1_F TGGAGATTATCAAAGCGAGTACTACGGC
lhx1_B CATGCTGCCCTCTACTGCTCTCTCC
lhx5_F GCTCAGTGCTCTCGGTGCTCG
lhx5_B AAGGTAGACTGGTTAGGTTGGAATCCC
lhx6_F GACTCAAGCAACTGCATCCCAAAAG
lhx6_B GCGCACACGTTCTTCCCGGT
lhx7_F CTCTTCAGCTGCACCAGTGTCATCA
lhx7_B ATCTTTGCAAATCCTTCAGTAAGTGCC
lhx9_F CTTCAGTTTTGCCTTATATCATCCGGA
lhx9_B AGGCTTCTCTGGGCTCATGGAG
lmo1_F GATTTCTTGAATATAGTTACAGTTTCGGAGCA
lmo1_B TCGGCACACCCTCTTCCTTGTCTA
lmx1b_F GGAGATGAGTTTGTACTGAAGGACGGAC
lmx1b_B CACCTCGAACGACGCCTTGAAG
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mbd3b_F ACAGACAGAGACCCAGATACGACAACAAC
mbd3b_B AACATGTCAGCCATCAAAGCCTCCT
neurod4_2F TTTCAGAAGTTCTGGAGAGCGGTCA
neurod4_2B TTCTGCTTCACGAGGTGATGGCT
nkx2.1b_F GCGCACTCATACGTTTCCATCCT
nkx2.1b_B CCTTTACCAACATCCGCCAACG
nkx2.2a_F GCTCCAGAACATGTCGTTGACCAAC
nkx2.2a_R GCTTCTTACCAGAGTCGCTGCCG
nr2e1_F AGCACGAGAGGGGACCGAGGA
nr2e1_R ATTCGCACACAGACTCGGTCGC
nr2f1a_F AATTTATTTTGCACAGCACTTTGGATC
nr2f1a_B GCTGACGCCGCCTGCTGT
nr2f1b_F GAGTAAAAGTGCGGTCATGTACATCTCC
nr2f1b_B TGGTTTTGCGCCGCGATC
nr4a2b_F TGTGCGGAGCCATGCCCTG
nr4a2b_R CTGCTTGAACGAGAATAACCGAGACATC
nr5a1a_F GAGGCTGTGCGTGCAGACCG
nr5a1a_B TTTCCTCTGCCGCTCTGCTCCT
nr5a2_2F CCCAGCAGACCTCACCATTACCTC
nr5a2_2B TCGACTGGCCTGTTCCTGCTG
nr6a1b_F CGGGATGCCAGGAGGAAGGAA
nr6a1b_B CTCCGACTGAGTCACGCTGTACCC
otx1l_F GCAGCAGAGCAGCACCAACTCAA
otx1l_B GCCTCCGAAATAAGAAGCAGCGTT
pax3b_F ATGCCATGTCGAGTCTGTCCCC
pax3b_B GAGGAGGATGAAGTATGCTGTCAGTAGTAAT
pax6a_F ACAAGCCAGTAATTCCTCAAGTCACATAC
pax6a_B TGTTCTCTTTTATTCTTCAAGTCTTTGTGTCC
pax6b_F CTTCACGCAGGAGCAGATCGAG
pax6b_B ACATGTCAGGCTCAGTTCCGGG
rfx2_F TTCGTCTGAAGCCGGACTCGC
rfx2_B TCTGATGGCTTGAGTGAGGGTGCT
roraa_F AAGCTTGACATTCCCCACGGTGT
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roraa_B ATCGCCCTGTTCTCCGCCTTC
sall1a_F CCTAGCCGAGCACAATGGGGAC
sall1a_B AGAAGAATCTGGTGACGAATCTGCTCTATG
satb2_F GATGATTCCTGTCTTCTGCGTGGTG
satb2_B TCTTTGAGGGCGTTGCGTACTGTT
sb:cb306_F CTGGGGTTTGTAGAAACGTCTGAATGC
sb:cb306_B GCATTAAAACAGAAGTACCTCAACTCACTGATTAC
sb:cb382_F CTGAATTCTTATAATCTCTCACCAAACCTACTTTTC
sb:cb382_B TAAGTTTGTGGATTTGAAAGGTCTGTTATGAG
sb:cb458_F TGTGTCTCCAGAGCCCAGTCCAG
sb:cb458_B AAGGTTTTCATTTGAAGGAGACTTTACACTC
sb:eu863_F AGTCCACCTGCTTTACATCCCCATG
sb:eu863_B GCCATGTTCCTCTGCTCTGAATGAG
sox11a_F CGAAGAAGAAACCAAAGCTGGACAGTT
sox11a_B CGAAGTTCAAACTGAAGTCAAAAAGCAAG
sox14_F CCTGGGCGACACGGATCACC
sox14_B TGGAGTCACATAGCAGCGGCGT
sp8_F AGCTGCTCTCTCTCCCCGTTCG
sp8_B TGAGTGAGGGAGGGATAGTCTGAGTTATAGC
spon1b_F TAATACACATACACACACATACACATGCCAG
spon1b_B CCGGATTAGAAACTGAAATGCTGACA
tbx2b_F GCTGACCCTTCCATCATTACGCA
tbx2b_B GAATTGTTGACTGTGTAGGCCGGAG
tcfcp2l1_F TGTGTTGACTGAGTGCTCCCCTTG
tcfcp2l1_B CTGATAGTGAAGCTTGCCTCCTCTGTAA
tcf7l1a_F TCAGCAAGGCCAGCATATGTACTCC
tcf7l1a_B TCTTCCTCTTTCTTCACGGGCACC
vgll2b_F CCTCAAGCAGTCGGCGCAGTT
vgll2b_B CGTTCAGAGCGTGTGCAGAGCC
zgc:103720_2F GCCTGTTCCACCAGTGCTCTATCTG
zgc:103720_2B CATATTATATCCAGAAAATGAACAGTGCACAATA
zic2a_F TGTTACTGGACGCAGGGCATCA
zic2a_B CAGCTGGGCGGCCGAGTAA
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znf536_F GCATCTCAACAAGCTGGCCATCA
znf536_B CAGCTGCATTGGCAAGTTCATCTTC
Table 6.14: TF probe primers
Primers for probes detecting neuropeptides:
Primer Sequences
aanat1_F CAGGGTCCTTCTGAAATCATTGTAGGG
aanat1_B GGAAGGTACATTAAAAGTTTGTCACATTGG
adra2a_F GCCGGAGAGATAAGAGGAGAGTGGTG
adra2a_B GACATCGACATGCACGTTGAGGC
agouti_F AAGCTGTCCACCTGCAGAGAAG
agouti_B ACACCTTAAAACCGCAGCCAAT
agt_fwd GATTACCCGACAAGATGAAGATGTTCCTC
agt_rev AAATAGAGGGTCACCAATGCACCGAAT
ak5l_F ATGCCGATCGAGAAGAGGATGACAT
ak5l_B CACTATTTCTGGCTTGAGCTCCAAATATAC
apelin_F CATAGCACCTGCTGGTTCTTCA
apelin_B CTGGGCTTGAGCATTTAGCTGT
ar_F ATATGGACGGACCGCGAGCG
ar_B CCTCCCTCCGTCAAACCTGCC
bombesin_F GGGGAAGAAAAGTGTCGTGGAC
bombesin_B GACGTTCGGGCGGATGTG
cck1_fwd TCACAAAACTGAATAAGGATGAACAGCGG
cck1_rev AGGAGCCGCATTTCTGTATTTATATGGTTTA
cck2_fwd ATGAACGCTGGACTCTGTGTATGTGCC
cck2_2_rev TATTCCTCGGCGCTTCGTCGG
chat_F CACTGAGGAGATGTTCTGCTGCTATG
chat_B GACTTGCTTCCATTCTTCATTACCTTAGG
cyp19a1a_F2 ATCCGTTCTTATGGCAGGTGATCTG
cyp19a1a_B2 AATGTGTGATTTGTGTGGTCGATGG
gad1_F CGGAGACGAGCGAAGGGAGAAG
gad1_B CCCACCACTGGTTTACACACAGACC
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gastrin_F CTGTGTGGTTTCGCTCACAGAC
gastrin_B AGCTGCACATGAGGTTTTCTCC
hdc_F GCGACGCAGGAGCTACTGAGGAA
hdc_B GCTGGCACGGCTGGTGATCA
kctd7_F2 GGAGGACACCCAGCCGCTG
kctd7_B2 CAGACGCCGATGCATTGCTG
lin7a_F CTGGAGGAAATGGAGGCGAGATT
lin7a_B CAGAGACACCAGCACCAAAAGAACC
mmp23al_F TGCCTCGTGGAAAAGTTGTGGG
mmp23al_B GACACGTGTGACTGTGAGCGGC
nts_fwd CAAACAACATGCAGATGCAGCTGACC
nts_rev CAGTAAATTACGCTTCTCTTGAGAATGTACGG
pDYN_F CGGAGAAACAAACGCGTTAAACAC
pDYN_B ACTTCATTATCGTAAACTCCCGTTTCGT
penk_fwd CAGTAATGAAGACCTTGACAGTTCCCATAAG
penk_rev ATCATCTTAATATCCCATAAATCCACCATACCTCT
penkl_fwd ATGGCGTTAATGATGAACTCCTGGTG
penkl_rev TCTAATCCATGAATCCTCCGTATCTCTTCTG
plcxd3_F GGTCTTCTATCACAATCCAATGGCTCTG
plcxd3_B GTATATGTGGAGGTTCAGGTGGCG
relaxin3c_F GAATCTCCAAAACTGGCTGGAT
relaxin3c_B TTCATGGTGCATCCAGAAGTACA
rhbdf1_F AGAGGCAAGGTTTCCACCGCAG
rhbdf1_B CCCTTGACCAGAGCTGCCGC
slc6a3_F GAGAGGCAGACCGGCGGTC
slc6a3_B ACCTCCAGACGTTGGCCAGATC
slc18a2_F AGGCACGTGTCGGTGTATGGAAG
slc18a2_B GACATACATGGCCGGAGGTTAGGAG
slit2_F CTTTGACACACTACATTCGCTCTCCACA
slit2_B ATTACCATGGAGAGACAACAAGCGCA
tafa5_F TTGTGCCACGGAGAGCATACTA
tafa5_B CGTTTCAGTGTTCCATGTCAGC
Uts1 Probe F TCCCATTGGTCCTGCTCA
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Uts1 Probe B GTGTGAATGTCGGATGCGTTAGC
vip_fwd AATGCTTGTGCGGAACGGCTCTC
vip_rev TGATTTCTTGCGTTCGGACTGACCTC
Table 6.15: Neuropeptide probe primers
6.1.13.3 Primers for cloning genes
Primers for the generation of the over-expression constructs:
Primer Sequence
otpa_ATG_AscI_F GGCGCGCCATGCTTTCGCATGCCGACCTGCTG
otpa_Stop_SalI_B GTCGACGGTGAAGCTCATGGACACTGTGTG
sim1a_ATG_Ascl_F GGCGCGCCATGAAGGAGAAGTCGAAAAACGCG
sim1a-STOP_SalI_B GTCGACGCTGCCATTGGTGATGATGACG
otpb_ATG_Ascl_F GGCGCGCCATGCTCTCTCATGCCGACCTCTTG
otpb-STOP_BspEI_B TCCGGAAGTGAAACTCATTGAAACGGTGTGCTC
foxb1.2_ATG_AscI_F GGCGCGCCATGCCCAGACCCGGGAGAAACA
foxb1.2 -STOP_salI_B GTCGACGTGCACCGCGACCGACTGCA
fezf2_ATG_AscI_F GGCGCGCCATGCTCACACCAAGTTGGGTAGAAGT
GG
fezf2 -STOP_salI_B GTCGACGTTTTGGTGTCCTCTGGAAGAATCGTTT
Table 6.16: Full lenght primers
6.1.13.4 Sequencing primer
For sequencing reaction the standard primers M13 fwd, M13 rev and T7 have been used.
6.1.13.5 Primers for MO control
Primer Sequence
sim1a_splice_F CGGCGGGAGAAGGAAAACAG
sim1a_splice_B ACCACCGCACGTCAATCCTG
otpb_MO_fwd ATACTCGCCTCGGTGAGTTATCGCCAC
otpb_MO_rev TGGCGGACCCGCTCCGAGACT
geno_fezf2_wt_1F CGCGGCCGTTCGTGTGTAAAGTAT
fezf2_stop_SalI_B GTCGACGTTTTGGTGTCCTCTGGAAGAATCGTTT
Table 6.17: MO control Primers
102 6 Material and Methods
6.1.13.6 Primers for constructs generated in this thesis
Primer Sequence
600uc_fwd AAGCAGCAGATGAATTCGGGTTCCAT
600uc_rev GCCGTACCTGTGAGGACTTTCCATTCA
3kb_fwd TTAGTCAGTTTGATTTGATTGAAGTTGGAATGACT
3kb_rev CCAGATTAATAAAGGGACTATAAGCCGAAAATAAA
MO_foxb1.2_5’ AATTCACGCGATTAGGACAGGATGCCCAGAG
MO_foxb1.2_3’ AATTCTCTGGGCATCCTGTCCTAATCGCGTG
Table 6.18: Cloning primers
6.1.13.7 Primers for real time PCR
Primer Sequence
ef1alpha2f CTGGAGGCCAGCTCAAACGT
ef1alpha2r ATCAAGAAGAGTAGTACCGCTAGCATTAC
otpa4f CTTCGCCAAAACCCACTATC
otpa2r ACACGTTGGTGGTCTTCTTGCG
Table 6.19: Real time PCR primers
The primer were designed and tested by Chen-Min Yeh (Ryu Laboratory).
6.1.13.8 Other primer
Primer Sequence
hsp70-4_NotI_F GCGGCCGCTCAGGGGTGTCGCTTGGTTATTTC
hsp70-4_XhoI_B CTCGAGCAGGAAAAAAAAAAACAATTAGAATTAATT
TTATATTTATAC
BamHI-Lyn_F CGCGGATCCATGGGCTGCATCAAGAGCAAGC
RV.XbaI.Tomato TGCTCTAGATTACTTGTACAGCTCGTCCATG
Table 6.20: Other Primers
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6.1.14 Primary and secondary Antibodies
Primary Antibody Source Used Dilution Provider
αOtpa rat 1:500 S. Ryu, Ryu Laboratory
(unpublished)
αOXTL rabbit 1:500 S. Ryu, Ryu Laboratory
(unpublished)
αAVPL rabbit 1:500 S. Ryu, Ryu Laboratory
(unpublished)
αGFP chicken 1:1000 Abcam
Table 6.21: Antibodies
Secondary Antibody Source Used Dilution Provider
Alexa Fluor 488 αchicken goat 1:1000 Invitrogen
Alexa Fluor 546 αrat goat 1:1000 Invitrogen
Table 6.22: Secondary Antibodies
6.1.15 Other reagents
Reagent Company
Agarose (low melting) Roth
Agarose (standard) Starlab
Alexa 488 tyramide (TSA Kit #12) Invitrogen / Molecular Probes
Alexa 555 tyramide (TSA Kit #41) Invitrogen / Molecular Probes
Alexa 647 tyramide (TSA Kit #16) Invitrogen / Molecular Probes
Anti-Digoxigenin-AP Fab fragment Roche
Anti-Digoxigenin-POD Fab fragment Roche
Anti-DNP-POD Perkin Elmer
Anti-Fluo-POD, IgG fraction Invitrogen
Blocking Reagent Roche
Bovine Serum Albumin Sigma-Aldrich
Dextran sulfate sodium salt Sigma-Aldrich
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DMSO Sigma-Aldrich
DNA ladder (1 kb) Fermentas
DNP-11-UTP Perkin Elmer
dNTPs (dATP, dTTP, dGTP, dCTP) Fermentas
DyLight 633 NHS Ester Thermo Scientific
Ethidiumbromide Gerbu
Fluorescein-12-UTP Roche
Glas capillaries TW100F-4 World Precisions Instruments, Inc.
4-Iodophenol Sigma-Aldrich
Normal sera (goat, sheep) PAA Laboratories GmbH
NTPs (ATP, TTP, GTP, CTP) Fermentas
Phenol red Sigma-Aldrich
PTU Sigma-Aldrich
RNA loading dye Ambion
RNA from torula yeast Type VI Sigma-Aldrich
Tyramine hydrochloride Sigma-Aldrich
5(6)-FAM, SE Invitrogen/Molecular Probes
5(6)-TAMRA, SE Invitrogen/Molecular Probes
Tricaine Sigma-Aldrich
Tween20 Roth
TritonX 100 Roth
Trizol Invitrogen
Table 6.23: Reagents
Standard chemicals like salts and solvents were ordered from Roth, Applichem, Merck
and Sigma.
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6.2 Experimental procedures
6.2.1 Fish maintenance
Zebrafish breeding and maintenance was performed under standard conditions at 28.5
°C according to Westerfield (2000). The Embryos were staged after Kimmel et al. (1995)
and fixed at desired developmental stage with 4 % PFA. To avoid pigmentation embryos
were kept in egg water with 0.2 mM 1-phenyl-2-thiourea (PTU).
6.2.2 Molecular biological methods
6.2.2.1 Standard techniques
Standard techniques like DNA and RNA quantification, isolation and precipitation,
digests and ligation were performed according to Sambrook and Russel (2001) if not
indicated differently. The following section describes other methods more in detail.
6.2.2.2 Polymerase chain reaction (PCR)
The amplification of DNA fragments by PCR was carried out according to Sambrook
and Russel (2001). Primers were designed using the software Gene Runner and ordered
at MWG-Biotech. Taq DNA polymerase was used as standard Polymerase. PCR
reactions that required proof reading activity were performed by using Phusion as
DNA Polymerase.
Thermal cycler program: standard PCR
1 95 °C, 5 min
2 95 °C, 30 s
3 optimal annealing T, 30 s
4 72 °C, 1 min/kb
5 go to step 2, 30-42x
6 72 °C, 5-10 min
7 10 °C, forever
Table 6.24: Standard PCR conditions
6.2.2.2.1 Real time PCR
The real time PCR was carried out according to the Power SYBR Green RNA-to-CT
1-Step Kit manual. Primers were designed using Primer 3 and ordered at MWG-Biotech.
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The primers (see table in 6.1.13.7) used for the real time PCR were designed and tested
by Chen-Min Yeh (Ryu Laboratory).
6.2.2.3 Gel electrophoresis
DNA and RNA gel electrophoresis using TBE buffer was performed as described in
Sambrook and Russel (2001). For standard low resolution gels 1 % agarose gels were
used. To achieve a higher resolution for small PCR products 2 % agarose gels were
made. Before hardening of the agarose 0.5 µg/ml ethidium bromide was added to stain
the DNA or RNA. For RNA gel electrophoresis RNA loading dye was used and the RNA
+ loading dye mixture was cooked for 5 min at 98 °C prior to loading.
6.2.2.4 DNA purification
6.2.2.4.1 Plasmids in bacterial cultures
Plasmids from bacterial overnight cultures have been purified following the instructions
of the GenElute Plasmid Miniprep Kit or the Qiagen Plasmid Midi Kit manual.
6.2.2.4.2 Gel extraction
DNA fragments from gels have been purified with the QIAquick Gelextraction Kit
(Qiagen) according to the manufacturers protocol.
6.2.2.4.3 PCR product purification
For the purification of PDR products the GenElute PCR Clean-Up Kit (Sigma-Aldrich)
was used following the Kit instruction.
6.2.2.5 Sequencing
In the beginning of the project sequencing was done in house. The sample preparation
was performed following the instruction of the BigDye Terminator v3.1 Cycle Sequencing
Kit (Applied Biosystems). Sequences were analyzed using SeqMan Pro within the
Lasergene Software (DNASTAR). In later phases of my project Sequencing was done
by a commercial sequencing service (GATC Biotech AG, Konstanz).
6.2.2.6 Isolation of total RNA from embryos
Total RNA was isolated using either Trizol reagent in combination with the PureLink
RNA Mini Kit (Ambion) for pure RNA extraction or the RNeasy Mini Kit (Qiagen) for
standard RNA isolation according to the manufacturers instruction. RNA was isolated
from single embryos or from a pool of 30 embryos. The homogenization of the tissue was
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done using Trizol or lysis buffer supplied by the Kit utilizing a 27G needle and a 1 ml
syringe (BD Plastipak). The quality and the amount of the isolated RNA was assessed
by spectrophotometry. RNA samples were stored at -80 °C.
6.2.2.7 First-strand cDNA synthesis
First-strand cDNA was synthesized from total RNA using Superscript III reverse
transcriptase (Invitrogen) following the manufacturers protocol. The RNA amount used
for the synthesis varied from 500 ng to 1 µg. Random primer (Invitrogen) were employed
to prime the synthesis reaction. The cDNA was stored at -20 °C or directly used for PCR
(RT-PCR).
6.2.2.8 In vitro transcription to generate RNA hybridization probes
Labeled RNA probes were generated by in vitro transcription. To incorporate into
the probes Dig-11-UTP (Dig labeling mix, Roche), DNP-11-UTP (Perkin Elmer) or
Fluorescein-12-UTP (Roche) the RNA polymerases SP6, T7 and T3 were used. For
these reactions the nucleotide mix contained 10 mM ATP, CTP, GTP and 6.5 mM
UTP combined with 3.5 mM labeled UTP. For the generation of ”run off” transcripts
linearized and purified plasmids were used as templates. The in vitro transcription
and the subsequent precipitation of the labeled RNA was performed according to the
instruction provided with the Dig labeling Mix (Roche). The quality of the RNA probe
was monitored by gel electrophoresis. To avoid RNA degradation the probes were
resuspended in 50 % Formamide. For the RNA hybridization probes used in this thesis
constructs, restriction enzymes and RNA polymerases are listed in the tables in section
6.1.12.
6.2.2.9 In vitro transcription to generate capped mRNA
To generate full length capped mRNA the plasmids pCS2FA-transposase and
pCS2+MOfoxb1.2 -EGFP were utilized. For the synthesis of the capped mRNA the
plasmids were linearized and purified. The following in vitro transcription was carried
out according to the manual of the mMessage mMachine (SP6 or T7 RNA Polymerase,
Ambion). The template DNA was removed using 2 U DNase I (15 min, 37 °C) and the
RNA was subsequently precipitated using the LiCl solution supplied with the kit and
stored at -80 °C. The amount and quality of the synthesized capped mRNA was assessed
by spectrophotometry and gel electrophoresis.
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6.2.3 Cloning
6.2.3.1 TA cloning of PCR products
Full-length PCR products have been amplified using Phusion DNA Polymerase while
PCR products for probe synthesis were amplified using Taq DNA Polymerase. Since the
Phusion is not generating PCR product with a 3’ A-overhang an A-tailing reaction using
Taq was subsequently performed. The generated PCR products were ligated according
to the Dual Promoter TA cloning Kit (Invitrogen) instruction into pCRII. Full-length
fragments were sequenced after the cloning procedure.
6.2.3.2 Directional cloning into plasmid vectors
For the generation of constructs expressing EGFP under the control of the otpa 600 bp
and 3 kb enhancer element in combination with the hsp70 heat shock promoter (Halloran
et al., 2000) as basal promoter, the enhancer elements were PCR amplified (primer
see section 6.1.13.6) and by blunt end cloning inserted into the Hsp339 (obtained from
Ettwiller Lab) containing EGFP and the hsp70. For the transgenic lines over-expressing
full-length cDNAs of otpa, otpb, sim1a, fezf2 and foxb1.2, the viral 2A peptide (Tang
et al., 2009) was placed between the cDNA and EGFP or tdTomato to report the
expression of the transgene and placed after the hsp70 heat shock promoter (Halloran
et al., 2000) in a multicistronic gene expression cassette. The full-length cDNAs of
otpa, otpb, sim1a, fezf2 and foxb1.2 were PCR-amplified and cloned into pCRII vector
(Invitrogen) using the primers listed in 6.1.13.3. By using the restriction sites added by
the PCR the cDNAs were cloned in frame into pT2G12A and pSceIn-lyntdTomato (A.
Gutierrez-Triana, Ryu laboratory) were the hsp70 heat shock promoter was inserted
before (primer see 6.1.13.6). To add the foxb1.2 morpholino binding site into the
pCS2+-EGFP(-ATG) in frame two complementary oligos with an added restriction site
were ordered (see 6.1.13.6). The oligos were phosphorylated and subsequently annealed
by which as double stranded oligo with stick ends was generated. This oligo was ligated
into pCS2+-EGFP(-ATG) to achieve pCS2+-foxb1.2MO-EGFP.
6.2.4 Genotyping
To genotype adult fish the fish were anesthetized in 1x Tricaine in system fish water,
placed onto a piece of Parafilm and a small piece of the caudal fin was cut using a
scalpel. To the fin 100 µl of 1x lysis buffer were added, the fin was heated to 98 °C for 10
min and after cooling down 5 µl of 20 mg/ml Proteinase K solution were added. After an
overnight incubation the proteinase K was heat inactivated (98 °C, 10 min). Up to 2 µl
of this solution could be used for a PCR reaction. To genotype embryos that underwent
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an in situ hybridization the tails of the respective embryos were cut by a scalpel and
treated in the same way as the fin of an adult fish (50 µl lysis buffer and 2.5 µl Proteinase
K). The primer used to genotype adult fish or embryos are listed in 6.1.13.1.
6.2.5 Phenotypical analysis of zebrafish embryos
6.2.5.1 Whole mount in situ hybridization (WISH)
WISH was performed according to (Hauptmann and Gerster, 1994) using the alkaline
phosphatase based color reaction. The Proteinase K (1 mg/ml) digestion times differed
according to the developmental stage. 1 dpf old embryos were digested for 3 min, 2 dpf
embryos were digested for 30 min and 3 dpf old embryo were digested for 75 min. Stained
embryos have been stored in 4 % PFA at 4 °C until analysis.
6.2.5.2 Whole mount fluorescent in situ hybridization (FISH)
Two color and three color FISH have been carried out according to (Lauter et al., 2011).
In the beginning of my thesis Tyramides from the commercial TSA Kits # 12, 16, 41
(Invitrogen) were used. Later in the project the Tyramides were synthesized as described
in (Lauter et al., 2011; Speel et al., 1998) to achieve a higher Tyramide concentration
and therefore a better signal amplification. The Proteinase K digest was performed as
described in section 6.2.5.1. Stained embryos should not be stored longer than 1 week in
PBS before imaging.
6.2.5.3 Whole mount immunohistochemistry (IHC)
Fluorescent immunohistochemistry was performed adapting an existent protocol from
(Solnica-Krezel and Driever, 1994). The rehydration, Proteinase K digest and the
postfixation were performed as in standard WISH. For blocking normal goat serum
(10 % in PBTX) was used for 2 h at room temperature. The incubation with the primary
antibody over night at 4 °C was also carried out in 10 % NGS in PBTX. Subsequent
washing steps at least 6 - 8 times throughout the whole day were performed in 1 % NGS
in PBTX as well as the over night incubation of the fluorescent secondary antibody. The
following washing steps were carried out in 0.1 % NGS in BPTX. Stained Embryos could
be stored in PBTX for several days before the analysis.
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6.2.6 Perturbation of gene expression (in vivo)
6.2.6.1 General procedure of microinjection
Glass capillaries with inner filaments (TW100F-4, World Precisions Instruments, Inc.)
were used to make the microinjection needles using a micropipette puller (Flaming /
Brown). The DNA and RNA samples or the morpholinos were diluted in water with
0.05 % Phenol red and loaded into the needle. Grooves in 1 % Agarose in 0.3x Danieau’s
were used to immobilize the eggs for injection at 1 cell stage. To determine the injection
volume a scale in the objective was used to estimate the diameter of the injected drop.
6.2.6.2 Morpholino injection
Morpholinos used in this study were synthesized at Gene Tools LLC. The fezf2 MO(Jeong
et al., 2006), the otpb MO (Ryu et al., 2007) and the sim1a MO (Rupp et al., 1994) have
been published recently and the indicated amounts of the MO’s were used. To control
if these MO’s work in my hands I tested them by RT-PCR by using cDNA from MO
injected embryos (primer listed in 6.1.13.5). Since no foxb1.2 MO was published so far
and the foxb1.2 gene has no introns I ordered an ATG MO at Gene Tools LLC. To
confirm the efficiency of the foxb1.2 MO, it was tested by using capped mRNA of a
construct containing the foxb1.2 MO binding site in frame with EGFP as reporter (the
construct is listed in 6.1.11). No EGFP expression in MO-injected embryos was detected.
6.2.6.3 mRNA injection
30 pg of capped mRNA of pCS2+-foxb1.2MO-EGFP were injected either with 1, 2, 4
and 8 ng of the respective MO or without MO to examine the function of the foxb1.2
MO. After injection the quality of the mRNA in the injection mix was verified by gel
electrophoresis.
6.2.6.4 Injection for the generation of transgenes
For the generation of stable transgenic lines constructs containing two flanking Tol2
transposase binding sites were co-injected (20 pg) with capped mRNA (100 pg) from
pCS2FA-transposase (Kwan et al., 2007) while constructs containing a I-SceI restriction
site were injected (17-30 pg) after the performance of a I-SceI digest.
6.2.6.5 Heat shock treatment
If not indicated differently heat shocks for embryos fixed at 2 dpf and at 3 dpf were
given starting at the evening before fixation for over night. Embryos dedicated for the
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heat shock experiment were cooled to RT and most of the egg water was removed before
prewarmed (42 °C) egg water with 1x PTU was added and the embryos were incubated
at 37 °C. After heat shock the embryos were sorted by color and fixed at the desired
developmental stage.
6.2.7 Microscopic analysis
6.2.7.1 Embryo embedding procedure
Fixed embryos that were analyzed under the DIC microscope were embedded in 100 %
glycerol while fixed embryos analyzed under the confocal microscope were embedded in
80 % buffered glycerol. Living embryos were anesthetized in 1x Tricaine in egg water or
analysis under the fluorescence microscope and for confocal imaging embedded in 0.8 %
low melting Agarose in 0.3x Danieau’s with 1x Tricaine.
6.2.7.2 Imaging
For DIC light images of fixed WISH embryos the Leica DM5500B automated upright
microscope system equipped with the Leica DFC500 camera has been used. To screen
for stable transgenic lines and to determine the quality of FISH and of fluorescent IHC
the Leica MZ16 was used. Confocal stacks of FISH and fluorescent IHC embryos were
recorded at the Leica SP5 laser scanning confocal microscope
6.2.8 Quantitative and statistical analysis
To analyze changes in cell number fixed and stained embryos were analyzed at the
DM5500 DIC microscope. The cell numbers of the embryos were analyzed and significance
of difference was evaluated by using Prism5 GraphPad.
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Abbreviations
A-P anterior-posterior
ACTH adrenocorticotropic hormone
AD anterior-dorsal
Amp ampicillin
aPV anterior periventricular nucleus
ARC arcuate nucleus
AVP arginine-vasopressin
Avpl arginine-vasopressin like
bHLH basic helix-loop-helix
Bmp bone morphogenetic protein
bp base pairs
◦C degree Celsius
Cck cholecystokinin
CNS central nervous system
CRH corticotropin-releasing hormone
D-V dorsal-ventral
DA dopamine
Di diencephalon
DNA deoxyribonucleic acid
dpf days post fertilization
Fezf2 forebrain embryonic zinc finger-like 2
Fgf fibroblast growth factor
Fig. figure
FISH whole-mount fluorescence in situ hybridization
GFP green fluorescent protein
GHRH growth hormone-releasing hormone
GnIH gonadotropin-inhibiting hormone
GnRH gonadotropin-releasing hormone
GOF gain of function
Hb hindbrain
HD homeodomain
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Hdc histidine decarboxylase
Hh hedgehog
HPA hypothalamic-pituitary-adrenal gland
hpf hours post fertilization
hsp heat shock promoter
KAN kanamycin
kb kilo base pairs
lacZ β-galactosidase from lac-operon
LB Luria Bertani
LHA lateral hypothalamic area
LOF loss of function
M molar
mM millimolar
MA mammillary area
MB mammillary body
MDO mid-diencephalic organizer
MHB mid-hindbrain boundary
MO morpholino
mtg mammillotegmental tract
mth mammillothalamic tract
n.s. non significant
ng nano gram
Ngn1 neurogenin 1
NMDA N-methyl-D-aspartate
NO nitric oxide
NPO neurosecretory preoptic area
Nr5a2 nuclear receptor subfamily 5, group A, member 2
OE over-expression
ON over night
OTP orthopedia
OXT oxytocin
Oxtl oxytocin-like
PCR polymerase chain reaction
Pdyn pdynorphin
Penka proenkephalin a
pHyp posterior hypothalamus
pm principal mammillary tract
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PMd dorsal premammillary nucleus
PO preoptic area
Pol. Polymerase
PT posterior tuberculum
PTU phenylthiourea
PV posterior-ventral
PVN paraventricular nucleus
RNA ribonucleic acid
RT room temperature
SCN suprachiasmatic nucleus
SF1 steroidogenic factor 1
Shh sonic hedgehog
SON supraoptic nucleus
SS somatostatin
SuM supramammillary area
Tel telencephalon
TF transcription factor
th tyrosine hydroxylase
TM tuberomammillary nucleus
TRH thyrotropin-releasing hormone
UCN1 urocortin 1
µm micrometer
Uts1 urotensin 1
vHyp ventral hypothalamus
VIP vasoactive intestinal peptide
VMH ventromedial nucleus
VMH ventromedial hypothalamus
WISH whole-mount in situ hybridization
Wnt combination of Wg for Wingless and Int-1 for integration 1
wt wild-type
ZLI zona limitans intrathalamica
115
Bibliography
Acampora, D., Postiglione, M. P., Avantaggiato, V., Di Bonito, M., Vaccarino,
F. M., Michaud, J. and Simeone, A. (1999). Progressive impairment of developing
neuroendocrine cell lineages in the hypothalamus of mice lacking the orthopedia gene.
Genes Dev. 13, 2787–800.
Adolf, B., Chapouton, P., Lam, C. S., Topp, S., Tannhauser, B., Strahle, U.,
Gotz, M. and Bally-Cuif, L. (2006). Conserved and acquired features of adult
neurogenesis in the zebrafish telencephalon. Dev. Biol. 295, 278–93.
Aguiar, D. C. and Guimaraes, F. S. (2011). Blockade of nmda or no in the dorsal
premammillary nucleus attenuates defensive behaviors. Physiol. Behav. 103, 279–83.
Akimenko, M. A., Ekker, M., Wegner, J., Lin, W. and Westerfield, M. (1994).
Combinatorial expression of three zebrafish genes related to distal-less: part of a
homeobox gene code for the head. J. Neurosci. 14, 3475–86.
Alderman, S. L. and Bernier, N. J. (2007). Localization of corticotropin-releasing
factor, urotensin i, and crf-binding protein gene expression in the brain of the zebrafish,
danio rerio. J. Comp. Neurol. 502, 783–93.
Allen, G. V. and Hopkins, D. A. (1988). Mamillary body in the rat: a
cytoarchitectonic, golgi, and ultrastructural study. J. Comp. Neurol. 275, 39–64.
Alvarez-Bolado, G., Zhou, X., Cecconi, F. and Gruss, P. (2000a). Expression
of foxb1 reveals two strategies for the formation of nuclei in the developing ventral
diencephalon. Dev. Neurosci. 22, 197–206.
Alvarez-Bolado, G., Zhou, X., Voss, A. K., Thomas, T. and Gruss, P. (2000b).
Winged helix transcription factor foxb1 is essential for access of mammillothalamic
axons to the thalamus. Development 127, 1029–38.
Babu, M. M., Luscombe, N. M., Aravind, L., Gerstein, M. and Teichmann,
S. A. (2004). Structure and evolution of transcriptional regulatory networks. Curr.
Opin. Struct. Biol. 14, 283–91.
Barresi, M. J., Hutson, L. D., Chien, C. B. and Karlstrom, R. O. (2005).
Hedgehog regulated slit expression determines commissure and glial cell position in
the zebrafish forebrain. Development 132, 3643–56.
Bassett, J. P., Tullman, M. L. and Taube, J. S. (2007). Lesions of the
tegmentomammillary circuit in the head direction system disrupt the head direction
signal in the anterior thalamus. J. Neurosci. 27, 7564–77.
116 Bibliography
Baumgardt, M., Karlsson, D., Terriente, J., Diaz-Benjumea, F. J. and Thor,
S. (2009). Neuronal subtype specification within a lineage by opposing temporal
feed-forward loops. Cell 139, 969–82.
Baumgardt, M., Miguel-Aliaga, I., Karlsson, D., Ekman, H. and Thor, S.
(2007). Specification of neuronal identities by feedforward combinatorial coding. PLoS
Biol. 5, e37.
Beracochea, D. (2005). Interaction between emotion and memory: importance of
mammillary bodies damage in a mouse model of the alcoholic korsakoff syndrome.
Neural Plast. 12, 275–87.
Bittencourt, J. C., Vaughan, J., Arias, C., Rissman, R. A., Vale, W. W. and
Sawchenko, P. E. (1999). Urocortin expression in rat brain: evidence against a
pervasive relationship of urocortin-containing projections with targets bearing type 2
crf receptors. J. Comp. Neurol. 415, 285–312.
Blackshaw, S., Scholpp, S., Placzek, M., Ingraham, H., Simerly, R. and
Shimogori, T. (2010). Molecular pathways controlling development of thalamus
and hypothalamus: from neural specification to circuit formation. J. Neurosci. 30,
14925–30.
Blader, P., Fischer, N., Gradwohl, G., Guillemot, F. and Strähle, U. (1997). The
activity of neurogenin1 is controlled by local cues in the zebrafish embryo. Development
124, 4557–4569.
Blair, H., Cho, J. and Sharp, P. (1999). The anterior thalamic head-direction signal
is abolished by bilateral but not unilateral lesions of the lateral mammillary nucleus.
J. Neurosci. 19, 6673–83.
Blair, H. T., Cho, J. and Sharp, P. E. (1998). Role of the lateral mammillary
nucleus in the rat head direction circuit: a combined single unit recording and lesion
study. Neuron 21, 1387–97.
Blechman, J., Borodovsky, N., Eisenberg, M., Nabel-Rosen, H., Grimm, J.
and Levkowitz, G. (2007). Specification of hypothalamic neurons by dual regulation
of the homeodomain protein orthopedia. Development 134, 4417–26.
Borodovsky, N., Ponomaryov, T., Frenkel, S. and Levkowitz, G. (2009). Neural
protein olig2 acts upstream of the transcriptional regulator sim1 to specify diencephalic
dopaminergic neurons. Dev. Dyn. 238, 826–34.
Bradford, Y., Conlin, T., Dunn, N., Fashena, D., Frazer, K., Howe, D.,
Knight, J., Mani, P., Martin, R., Moxon, S., Paddock, H., Pich, C.,
Ramachandran, S., Ruef, B., Ruzicka, L., Bauer Schaper, H., Schaper,
K., Shao, X., Singer, A., Sprague, J., Sprunger, B., Van Slyke, C. and
Westerfield, M. (2011). Zfin: enhancements and updates to the zebrafish model
organism database. Nucleic Acids Res. 39(suppl 1), D822–D829.
Bibliography 117
Briscoe, J. and Novitch, B. G. (2008). Regulatory pathways linking progenitor
patterning, cell fates and neurogenesis in the ventral neural tube. Philos. Trans. R.
Soc. Lond. B. Biol. Sci. 363, 57–70.
Brivanlou, A. H. and Darnell, J. E., J. (2002). Signal transduction and the control
of gene expression. Science 295, 813–8.
Brobeck, J. R. (1946). Mechanism of the development of obesity in animals with
hypothalamic lesions. Physiol. Rev. 26, 541–59.
Canteras, N. S., Kroon, J. A., Do-Monte, F. H., Pavesi, E. and Carobrez, A. P.
(2008). Sensing danger through the olfactory system: the role of the hypothalamic
dorsal premammillary nucleus. Neurosci. Biobehav. Rev. 32, 1228–35.
Canteras, N. S., Ribeiro-Barbosa, E. R. and Comoli, E. (2001). Tracing from
the dorsal premammillary nucleus prosencephalic systems involved in the organization
of innate fear responses. Neurosci. Biobehav. Rev. 25, 661–8.
Canteras, N. S. and Swanson, L. W. (1992). The dorsal premammillary nucleus:
an unusal component of the mammillary body. Proc. Natl. Acad. Sci. U. S. A. 89,
10089–10093.
Caqueret, A., Yang, C., Duplan, S., Boucher, F. and Michaud, J. L. (2005).
Looking for trouble: a search for developmental defects of the hypothalamus. Horm.
Res. 64, 222–30.
Cavodeassi, F. and Houart, C. (2012). Brain regionalization: of signaling centers
and boundaries. Dev. Neurobiol. 72, 218–33.
Cayouette, M., Poggi, L. and Harris, W. A. (2006). Lineage in the vertebrate
retina. Trends Neurosci. 29, 563–70.
Ceccatelli, S., Eriksson, M. and Hokfelt, T. (1989). Distribution and coexistence
of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokin-, galanin-
and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the
parvocellular part of the paraventricular nucleus. Neuroendocrinology 49, 309–323.
Chen, B., Schaevitz, L. and McConnell, S. K. (2005a). Fezl regulates the
differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral
cortex. Proc. Natl. Acad. Sci. U. S. A. 102.
Chen, J., Rasin, M., Kwan, K. and Sestan, N. (2005b). Zfp312 is required
for subcortical axonal projections and dendritic morphology of deep-layer pyramidal
neurons of the cerebral cortex. Proc. Natl. Acad. Sci. U. S. A. 102, 17792–7.
Chen, L., Zheng, J., Yang, N., Li, H. and Guo, S. (2011). Genomic selection
identifies vertebrate transcription factor fezf2 binding sites and target genes. J. Biol.
Chem. 286, 18641–9.
Chuang, J. C., Mathers, P. H. and Raymond, P. A. (1999). Expression of three
rx homeobox genes in embryonic and adult zebrafish. Mech. Dev. 84, 195–198.
118 Bibliography
Cleveland, D. and Davis, L. (1936). Further studies on the effect of hypothalamic
lesions upon carbohydrate metabolism. Brain 59, 459–465.
Colombo, A., Reig, G., Mione, M. and Concha, M. L. (2006). Zebrafish barh-like
genes define discrete neural domains in the early embryo. Gene Expr. Patterns 6,
347–52.
Dale, J. K., Vesque, C., Lints, T. J., Sampath, T. K., Furley, A., Dodd, J.
and Placzek, M. (1997). Cooperation of bmp7 and shh in the induction of forebrain
ventral midline cells by prechordal mesoderm. Cell 90, 257–69.
Del Giacco, L., Sordino, P., Pistocchi, A., Andreakis, N., Tarallo, R.,
Di Benedetto, B. and Cotelli, F. (2006). Differential regulation of the zebrafish
orthopedia 1 gene during fate determination of diencephalic neurons. BMC Dev. Biol.
6, 50.
Duplan, S. M., Boucher, F., Alexandrov, L. and Michaud, J. L. (2009). Impact
of sim1 gene dosage on the development of the paraventricular and supraoptic nuclei
of the hypothalamus. Eur. J. Neurosci. 30, 2239–49.
Dutta, S., Dietrich, J. E., Aspock, G., Burdine, R. D., Schier, A., Westerfield,
M. and Varga, Z. M. (2005). pitx3 defines an equivalence domain for lens and
anterior pituitary placode. Development 132, 1579–90.
Eaton, J. L. and Glasgow, E. (2006). The zebrafish bhlh pas transcriptional regulator,
single-minded 1 (sim1), is required for isotocin cell development. Dev. Dyn. 235,
2071–82.
Eaton, J. L. and Glasgow, E. (2007). Zebrafish orthopedia (otp) is required for
isotocin cell development. Dev. Genes Evol. 217, 149–58.
Eaton, J. L., Holmqvist, B. and Glasgow, E. (2008). Ontogeny of
vasotocin-expressing cells in zebrafish: Selective requirement for the transcriptional
regulators orthopedia and single-minded 1 in the preoptic area. Dev. Dyn. 237,
995–1005.
Elsalini, O. A., von Gartzen, J., Cramer, M. and Rohr, K. B. (2003). Zebrafish
hhex, nk2.1a, and pax2.1 regulate thyroid growth and differentiation downstream of
nodal-dependent transcription factors. Dev. Biol. 263, 67–80.
Filippi, A., Durr, K., Ryu, S., Willaredt, M., Holzschuh, J. and Driever, W.
(2007). Expression and function of nr4a2, lmx1b, and pitx3 in zebrafish dopaminergic
and noradrenergic neuronal development. BMC Dev. Biol. 7, 135.
Fink, G. (2000). Encyclopedia of Stress. Academic Press.
Forlano, P. M. and Cone, R. D. (2007). Conserved neurochemical pathways involved
in hypothalamic control of energy homeostasis. J. Comp. Neurol. 505, 235–48.
Gainer, H. and Wray, S. (1994). The physiology of reproduction: Cellular and
molecular biology of oxytocin and vasopressin. New York: Raven Press.
Bibliography 119
Givens, B. (1995). Low doses of ethanol impair spatial working memory and reduce
hippocampal theta activity. Alcohol. Clin. Exp. Res. 19, 763–7.
Glasgow, E. and Tomarev, S. I. (1998). Restricted expression of the homeobox gene
prox 1 in developing zebrafish. Mech. Dev. 76, 175–178.
Goossens, N., Dierickx, K. and Vandesande, F. (1977). Immunocytochemical
localization of vasotocin and isotocin in the preopticohypophysial neurosecretory
system of teleosts. Gen. Comp. Endocrinol. 32, 371–5.
Goshu, E., Jin, H., Lovejoy, J., Marion, J. F., Michaud, J. L. and Fan, C. M.
(2004). Sim2 contributes to neuroendocrine hormone gene expression in the anterior
hypothalamus. Mol. Endocrinol. 18, 1251–62.
Guillemot, F. (2007). Spatial and temporal specification of neural fates by transcription
factor codes. Development 134, 3771–80.
Guo, S., Wilson, S. W., Cooke, S., Chitnis, A. B., Driever, W. and Rosenthal,
A. (1999). Mutations in the zebrafish unmask shared regulatory pathways controlling
the development of catecholaminergic neurons. Dev. Biol. 208, 473–87.
Gurskaya, N. G., Verkhusha, V. V., Shcheglov, A. S., Staroverov, D. B.,
Chepurnykh, T. V., Fradkov, A. F., Lukyanov, S. and Lukyanov, K. A.
(2006). Engineering of a monomeric green-to-red photoactivatable fluorescent protein
induced by blue light. Nat. Biotechnol. 24, 461–5.
Haas, H. and Panula, P. (2003). The role of histamine and the tuberomamillary
nucleus in the nervous system. Nat. Rev. Neurosci. 4, 121–30.
Halloran, M. C., Sato-Maeda, M., Warren, J. T., Su, F., Lele, Z., Krone,
P. H., Kuwada, J. Y. and Shoji, W. (2000). Laser-induced gene expression in
specific cells of transgenic zebrafish. Development 127, 1953–60.
Hashimoto, H., Yabe, T., Hirata, T., Shimizu, T., Bae, Y., Yamanaka, Y.,
Hirano, T. and Hibi, M. (2000). Expression of the zinc finger gene fez-like in
zebrafish forebrain. Mech. Dev. 97, 191–5.
Hauptmann, G. and Gerster, T. (1994). Two-color whole-mount in situ hybridization
to vertebrate and drosophila embryos. Trends Genet. 10, 266.
Hauptmann, G. and Gerster, T. (1996). Complex expression of the zp-50 pou
gene in the embryonic zebrafish brain is altered by overexpression of sonic hedgehog.
Development 122, 1769–80.
Hill, A. J., Heiden, T. C., Heideman, W. and Peterson, R. E. (2009). Potential
roles of arnt2 in zebrafish larval development. Zebrafish 6, 79–91.
Hirata, T., Nakazawa, M., Muraoka, O., Nakayama, R., Suda, Y. and Hibi, M.
(2006). Zinc-finger genes fez and fez-like function in the establishment of diencephalon
subdivisions. Development 133, 3993–4004.
120 Bibliography
Hirata, T., Suda, Y., Nakao, K., Narimatsu, M., Hirano, T. and Hibi, M.
(2004). Zinc finger gene fez-like functions in the formation of subplate neurons and
thalamocortical axons. Dev. Dyn. 230, 546–56.
Hobert, O. (2008). Regulatory logic of neuronal diversity: terminal selector genes and
selector motifs. Proc. Natl. Acad. Sci. U. S. A. 105, 20067–71.
Hokfelt, T., Fahrenkrug, J., Ju, G., Ceccatelli, S., Tsuro, Y., Meister,
B., Mutt, V., Rundgren, M., Brodin, E., Terenius, L., Hulting, A.,
Werner, S., Bjorklund, H. and Vale, W. (1987). Analysis of peptide histidine
isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central
nervous system with special reference to their relation to corticotropin releasing factor-
and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus.
Neuroscience 23, 827–857.
Holzschuh, J., Ryu, S., Aberger, F. and Driever, W. (2001). Dopamine
transporter expression distinguishes dopaminergic neurons from other
catecholaminergic neurons in the developing zebrafish embryo. Mech. Dev. 101,
237–43.
Hsu, S. Y. and Hsueh, A. J. (2001). Human stresscopin and stresscopin-related
peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.
Nat. Med. 7, 605–11.
Inoue, A., Takahashi, M., Hatta, K., Hotta, Y. and Okamoto, H. (1994).
Developmental regulation of islet-1 mrna expression during neuronal differentiation
in embryonic zebrafish. Dev. Dyn. 199, 1–11.
Jain, S., Mathur, R., Sharma, R. and Nayar, U. (1999). Neural tissue transplant
in the lateral hypothalamic lesioned rats: functional recovery pattern. Neurobiology 7,
421–430.
Jeong, J.-Y., Einhorn, Z., Mathur, P., Chen, L., Lee, S., Kawakami, K. and
Guo, S. (2007). Patterning the zebrafish diencephalon by the conserved zinc-finger
protein fezl. Development 134, 127–136.
Jeong, J.-Y., Einhorn, Z., Mercurio, S., Lee, S., Lau, B., Mione, M., Wilson,
S. W. and Guo, S. (2006). Neurogenin1 is a determinant of zebrafish basal forebrain
dopaminergic neurons and is regulated by the conserved zinc finger protein tof/fezl.
Proc. Natl. Acad. Sci. U. S. A. 103, 5143–8.
Kapsimali, M., Caneparo, L., Houart, C. and Wilson, S. W. (2004). Inhibition of
wnt/axin/beta-catenin pathway activity promotes ventral cns midline tissue to adopt
hypothalamic rather than floorplate identity. Development 131, 5923–33.
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B. and Schilling,
T. F. (1995). Stages of embryonic development of the zebrafish. Dev. Dyn. 203,
253–310.
Bibliography 121
Kimura, S., Hara, Y., Pineau, T., Fernandez-Salguero, P., Fox, C. H., Ward,
J. M. and Gonzalez, F. J. (1996). The t/ebp null mouse: thyroid-specific
enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral
forebrain, and pituitary. Genes Dev. 10, 60–9.
Kobayashi, M., Toyama, R., Takeda, H., Dawid, I. B. and Kawakami, K.
(1998). Overexpression of the forebrain-specific homeobox gene six3 induces rostral
forebrain enlargement in zebrafish. Development 125, 2973–82.
Koudijs, M. J., den Broeder, M. J., Keijser, A., Wienholds, E., Houwing, S.,
van Rooijen, E. M., Geisler, R. and van Eeden, F. J. (2005). The zebrafish
mutants dre, uki, and lep encode negative regulators of the hedgehog signaling pathway.
PLoS Genet. 1, e19.
Krauss, S., Concordet, J. P. and Ingham, P. W. (1993). A functionally conserved
homolog of the drosophila segment polarity gene hh is expressed in tissues with
polarizing activity in zebrafish embryos. Cell 75, 1431–44.
Kurrasch, D. M., Cheung, C. C., Lee, F. Y., Tran, P. V., Hata, K. and
Ingraham, H. A. (2007). The neonatal ventromedial hypothalamus transcriptome
reveals novel markers with spatially distinct patterning. J. Neurosci. 27, 13624–34.
Kwan, K. M., Fujimoto, E., Grabher, C., Mangum, B. D., Hardy, M. E.,
Campbell, D. S., Parant, J. M., Yost, H. J., Kanki, J. P. and Chien, C. B.
(2007). The tol2kit: a multisite gateway-based construction kit for tol2 transposon
transgenesis constructs. Dev. Dyn. 236, 3088–99.
Lako, M., Lindsay, S., Bullen, P., Wilson, D. I., Robson, S. C. and Strachan,
T. (1998). A novel mammalian wnt gene, wnt8b, shows brain-restricted expression
in early development, with sharply delimited expression boundaries in the developing
forebrain. Hum. Mol. Genet. 7, 813–22.
Latchman, D. S. (1997). Transcription factors: an overview. Int. J. Biochem. Cell
Biol. 29, 1305–12.
Lauter, G., Soll, I. and Hauptmann, G. (2011). Multicolor fluorescent in situ
hybridization to define abutting and overlapping gene expression in the embryonic
zebrafish brain. Neural Dev. 6, 10.
Lee, J. E., Wu, S. F., Goering, L. M. and Dorsky, R. I. (2006). Canonical wnt
signaling through lef1 is required for hypothalamic neurogenesis. Development 133,
4451–61.
Lee, S., Lee, B., Joshi, K., Pfaff, S. L., Lee, J. W. and Lee, S. K. (2008).
A regulatory network to segregate the identity of neuronal subtypes. Dev. Cell 14,
877–89.
Leibowitz, S. F., Hammer, N. J. and Chang, K. (1981). Hypothalamic
paraventricular nucleus lesions produce overeating and obesity in the rat. Physiol.
Behav. 27, 1031–40.
122 Bibliography
Levkowitz, G., Zeller, J., Sirotkin, H. I., French, D., Schilbach, S., Hashimoto,
H., Hibi, M., Talbot, W. S. and Rosenthal, A. (2003). Zinc finger protein too
few controls the development of monoaminergic neurons. Nat. Neurosci. 6, 28–33.
Lewis, K., Li, C., Perrin, M., Blount, A., Kunitake, K., Donaldson, C.,
Vaughan, J., Reyes, T., Gulyas, J., Fischer, W., Bilezikjian, L., Rivier, J.,
Sawchenko, P. and Vale, W. (2001). Identification of urocortin iii, an additional
member of the corticotropin-releasing factor (crf) family with high affinity for the crf2
receptor. Proc. Natl. Acad. Sci. U. S. A. 98, 7570–7575.
Li, Y., Allende, M. L., Finkelstein, R. and Weinberg, E. S. (1994). Expression
of two zebrafish orthodenticle-related genes in the embryonic brain. Mech. Dev. 48,
229–244.
Löhr, H. (2009). A genetic screen for mutations affecting development of
catecholaminergic systems in zebrafish reveals a novel role for the transcription factors
Arnt2 and Sim1 . Ph.D. thesis, University of Freiburg.
Löhr, H. and Hammerschmidt, M. (2011). Zebrafish in endocrine systems: recent
advances and implications for human disease. Annu. Rev. Physiol. 73, 183–211.
Löhr, H., Ryu, S. and Driever, W. (2009). Zebrafish diencephalic a11-related
dopaminergic neurons share a conserved transcriptional network with neuroendocrine
cell lineages. Development 136, 1007–17.
Machluf, Y., Gutnick, A. and Levkowitz, G. (2011). Development of the zebrafish
hypothalamus. Ann. N. Y. Acad. Sci. 1220, 93–105.
Manning, L., Ohyama, K., Saeger, B., Hatano, O., Wilson, S. A., Logan, M.
and Placzek, M. (2006). Regional morphogenesis in the hypothalamus: a bmp-tbx2
pathway coordinates fate and proliferation through shh downregulation. Dev. Cell 11,
873–85.
Marion, J. F., Yang, C., Caqueret, A., Boucher, F. and Michaud, J. L. (2005).
Sim1 and sim2 are required for the correct targeting of mammillary body axons.
Development 132, 5527–37.
Mathieu, J., Barth, A., Rosa, F. M., Wilson, S. W. and Peyrieras, N. (2002).
Distinct and cooperative roles for nodal and hedgehog signals during hypothalamic
development. Development 129, 3055–65.
Mattes, B., Weber, S., Peres, J., Chen, Q., Davidson, G., Houart, C.
and Scholpp, S. (2012). Wnt3 and wnt3a are required for induction of the
mid-diencephalic organizer in the caudal forebrain. Neural Dev. 7, 12.
McNay, D. E., Pelling, M., Claxton, S., Guillemot, F. and Ang, S. L.
(2006). Mash1 is required for generic and subtype differentiation of hypothalamic
neuroendocrine cells. Mol. Endocrinol. 20, 1623–32.
Michaud, J. L., DeRossi, C., May, N. R., Holdener, B. C. and Fan, C. M.
(2000). Arnt2 acts as the dimerization partner of sim1 for the development of the
hypothalamus. Mech. Dev. 90, 253–61.
Bibliography 123
Michaud, J. L., Rosenquist, T., May, N. R. and Fan, C. M. (1998). Development
of neuroendocrine lineages requires the bhlh-pas transcription factor sim1. Genes Dev.
12, 3264–75.
Miura, H., Yanazawa, M., Kato, K. and Kitamura, K. (1997). Expression
of a novel aristaless related homeobox gene ’arx’ in the vertebrate telencephalon,
diencephalon and floor plate. Mech. Dev. 65, 99–109.
Molyneaux, B. J., Arlotta, P., Hirata, T., Hibi, M. and Macklis, J. D. (2005).
Fezl is required for the birth and specification of corticospinal motor neurons. Neuron
47, 817–31.
Molyneaux, B. J., Arlotta, P., Menezes, J. R. and Macklis, J. D. (2007).
Neuronal subtype specification in the cerebral cortex. Nat. Rev. Neurosci. 8, 427–37.
Mori, H., Miyazaki, Y., Morita, T., Nitta, H. and Mishina, M. (1994). Different
spatio-temporal expressions of three otx homeoprotein transcripts during zebrafish
embryogenesis. Brain Res. Mol. Brain Res. 27, 221–231.
Morita, T., Nitta, H., Kiyama, Y., Mori, H. and Mishina, M. (1995). Differential
expression of two zebrafish emx homeoprotein mrnas in the developing brain. Neurosci.
Lett. 198, 131–4.
Nakai, S., Kawano, H., Yudate, T., Nishi, M., Kuno, J., Nagata, A., Jishage,
K., Hamada, H., Fujii, H., Kawamura, K. and et al. (1995). The pou domain
transcription factor brn-2 is required for the determination of specific neuronal lineages
in the hypothalamus of the mouse. Genes Dev. 9, 3109–21.
Nieuwenhuys, R., Donkelaar, H. J. and Nicholson, C. (1998). The Central
Nervous System of Vertebrates, volume 1. Berlin: Springer.
Nussdorfer, G. G. and Malendowicz, L. K. (1998). Role of vip, pacap, and related
peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19,
1443–67.
Odenthal, J. and Nüsslein-Volhard, C. (1998). fork head domain genes in zebrafish.
Dev. Genes Evol. 208, 245–258.
Oki, Y. and Sasano, H. (2004). Localization and physiological roles of urocortin.
Peptides 25, 1745–9.
Pabst, O., Herbrand, H., Takuma, N. and Arnold, H. H. (2000). Nkx2 gene
expression in neuroectoderm but not in mesendodermally derived structures depends
on sonic hedgehog in mouse embryos. Dev. Genes Evol. 210, 47–50.
Pan, W. X. and McNaughton, N. (2004). The supramammillary area: its
organization, functions and relationship to the hippocampus. Prog. Neurobiol. 74,
127–66.
Park, H.-C., Mehta, A., Richardson, J. S. and Appel, B. (2002). olig2 is required
for zebrafish primary motor neuron and oligodendrocyte development. Dev. Biol. 248,
356–368.
124 Bibliography
Passemard, S., Sokolowska, P., Schwendimann, L. and Gressens, P. (2011).
Vip-induced neuroprotection of the developing brain. Curr. Pharm. Des. 17, 1036–9.
Pepels, P. P., Meek, J., Wendelaar Bonga, S. E. and Balm, P. H. (2002).
Distribution and quantification of corticotropin-releasing hormone (crh) in the brain
of the teleost fish oreochromis mossambicus (tilapia). J. Comp. Neurol. 453, 247–68.
Peter, P. (1977). Preoptic nucleus in fishes - comparative discussion of function-activity
relationships. Am. Zool. 17, 775–785.
Pistocchi, A., Gaudenzi, G., Carra, S., Bresciani, E., Del Giacco, L. and
Cotelli, F. (2008). Crucial role of zebrafish prox1 in hypothalamic catecholaminergic
neurons development. BMC Dev. Biol. 8, 27.
Radyushkin, K., Anokhin, K., Meyer, B. I., Jiang, Q., Alvarez-Bolado, G. and
Gruss, P. (2005). Genetic ablation of the mammillary bodies in the foxb1 mutant
mouse leads to selective deficit of spatial working memory. Eur. J. Neurosci. 21,
219–29.
Reyes, T., Lewis, K., Perrin, M., Kunitake, K., Vaughan, J., Arias, C.,
Hogenesch, J., Gulyas, J., Rivier, J., Vale, W. and Sawchenko, P. (2000).
Urocortin ii: A member of the corticotropin-releasing factor (crf) neuropeptide family
that is selectively bound by type 2 crf receptors. Proc. Natl. Acad. Sci. U. S. A. 98,
2843–2848.
Rohr, K. B., Barth, K. A., Varga, Z. M. and Wilson, S. W. (2001). The nodal
pathway acts upstream of hedgehog signaling to specify ventral telencephalic identity.
Neuron 29, 341–51.
Rohr, K. B. and Concha, M. L. (2000). Expression of nk2.1a during early
development of the thyroid gland in zebrafish. Mech. Dev. 95, 267–70.
Rupp, R. A., Snider, L. and Weintraub, H. (1994). Xenopus embryos regulate the
nuclear localization of xmyod. Genes Dev. 8, 1311–23.
Russek-Blum, N., Gutnick, A., Nabel-Rosen, H., Blechman, J., Staudt, N.,
Dorsky, R. I., Houart, C. and Levkowitz, G. (2008). Dopaminergic neuronal
cluster size is determined during early forebrain patterning. Development 135,
3401–13.
Ryu, S., Holzschuh, J., Erhardt, S., Ettl, A.-K. and Driever, W. (2005).
Depletion of minichromosome maintenance protein 5 in the zebrafish retina causes
cell-cycle defect and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 102, 18467–18472.
Ryu, S., Mahler, J., Acampora, D., Holzschuh, J., Erhardt, S., Omodei, D.,
Simeone, A. and Driever, W. (2007). Orthopedia homeodomain protein is essential
for diencephalic dopaminergic neuron development. Curr. Biol. 17, 873–80.
Saito, D., Komatsuda, M. and Urano, A. (2004). Functional organization of
preoptic vasotocin and isotocin neurons in the brain of rainbow trout: central and
neurohypophysial projections of single neurons. Neuroscience 124, 973–84.
Bibliography 125
Sambrook, J. and Russel, D. (2001). Molecular Cloning: A Laboratory Manual,
volume 3. Cold Spring Harbor: Cold Spring Harbor Laboratory.
Saper, C. (2004). Hypothalamus, volume 4, chapter 17. Elsevier, 2 edition.
Saper, C. B. (2000). Hypothalamic connections with the cerebral cortex. Prog. Brain
Res. 126, 39–48.
Sarrieau, A., Najimi, M., Chigr, F., Kopp, N., Jordan, D. and Rostene, W.
(1994). Localization and developmental pattern of vasoactive intestinal polypeptide
binding sites in the human hypothalamus. Synapse 17, 129–40.
Scholpp, S. and Lumsden, A. (2010). Building a bridal chamber: development of the
thalamus. Trends Neurosci. 33, 373–80.
Schonemann, M. D., Ryan, A. K., McEvilly, R. J., O’Connell, S. M., Arias,
C. A., Kalla, K. A., Li, P., Sawchenko, P. E. and Rosenfeld, M. G. (1995).
Development and survival of the endocrine hypothalamus and posterior pituitary gland
requires the neuronal pou domain factor brn-2. Genes Dev. 9, 3122–35.
Sharp, P. E. and Turner-Williams, S. (2005). Movement-related correlates of
single-cell activity in the medial mammillary nucleus of the rat during a pellet-chasing
task. J. Neurophysiol. 94, 1920–7.
Shen, Q., Wang, Y., Dimos, J. T., Fasano, C. A., Phoenix, T. N., Lemischka,
I. R., Ivanova, N. B., Stifani, S., Morrisey, E. E. and Temple, S. (2006). The
timing of cortical neurogenesis is encoded within lineages of individual progenitor cells.
Nat. Neurosci. 9, 743–51.
Shimizu, T. and Hibi, M. (2009). Formation and patterning of the forebrain and
olfactory system by zinc-finger genes fezf1 and fezf2. Dev. Growth Differ. 51, 221–31.
Shimogori, T., Lee, D. A., Miranda-Angulo, A., Yang, Y., Wang, H., Jiang,
L., Yoshida, A. C., Kataoka, A., Mashiko, H., Avetisyan, M., Qi, L., Qian,
J. and Blackshaw, S. (2010). A genomic atlas of mouse hypothalamic development.
Nat. Neurosci. 13, 767–75.
Shirasaki, R. and Pfaff, S. L. (2002). Transcriptional codes and the control of neuronal
identity. Annu. Rev. Neurosci. 25, 251–81.
Simeone, A., D’Apice, M. R., Nigro, V., Casanova, J., Graziani,
F., Acampora, D. and Avantaggiato, V. (1994). Orthopedia, a novel
homeobox-containing gene expressed in the developing cns of both mouse and
drosophila. Neuron 13, 83–101.
Simerly, R. B. (2004). Anatomical substrates of hypothalamic integration. Amsterdam:
Elsevier, pages 335–368.
Skidmore, J. M., Waite, M. R., Alvarez-Bolado, G., Puelles, L. and Martin,
D. M. (2012). A novel taulacz allele reveals a requirement for pitx2 in formation of
the mammillothalamic tract. Genesis 50, 67–73.
126 Bibliography
Solnica-Krezel, L. and Driever, W. (1994). Microtubule arrays of the zebrafish yolk
cell: organization and function during epiboly. Development 120, 2443–55.
Spaniol, P., Bornmann, C., Hauptmann, G. and Gerster, T. (1996). Class iii pou
genes of zebrafish are predominantly expressed in the central nervous system. Nucleic
Acids Res. 24, 4874–4881.
Speel, E. J., Saremaslani, P., Roth, J., Hopman, A. H. and Komminoth,
P. (1998). Improved mrna in situ hybridization on formaldehyde-fixed and
paraffin-embedded tissue using signal amplification with different haptenized
tyramides. Histochem. Cell Biol. 110, 571–7.
Stackman, R. W. and Taube, J. S. (1998). Firing properties of rat lateral mammillary
single units: head direction, head pitch, and angular head velocity. J. Neurosci. 18,
9020–37.
Staudt, N. and Houart, C. (2007). The prethalamus is established during gastrulation
and influences diencephalic regionalization. PLoS Biol. 5, e69.
Sundvik, M., Kudo, H., Toivonen, P., Rozov, S., Chen, Y. C. and Panula, P.
(2011). The histaminergic system regulates wakefulness and orexin/hypocretin neuron
development via histamine receptor h1 in zebrafish. FASEB J. 25, 4338–47.
Swanson, L. W. (1987). The Hypothalamus. Amsterdam: Elsevier, pages 1–124.
Sylvester, J. B., Rich, C. A., Loh, Y. H., van Staaden, M. J., Fraser, G. J.
and Streelman, J. T. (2010). Brain diversity evolves via differences in patterning.
Proc. Natl. Acad. Sci. U. S. A. 107, 9718–23.
Szabo, N. E., Zhao, T., Cankaya, M., Stoykova, A., Zhou, X. and
Alvarez-Bolado, G. (2011). Interaction between axons and specific populations of
surrounding cells is indispensable for collateral formation in the mammillary system.
PLoS One 6, e20315.
Szarek, E., Cheah, P. S., Schwartz, J. and Thomas, P. (2010). Molecular genetics
of the developing neuroendocrine hypothalamus. Mol. Cell. Endocrinol. 323, 115–23.
Takeuchi, Y., Allen, G. V. and Hopkins, D. A. (1985). Transnuclear transport
and axon collateral projections of the mamillary nuclei in the rat. Brain Res. Bull.
14, 453–68.
Tang, W., Ehrlich, I., Wolff, S. B., Michalski, A. M., Wolfl, S., Hasan, M. T.,
Luthi, A. and Sprengel, R. (2009). Faithful expression of multiple proteins via
2a-peptide self-processing: a versatile and reliable method for manipulating brain
circuits. J. Neurosci. 29, 8621–9.
Thisse, B., Pflumio, S., Fürthauer, M., Loppin, B., Heyer, V., Degrave, A.,
Woehl, R., Lux, A., Steffan, T., Charbonnier, X. and Thisse, C. (2001).
Expression of the zebrafish genome during embryogenesis. zfin direct data submission.
Bibliography 127
Tomasini, A. J., Schuler, A. D., Zebala, J. A. and Mayer, A. N. (2009).
Photomorphs: a novel light-activated reagent for controlling gene expression in
zebrafish. Genesis 47, 736–43.
Toro, S. and Varga, Z. M. (2007). Equivalent progenitor cells in the zebrafish anterior
preplacodal field give rise to adenohypophysis, lens, and olfactory placodes. Semin.
Cell Dev. Biol. 18, 534–42.
Tyurina, O. V., Guner, B., Popova, E., Feng, J., Schier, A. F., Kohtz, J. D.
and Karlstrom, R. O. (2005). Zebrafish gli3 functions as both an activator and a
repressor in hedgehog signaling. Dev. Biol. 277, 537–56.
VanDunk, C., Hunter, L. A. and Gray, P. A. (2011). Development, maturation, and
necessity of transcription factors in the mouse suprachiasmatic nucleus. J. Neurosci.
31, 6457–67.
Vann, S. D. (2010). Re-evaluating the role of the mammillary bodies in memory.
Neuropsychologia 48, 2316–27.
Vann, S. D. and Aggleton, J. P. (2004). The mammillary bodies: two memory
systems in one? Nat. Rev. Neurosci. 5, 35–44.
Varga, Z. M., Wegner, J. and Westerfield, M. (1999). Anterior movement of
ventral diencephalic precursors separates the primordial eye field in the neural plate
and requires cyclops. Development 126, 5533–46.
Vaughan, J., Donaldson, C., Bittencourt, J., Perrin, M., Lewis, K., Sutton,
S., Chan, R., Turnbull, A., Lovejoy, D., Rivier, C., Rivier, J., Sawchenko, P.
and Vale, W. (1995). Urocortin, a mammalian neuropeptide related to fish urotensin
i and to corticotropin-releasing factor. Nature 378, 287–292.
Veazey, R. B., Amaral, D. G. and Cowan, W. M. (1982). The morphology
and connections of the posterior hypothalamus in the cynomolgus monkey (macaca
fascicularis). i. cytoarchitectonic organization. J. Comp. Neurol. 207, 114–34.
Visel, A., Minovitsky, S., Dubchak, I. and Pennacchio, L. (2007). Vista enhancer
browser-a database of tissue-specific human enhancers. 35, D88–92.
Vosko, A. M., Schroeder, A., Loh, D. H. and Colwell, C. S. (2007). Vasoactive
intestinal peptide and the mammalian circadian system. Gen. Comp. Endocrinol. 152,
165–75.
Wang, W., Grimmer, J. F., Van De Water, T. R. and Lufkin, T. (2004).
Hmx2 and hmx3 homeobox genes direct development of the murine inner ear and
hypothalamus and can be functionally replaced by drosophila hmx. Dev. Cell 7,
439–53.
Wang, W. and Lufkin, T. (2000). The murine otp homeobox gene plays an essential
role in the specification of neuronal cell lineages in the developing hypothalamus. Dev.
Biol. 227, 432–49.
128 Bibliography
Wang, X., Chu, L. T., He, J., Emelyanov, A., Korzh, V. and Gong, Z. (2001).
A novel zebrafish bhlh gene, neurogenin3, is expressed in the hypothalamus. Gene
275, 47–55.
Wehr, R., Mansouri, A., de Maeyer, T. and Gruss, P. (1997). Fkh5-deficient
mice show dysgenesis in the caudal midbrain and hypothalamic mammillary body.
Development 124, 4447–4456.
Westerfield, M. (2000). The zebrafish book. A guide for the laboratory use of zebrafish
(Danio rerio).. Eugene: Univ. of Oregon Press, 4 edition.
Wilson, S. W. and Houart, C. (2004). Early steps in the development of the forebrain.
Dev. Cell 6, 167–81.
Winter, S. S., Wagner, S. J., McMillin, J. L. and Wallace, D. G. (2011).
Mammillothalamic tract lesions disrupt dead reckoning in the rat. Eur. J. Neurosci.
33, 371–381.
Xi, D., Gandhi, N., Lai, M. and Kublaoui, B. M. (2012). Ablation of sim1 neurons
causes obesity through hyperphagia and reduced energy expenditure. PLoS One 7,
e36453.
Yulis, C. R., Lederis, K., Wong, K. L. and Fisher, A. W. (1986). Localization
of urotensin i- and corticotropin-releasing factor-like immunoreactivity in the central
nervous system of catostomus commersoni. Peptides 7, 79–86.
Zhao, T., Szabo, N., Ma, J., Luo, L., Zhou, X. and Alvarez-Bolado, G. (2008).
Genetic mapping of foxb1-cell lineage shows migration from caudal diencephalon to
telencephalon and lateral hypothalamus. Eur. J. Neurosci. 28, 1941–55.
Acknowledgements
First of all I would like to thank Professor Dr. Detlev Arendt for his willingness to
review my dissertation, our paper and for all his helpful comments, which exceedingly
contributed to the success of this work.
I am truly indebted and thankful to Dr. Soojin Ryu to accept me as her first
PhD student in her research group “Developmental Genetics of Nervous System” at the
Max-Planck-Institute for Medical Research. I am especially thankful for her supervision
of my work, for her faith in me to always improve myself and for her willingness and
availability to always discuss my research when necessary.
I am sincerely and heartily grateful to the present and the past members of the
Ryu lab spending this important time with me. Particularly indebted, I am to the
“Mädels” Chen-Min Yeh, Dr. Colette Maurer and Antonia Groneberg who were always
willing to discuss and to support me in all my problems no matter if personal or scientific.
I owe sincere and earnest thankfulness to Regina Singer, who took care of all
kind of consumables (from buffers, tips and fish, to cake and strawberries) and for doing
so many boring midis and washing steps for me that I can not count them anymore.
I want to thank Klaus Schott for making me smile, for keeping our fish facility running
and for fixing all these broken things in the lab.
I also want to thank Gabi Shoeman, Angelika Schoell and Christiane Brandel for
excellent fish care and for the preparation of the media and the selective plates.
The time of being a PhD representative together with Regina Schweizer not only
gave me several lessons to learn for my entire life but also gave me a wonderful
friendship hopefully lasting as long.
I am deeply grateful to my family and yes my fish are well.
This dissertation would not have been possible without my new family, my best
friend, my partner, my bridge over troubled water, my personal IT: my husband Markus.
There are no words to express how grateful I am.

Eidesstattliche Erklärung
Erklärungen gemäß § 8 (3) der Promotionsordnung der Universität Heidelberg für die
Naturwissenschaftlich-Mathematische Gesamtfakultät vom 22. September 2006 erkläre
ich hiermit, dass ich die vorgelegte Dissertation selbst verfasst und mich dabei keiner
anderen als der von mir ausdrücklich bezeichneten Quellen und Hilfen bedient habe.
Ferner erkläre ich, dass ich an keiner anderen Stelle ein Prüfungsverfahren beantragt
bzw. die Dissertation in dieser oder anderer Form bereits anderweitig als Prüfungsarbeit
verwendet oder einer anderen Fakultät als Dissertation vorgelegt habe.
Andrea Wolf
Heidelberg, den 13.08.2012
